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Studies into sonoporation and electroporation have grown rapidly in biotechnology and 
medicine in recent years. This research presents a microfluidic system for cell 
transfection using sonoporation and electroporation. This research has studied, 
designed, developed and tested the sonoporation system and electroporation system 
with certain biological cells. Ultrasonic standing waves, previously used for ultrasonic 
particle manipulation, have been used in the development of the sonoporation aspects 
of the system. MATLAB has also been used to analyse the required acoustic conditions 
within the chamber. Furthermore, the electroporation system makes use of a relatively 
simple circuit consisting of a control module, a pulse generation circuit and a high 
voltage switch using a power MOSFET. The electroporation system has been designed, 
developed and tested. The system was evaluated with HeLa cells, THP-1 cells and 
plasmid DNA (pEGFP-N1) to evaluate transfection rates under a variety of 
sonoporation conditions. This study also determined cell viability under a range of 
sonoporation and electroporation conditions.   
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Chapter 1   
Introduction 
1.1 Overview of Research 
The subject of this thesis is the use of sonoporation and electroporation for cell 
transfection. Recent developments in sonoporation and electroporation have enabled a 
broad range of biological applications. For example, the use of sonoporation and 
electroporation systems in biotechnology and medicine has lead to new methods of 
cancer treatment, gene therapy and drug delivery. Sonoporation is an ultrasonic 
technique that enables molecules to penetrate the cell by opening pores in the cell 
membrane. (The term ultrasound applies to sound waves at a high frequency above 
limits of human audibility (frequency approximately 20 KHz)). This has been used to 
transfer DNA (Deoxyribonucleic acid) into cells which is known as transfection. 
Electroporation is an alternative technique when an electric field applied across a cell 
opens pores in the cell membrane thereby enabling the delivery of foreign materials 
into the cell.  
However, not all cell lines respond well to poration, with some being unsuitable for 
sonoporation, others being unsuited to electroporation, and some being unsuited to 
either. The vision that inspires this research is to investigate in more detail the 
conditions under which cells respond to the different techniques with a view to 
informing the design of a combined system using both sonoporation and 
electroporation to increase the range of cells for which poration can be achieved. A 
combination of both techniques may well give a lower total stress to cells, improving Chapter 1 Introduction 
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their viability after poration. This research is also informed by recent work in ultrasonic 
standing wave particle manipulation, and the possible combination of ultrasonic 
particle manipulation, controlled sonoporation and electroporation offers a novel 
contribution to cell manipulation. 
To progress towards this aim, this research investigates the development of an 
ultrasonic microfluidic chamber for biological applications that combines sonoporation 
and ultrasonic cell manipulation. Further, the process of electroporation is investigated 
with the development of an electroporation system for the process of porating cells. 
The final vision of this system will be the design and implementation of a combined 
sonoporation and electroporation system, allowing different cell lines, such as single 
cell lines, stem cells [1], neuronal cells[2] to be investigated. For example, in the past 
few years Pape.J et.al.[3] have investigated the comparison of sonoporation and 
electroporation in cell transfection. They have found that electroporation had a better 
transfection efficiency and cell viability for nonprimary cells (Jurkat lymphocytes) and 
sonoporation was superior in terms of transfection and cell viability for primary cell 
(human peripheral blood mononuclear cells).  
Ultrasonic cell manipulation is a method to concentrate cells in a standing wave field 
which tends to move these cells to position of pressure minimum at a node [4]. This 
research adds novelty because to date there has been no research on the combination of 
sonoporation and cell manipulation combined in the same device. The combination of 
sonoporation with ultrasonic cell manipulation is a promising approach for the 
following reason. Ultrasonic cell manipulation enables the control of both the cell and 
the target material DNA location within the chamber and can place them in close 
proximity. This will potentially increase the chance of transfection. The efficiency of 
transfection is also dependent on various operating conditions such as amplitude, 
exposure time and frequency as this influences the acoustic forces that the cells 
experience. The cells and DNA will accumulate in the standing wave pressure node 
where they experience constant controllable and repeatable fluid forces.  
To design a resonant sonoporation chamber, this research has built upon the analytical 
models developed during previous research to design a microfluidic ultrasonic 
separator. These models give a prediction of energy density and operating frequency 
for different dimensions of the chamber. The objective of the design exercise is to Chapter 1 Introduction 
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achieve a chamber that is able to simultaneously achieve sonoporation and control the 
position of cells. 
Another strand of this research is also to evaluate electroporation and compare the two 
techniques. This research investigated the electroporation parameters such as field 
strength and pulse length and the results gained were compared with those from the 
sonoporation. This study led to an understanding of the electroporation system and it 
was able to give an idea to design and develop electroporation in the same device as the 
sonoporation chamber. 
The investigation into the chamber performance was determined by observing the 
transfection rate and cell viability with HeLa cells and THP-1 and pEGFP-N1 (plasmid 
DNA). 
In the event, time constraints meant it was not possible to combine both the 
electroporation and the sonoporation, but the sonoporation technique proved so 
promising that this was investigated in more detail. However, the concept of the 
combination of electroporation and sonoporation is still valid and ways to implement 
this are detailed in the section on future work. 
 
1.2 Report and accepted papers 
Rodamporn S., ‘Microfluidic system for biological applications by using sonoporation’, 
MPhil/PhD 9 Month Report, University of Southampton, 2006  
Rodamporn S., ‘Microfluidic systems for cells poration using sonoporation and 
electroporation’, a mini thesis for transfer from MPhil to PhD, University of 
Southampton, 2008 
Rodamporn, S, Beeby, S.P, Harris, N.R., Brown, A.D, Hill, M and Chad, J.E, 
‘Microfluidic system for cells transfection using sonoporation and ultrasonic particle 
manipulation’,  International Conference on Cellular & Molecular Bioengineering 
(ICCMB), 10-12 December 2007, Singapore  
Rodamporn, S, Beeby, S.P, Harris, N.R.
  , Brown, A.D and Chad, J.E,  Design and 
Construction of a Programmable Electroporation system for Biological application, The Chapter 1 Introduction 
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1
st Symposium on Thai Biomedical Engineering (ThaiBME2007), 18-19 December 
2007,Thailand  
1.3  Document Structure 
The structure of this thesis reflects the flow of information identified in overview of the 
research described in Chapter 1.  
An overview of the cell and transfection methods is presented in Chapter 2 in order to 
introduce cell structure, sonoporation, electroporation and the parameters that affect 
their performance. 
Chapter 3 presents the design of the sonoporation system. This describes a general 
overview of the numerical analysis for an ultrasonic separator. The analysis is then 
applied and the resulting sonoporation chamber design, chamber fabrication and its 
acoustic impedance is also presented in this chapter. 
Chapter 4 describes the design of the electroporation system. This presents a general 
overview of the parameters affecting electroporation. A circuit designed to enable 
investigation of the electroporation parameters is also described in this chapter.  
Chapter 5 describes initial experiments investigating cell poration and cell viability 
using sonoporation and electroporation systems with HeLa cells and propidium Iodide.  
Chapter 6 describes the determination of the transfection efficiency under a range of 
fixed frequencies and a swept frequency approach, using HeLa cells with pEGPF-N1. 
Chapter 7 presents and evaluates transfection efficiency and cell viability using the 
sonoporation chamber under a range of voltage and exposure times using HeLa cells 
with pEGFP-N1.  
Chapter 8 describes an investigation of the transfection efficiency of THP-1 cells with 
pEGFP-N1 using different sonoporation conditions. 
Finally, chapter 9 details the conclusion and future work.  Chapter 1 Introduction 
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1.4  Declaration 
This thesis describes the research undertaken by the author while working within a 
collaborative research environment. This report documents the original work of the 
author except in the literature reviews and relevant discussion in the literature. 
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Chapter 2   
Literature Review  
2.1  Introduction 
This chapter presents the background and literature review of the state of the art in 
sonoporation, electroporation and ultrasonic particle manipulation. Additionally, 
biological cells are introduced in this chapter providing more detail of the type of cells 
used in this research.  
2.2  Microfluidics 
Research into microfluidics started in the 1990s and covers devices concerned with the 
manipulation of minute quantities of fluid, typically processing microliters to picoliters 
[5]. Typical microfluidic devices include flow sensors, integrated micro-pumps, micro-
valves and micro-mixers [6]. More recently, microfluidic systems have been developed 
for applications including biological cell suspension handling and measurement, DNA 
processing and combination chemistry. One attractive use of microfluidics in biological 
applications is the transfection of DNA. 
 Chapter 2 Literature Review 
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2.3  Cells 
Cells are the structural and functional unit of all living organisms and are called the 
“building blocks of life” [7]. They are divided into two types. Bacteria cells are 
prokaryotic; all other cells are eukaryotic of which there are four kinds: animal, plant, 
fungi and protista. Prokaryotic and eukaryotic are compared in table 2-1. Prokaryotic 
cells (shown in figure 2-1) are smaller than eukaryotic cells (shown in figure 2-2). 
Prokaryotic cells have no nucleus and a typical cell size of less than 5µm. Typical cell 
mass is around 1 nanogram. This research used HeLa and THP-1 cells which are 
described in detail in section 2.3.2 and 2.3.3. 
 
 
1µm  
Figure 2-1:  Prokaryotic cell [8]  
The components of prokaryotic cells all are as follows. A cell wall is a fairly rigid layer 
surrounding a cell. The function of the cell wall is to provide physical and structural 
support, protection and to act as a filtering mechanism. Ribosomes are assembling 
protein and RNA. The nucleus is a chamber specialized in DNA functions. It is 
enclosed by a double layer membrane called the nuclear envelope. Plasmids are small 
circles of DNA, used to exchange DNA between bacterial cells. The cell membrane 
separates the contents of the cell from the outside environment and controls the entry Chapter 2 Literature Review 
  8
and exit of materials. This is discussed in more detail in section 2.3.1. Finally the 
flagellum is a rigid  rotating helical-shaped tail and is used  for propulsion [7]. 
 
 
Figure 2-2: Eukaryotic cell [7] 
Eukaryotic cells typically contain the follow additional components. Lysosomes are 
used to break down unwanted chemicals, toxins, and organelles. The Golgi body is 
used to transport protein from the Rough Endoplasmic Reticulum (RER) to the cell 
membrane for export. The cell membrane is a very flexible and thin layer surrounding 
the cells. The cell wall is a tough and thick layer outside the cell membrane. The cell 
wall is used to give a physical rigidity and allows chemical and cellular material to pass 
through the cells. These cells are found in plants, animals and fungi. The Undulipodium 
is a flexible tail whose function is to provide motility.  
 
 
 
 Chapter 2 Literature Review 
  9
Table 2-1: Summary of the prokaryotic and eukaryotic cells type [7] 
PROKARYOTIC CELLS  EUKARYOTIC CELLS 
small cells (< 5 μm)  larger cells (> 10 μm) 
always unicellular  often multicellular 
No nucleus or any membrane-
bound organelles 
always have nucleus and other 
membrane-bound organelles 
DNA is circular, without proteins  DNA is linear and associated with 
proteins to form chromatin 
ribosome are small (70S)  ribosome are large (80S) 
No cytoskeleton  always has a cytoskeleton 
Cell division is by binary fission  cell division is by mitosis or 
meiosis 
reproduction is always asexual  reproduction is asexual or sexual 
 
2.3.1  Cell membrane 
The cell membrane or plasma membrane is composed of a lipid bilayer. The cell 
membrane contains the cell cytoplasm and membranes are found on all living cells. The 
cell membrane is shown in figure 2-3. The function of the cell membrane is to be 
selectively permeable to particular chemicals that can pass in and out of cells. It is also 
an interlocking surface that binds cells together. The cell membrane is only about 10 
nm thick. There are two part molecules called phospholipids which compose the layers. 
Hydrophilic phosphate heads facing outwards, and their non-polar, hydrophobic fatty 
acid tails facing each other in the middle of the bilayer. The lipids (fatty acids) are a 
hydrophobic layer that acts as a barrier to all but the smallest molecules, effectively 
isolating the two sides of the membrane. 
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Figure 2-3: Cell membrane [7] 
2.3.2  Human cervical cancer cells (HeLa cells) 
Human cervical cancer cells (HeLa cells) have been cultured for scientific use since 
they were first taken from the tumor of a woman suffering from cervical cancer in the 
1950s [9]. Many researchers use HeLa cells in many areas of gene therapy and drug 
delivery due to the HeLa cells were rapidly cultivated and propagated in culture cell as 
well as cell survival situation [10-14]. This cell has been used in many research areas. 
For example, HeLa cell lines have been used in research on many subjects such as 
cancer, proteins, synthesis, radiation, and genetic control mechanisms. This research 
has used the HeLa cell for evaluating cell transfection using sonoporation and 
electroporation systems. HeLa cells are shown in figure 2-4. Chapter 2 Literature Review 
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Figure 2-4:  HeLa cell culture [9] 
2.3.3   Human monocytic leukemia cell line (THP-1) 
A human leukemic cell line THP-1 was derived from the blood of a 1 year old  boy  
with acute monocytic leukaemia [15]. THP-1 cells have been used to study a broad 
range of gene therapy[16], drug delivery, and cell separation[17-19] mechanisms. The 
THP-1 cell is able to grow continually in culture and THP-1 cells can be used to 
differentiate from the monocytic pathway. Therefore, it is very useful for studying gene 
therapy. This research has used THP-1 to investigate transfection efficiency and cell 
viability in a range of sonoporation conditions. The THP-1 is shown in figure 2-5. Chapter 2 Literature Review 
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Figure 2-5: THP-1 [20] 
2.3.4  Cell viability 
Cell viability measurements are used to determine the number of living or dead cells in 
a total sample [21]. The test of cell viability usually involves looking at a sample cell 
population and staining the cells (e.g. with trypan blue or propidium iodide) to show 
which are living and which are dead. When a sample is stained with dyes or treated 
with chemicals, it is then subject to microscopic examination to evaluate cell viability 
(see below). The usual criteria are whether the cells will exclude a dye such as 
propidium iodide. If the membranes have resealed successfully (i.e. the cell is still 
viable), then propidium iodide should not get into the nucleus. An alternative is trypan 
blue, which is easier to image as it does not require a fluorescence set-up. A second 
approach to determine viability is whether the cells can continue to grow and divide. If 
they can be put back into culture and grow then we can be sure they have resealed and 
recovered. Chapter 2 Literature Review 
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2.3.5  Propidium iodide  
Propidium iodide (PI) is a fluorescent molecule [22]. Propidium iodide is suitable for 
fluorescence microscopy and flow cytometry. PI is typically used for identifying dead 
cells in a population. It is usually used to counter stain in multicolour fluorescent 
methods. PI can arrive in the nucleus by passing through disordered areas of a dead 
cell’s membrane, and inserting itself into the DNA of the cell to emit red fluorescence 
as shown in figure 2-6 [23].  The absorption and fluorescence emission of propidium 
iodide is shown in figure 2-7. This research has also used this dye for investigating 
poration rate as shown in chapter 5. 
 
Figure 2-6 : PI stains dead cell [23] 
 
 
Figure 2-7: Absorption and fluorescence emission profiles of propidium iodide [22]. 
Fluorescence emission AbsorbanceChapter 2 Literature Review 
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The maximum absorbance for PI is 535 nm and the fluorescence emission maximum is 
617 nm as show in figure 2-7.  
2.3.6  Trypan blue 
Trypan blue is a vital dye which is typically used to assess cell viability [24]. The 
reactive trypan blue interacts with dead cells and passes through the cell membrane 
which is damaged. It is used to counter stain cells in microscope. All the cells which 
exclude the trypan blue dye are viable. This research has also used this trypan blue dye 
for assessment of cell viability as shown in chapters 5, 6, 7 and 8. 
2.4  Transfection method  
Transfection is the process of opening pores in the cell membrane which allows 
physical transfer of foreign DNA into a biological cell as shown in figure 2-8. At 
present, transfection is usually used for studying gene function, the modulation of gene 
expression and biochemical mapping [25, 26]. There are various methods of achieving 
transfection; for example, viral transfection, magnet assisted transfection, 
electroporation and sonoporation. Sonoporation and electroporation are the topic of this 
research and are discussed in more detail as following sections. 
 
Figure 2-8: Transfection method by sonoporation Chapter 2 Literature Review 
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2.4.1  Sonoporation 
Sonoporation is the use of ultrasound to produce transient pores in a cell membrane that 
allow transfection to occur. The mechanism that produces the pores in the cell 
membrane is still little understood. One theory is that the ultrasonic pressure waves 
induce cavitation bubbles near the cells that collapse releasing energy and creating 
transient pores in the cell membrane [27] (see section 2.4.2). Another aspect of 
ultrasound that can achieve sonoporation without cavitation is the ultrasonic pressure 
wave form itself [28]. Finally, sonoporation may also be caused by ultrasonic streaming 
which is a liquid flow in direction of sound field [29, 30]. When the ultrasonic pressure 
wave and ultrasonic streaming acts on the cell, its size will change (e.g. expand) [28]. 
The cell membrane will stretch and become thinner and pores will open and expand. 
The dynamic characteristics of the sonoporation process can determine the formation, 
duration, and resealing of the pores in the cell membrane. In particular, the 
sonoporation process is controlled by the following parameters.  
i.  Ultrasound power output and pressure wave magnitude 
ii.  Frequency  
iii.  Duty cycle of the ultrasonic wave 
iv.  Application time  
These parameters should be controlled to enable sonoporation whilst ensuring post 
ultrasound cell survival. When sonoporation is compared with other transfection 
methods in terms of cell viability, it causes little irreversible cell damage in most cell 
lines [31], except nonprimary cells (Jurkat lymphocytes) [3]. Sonoporation typically 
utilises ultrasonic frequencies from 1 MHz to 3 MHz. Normally, the ultrasound is 
applied across or in a fluidic chamber irrespective of the design or frequency behaviour 
of the chamber.  Pressures can vary across the fluid depending upon conditions making 
repeatability difficult to achieve. This research will investigate how the design of the 
chamber and the frequency of operation can be controlled to improve sonoporation 
performance and repeatability. This is described further in section 2.6. 
 Chapter 2 Literature Review 
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2.4.2  Acoustic cavitation 
Cavitation describes a phenomenon of a rapid formation and collapse of bubble or 
voids in a fluid and is shown in figures 2-9 and 2-10. Figure 2-9 shows an ultrasonic 
transducer and glass beaker with water. Cavitation occurs when the transducer is 
generating sufficient amplitude of ultrasound. A range of ultrasound which can produce 
cavitation is within a wide range of frequencies (e.g. 0.02 to 3 MHz) [32]. Figure 2-10 
shows the formation of acoustic cavitation bubbles in more detail. The ultrasound 
causes variations of pressure within the fluid. These bubbles will grow over the period 
of a few cycles to an unstable size for the frequency applied. Bubble formation is 
affected by the acoustic pressure within the bubble when the size of bubble increases 
but the pressure inside the bubble will decrease [33]. If the bubbles reach a maximum 
radius and unstable size, the bubbles will then collapse in the following compression 
cycle. Cavitation creates small shock waves which can cause cell death but will 
potentially increase cell permeability if controlled [34].  
 
      
 
 
Figure 2-9: Acoustic cavitation bubbles 
 
Acoustic Cavitation Bubbles 
Microbubbles Collapse 
Ultrasonic pressure Wave 
Ultrasonic Transducer
Glass Beaker with WaterChapter 2 Literature Review 
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Figure 2-10: Acoustic cavitation 
2.4.3  The contrast agent microbubble  
Microbubbles are encapsulated gas bubbles that can be used as drug or gene carries, to 
insert gene or plasmid through the cell membrane. The shell of the microbubbles is 
composed of proteins, lipids or polymers. Microbubbles are of a much lower density 
than water and create an acoustic impedance mismatch between biological tissues and 
fluids. Therefore, the microbubbles are efficient reflectors of ultrasound and are useful 
as ultrasound contrast agents. Microbubbles expand and contract in response to the 
pressure changes in an ultrasound wave. In addition microbubbles also have low 
threshold of energy for cavitation. Figure 2-11 shows the effect of microbubble 
cavitation on microvascular permeability, enabling nansopheres and drugs to be 
delivered into the interstitium. This contrast agent approach has been used to enable 
cavitation and achieve successful sonoporation and high cell viability as shown in the 
section 2.5. This is known as enhanced sonoporation. Chapter 2 Literature Review 
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Figure 2-11: The effect of cavitation on microvascular microbubble [10] 
2.5  Previous sonoporation research  
Studies into the use of sonoporation have grown rapidly in recent years. The use of 
sonoporation systems in biotechnology and medicine has lead to new methods of gene 
therapy, drug delivery, cancer treatment. The most commonly used frequency of 
ultrasound in sonoporation is 1 to 3 MHz because this is the most suitable for use with 
microbubbles. Related developments have been shown that can be applied to transfect 
cells both in vitro and in vivo. This is first looked at for in vitro transfection and 
followed by a discussion of in vivo transfection. 
Miller et al [35] demonstrated plasmid DNA (pEGFP-N1) transfer using enhanced 
sonoporation in monolayer cells (Epidemoid cell A434) in vitro. Low power diagnostic 
ultrasound (1.5 MHz) was used to investigate gene transfer with the contrast agent 
Optison
®. The plasmid solution contained 2 mg per mL
-1 and the gas body size was 
between 2 and 4.5 µm in diameter. This experiment was performed using a pulse 
intensity of 1.5μsec at 1.5MHz and 0.6μsec at 3.3 MHz. To investigate the transfer of 
DNA, plasmid coding for green fluorescent protein (GFP) were added into the medium, 
GFP fluorescence was investigated using a flowcytometer after 2 days and a 
transfection rate of 3.7% (1.2% SD: standard deviation) was achieved using 2% optison 
combined with DNA concentrate 20µg/ml
-1 at 3.3 MHz and control condition was 
obtained 0.4% (0.7% SD). After treatment, cell viability was determined immediately 
using a staining solution (Live/Dead viability kit, Molecular Probes Inc). The Chapter 2 Literature Review 
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percentage of cell viability was 3.4% (1.7% SD) of cell survival under control 
conditions and 28.6% (6.3% SD) at an exposure of 2.3 MPa. This research 
demonstrated the use of low power ultrasonic diagnostic equipment to achieve 
sonoporation when combined with contrast agent. 
Miller et al [36] have also carried out a study on the plasmid DNA (pGL2) transfection 
by sonoporation of cultured mammalian cells (Chinese hamster ovary) in a rotating 
tube system. The effect on the cell membrane was observed using fluorescent dextrin 
uptake during exposure and dye exclusion after exposure. Their experiment used a 
fixed ultrasonic frequency of 2.25 MHz and a range of pressure amplitudes from 0.2 to 
0.8 MPa. The experiment was done in a polyethylene chamber contain 4.5 mL which 
was rotated at 60 rpm. A gas body based contrast agent (10% of Albunex(R)) was 
added to help initiate cavitation activity. The type of ultrasonic transducer used in this 
research was a thin film hydrophone (type y-34-3598 GFC). This study showed a 
significant plasmid transfection when a contrast agent and tube rotation were 
combined. In addition, significant cell lysis occurred at 0.2 MPa and increased quickly 
to about 0.4 MPa. Moreover, this study demonstrated Luciferase production was 
achieved for 0.2 MPa exposures and obtained 0.33 ng per 10
6 cells at 0.8 MPa. The 
Luciferase production shows significant improvement for cells exposed in medium 
supplemented with serum and better than cells exposed in serum –free medium. It was 
concluded that sonoporation using ultrasonic cavitation in a rotating tube was 
successful for plasmid transfection. However, this research did not describe results 
from a non-rotating chamber. 
Lai et al. [11] demonstrated ultrasound for gene delivery in mammalian systems. They 
qualitatively studied the effect of cavitation induced by 1 MHz pulsed ultrasound wave 
(pulse duration 1-10 cycles) and the contrast agent Levovist
® on the delivery of short 
DNA-FITC molecule into HeLa cells. A separate transducer sampling at 10 MHZ is 
used for detecting sonoporation. The microbubbles (between 1 and 3μm) have an 
average size of 1.7μm. The system experiments were performed using a cylindrical 
cavity 5 mm in a diameter and 2.5 cm deep made in agarose phantom (2% 
concentration) which is a gel acoustically similar to the human tissue and evaluated a 
range of acoustic pressures from 0.48 to 1.32 MPa and pulse durations of 1 to 10 
cycles). This research successfully showed evidence of combination gene delivery and Chapter 2 Literature Review 
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cavitation to increase both the sonoporation rate and cell viability. This study obtained 
sonoporation rates of ~28% and 62% cell viability was achieved. Figure 2-12 shows the 
set up for the cavitation experiment.  
 
Figure 2-12: Set up cavitation experiment  [11] 
 
Figure 2-13: Schematic of a resonant acoustic field [37] 
 
Figure 2-13 shows a schematic of a resonant acoustic field described by Yu-Hsing et al 
[37] which demonstrated that ultrasound induced cavitation can be used to enhance the 
efficiency of non-viral based gene therapy. They have investigated and harnessed an 
alternative approach using a resonant acoustic field (RAF) and ecotropic retroviruses. 
The application of a RAF was achieved using 1 MHz, 30 Vp-p, for exposure time of 0, 
5, 10, 15, 20 min. In this study, the NIH 3T3 culture medium was mixed with ecotropic Chapter 2 Literature Review 
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retroviruses. The experiment exposed cells and retroviruses in the RAF for 6 min in the 
presence of 8μg/mLof Polybrene. They found NIH 3T3 cell bands were formed at 
rapidly nodal planes and became visible after 5sec of ultrasound treatment. To 
determine viability, this research used a haemocytometer with the trypan blue exclusion 
method. In conclusion, it was found that the RAF can be worked in megahertz 
frequency with ecotropic retroviruses and improved an enhancement of retroviral 
transduction efficiency. A 2 fold increase in retroviral transduction rate was obtained 
when compared to non RAF exposure.  
Miller et al. [38] have also carried out a study on the sonoporation of epidermoid and 
phagocytic monolayer cells by diagnostic ultrasound activation of contrast agent gas 
bodies. This method can be applied to Epidermoid A431 (human carcinoma) and 
phagocytic RAW- 264.7 cells. Cells were grown as monolayers on 5 µm thick Mylar 
sheets. A diagnostic ultrasonic machine in spectral Doppler mode was performed for 
exposure at 3.5 MHz. Following sonoporation, cell lysis was studied for measurement 
of cell membrane damage. Four new findings were provided; the first is significant cell 
lysis was found to occur (~20% at 0.83 MPa) with 5% of Optison
®; the second, 
membrane damage was found for the phagocytic RAW cell line and the third, that the 
phagocytic cells retained gas bodies after rinsing and remained vulnerable to the effects 
at pressure amplitudes. Finally, thresholds were identified for the effects. Sonoporation 
and cell lysis from diagnostic ultrasonic activation of contrast agent gas bodies was 
detectable at pressure amplitudes more than an order of magnitude below the maximum 
pulse average intensities available from diagnostic ultrasonic equipment. This research 
indicated that the use of diagnostic ultrasound and contrast agent gas bodies achieved 
cell transfection with a low percentage of membrane damage (~20%). 
S. Tsunoda et al. [39] have developed sonoporation using microbubble BR14 to   
promote pDNA/siRNA transduction to adult murine heart. The sonoporator has an 
output intensity of 2.0w/cm
2 and the cells were exposed to ultrasound at 1MHZ for 60 
sec (50% duty cycle).This method was applied to genetically engineer in vivo an adult 
murine heart. This study has also indicated that sonoporation mediated pDNA uptake is 
strongly enhanced by the use of microbubbles (BR14). An ultrasound platform (Nemio 
30, Toshiba Medical) was used to perform echocardiography. Electropcardiographyic 
(limb lead II) used for monitoring M-mode images during the sonoporation and Chapter 2 Literature Review 
  22
evaluated the LV (left ventricular) contractility pre transfection and post transfection. 
Sonoporation was performed at 2.0w/50% a pulse duty ratio (PDR) which obtained the 
high percentage of transfection than 1.0 W/ 20% PDR (46 fold and 13 fold, 
respectively). In addition, this study demonstrated that this method can transfer 
synthetic siRNA duplexes into the heart in vivo. The ultrasound mediated with 
microbubble method was also applied to skeletal muscle of mice [40] and rat 
myocardium as well as in vivo [41].  
Danialou et al. studied plasmid mediated gene transfer to dystrophic muscles without 
collateral damage using ultrasound (1MHz, 1.5 w/cm2) [42]. They have shown that 
ultrasound used in combination with microbubble contrast agent (Definity) can increase 
cell membrane permeability to plasmid DNA (LacZ protein (22-fold)). Since 
ultrasound is a non painful tool in clinical medicine; and the results of their experiment 
showed no associated increase in muscle damage. It can be concluded that ultrasound 
provides a safe and effective method for transfer gene into dystrophic muscles. 
Gachagan et al demonstrated the use of the finite element method to design a high 
power ultrasonic transducer in a test chamber. A single 40 KHz transducer was used to 
generate acoustic cavitation [43]. This research evaluated the generated pressure fields 
as a function of frequency. The system consists of transducer and a rectangular test 
chamber, which was constructed from a 10 mm thickness of Perspex, internal height 24 
cm and width 27 mm, as shown in figure 2-14. The experimental results indicated the 
potential of the finite element design approach to assist the design engineer in 
understanding the influence of the different fluid media on the chamber’s ability to 
produce a strong cavitation field.  
 
Figure 2-14: Cross section of propose cavitation test cell [43] Chapter 2 Literature Review 
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Deng et al [44] have observed the formation of temporary pores in the cell membrane 
using a voltage clamp technique and ultrasound contrast agent as shown in figure 2-15. 
This experiment would aid in the understanding of the mechanism and the process of 
cell sonoporation. In this study, researchers have explored the dynamics of 
sonoporation using the voltage clamp technique to measure in real-time the 
transmembrane current during applied ultrasound. This can identify the formation and 
reseal ability of pores in the cell membrane. In this experiment, a circular planar 
piezoelectric (0.96 MHz) had a diameter 5.1 cm which was used to investigate 
formation of temporary pores in the cell membrane. In addition, the cylindrical 
chamber had a 1.5 cm radius and 0.3 cm depth and had an acoustic thin plastic film 
attached at the bottom. They have applied this method for real time monitoring of 
sonoporation of cells. A voltage clamp technique was used to measure transmembrane 
current of animal (Xenopus oocytes (~0.8 mm diameter) cells. Transmembrane current 
amplitude changes reflect directly in the change in cell membrane conductance and can 
be indicative of the formation and resealing of pores in the cell membrane. In this 
study, Ca
2+ also entered into the cell during sonoporation in order to induce resealing of 
cell membrane. They have discovered that when ultrasound increased the 
transmembrane current then the reduced membrane resistance was due to pore 
formation.  
 
Figure 2-15: The experimental setup for monitoring and characterization of 
sonoporation of the plasma membrane of Xenopus Oocyte [44] Chapter 2 Literature Review 
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Fischer et al. performed further work on developing ultrasound mediated gene transfer 
into neural cells [2]. They have observed that sonoporation can be used to transfer 
plasmid DNA into different types of primary neuronal cells such as chick retina, 
forebrain, optic tectum, rat cerebellum and mouse hippocampus. Sonoporation is an 
effective means of gene transfer for primary cultures of neuronal cells. They have 
found that sonoporation mediated gene transfer did not disturb basic neuronal 
functions; for example, neurite outgrowth and long term survival. 
Karshafian et al [45] investigated experimental sonoporation by ultrasound-activated 
microbubble contrast agent and in particular the effect of acoustic exposure parameters 
on cell membrane permeability and cell viability. The schematic diagram of the 
ultrasound exposure apparatus is shown in figure 2-16. This research investigated and 
evaluated the effect of sonoporation of cells in suspension (KHT-C) using perflutren 
microbubbles. They have found that ultrasound caused either reversiable cell 
membrane disruption, which in turn allowed cell membrane-impermeable molecules to 
pass, or it caused irreversible cell membrane damage resulting in cell death. In addition, 
cell permeability increased while cell viability decreased depending upon increasing 
peak negative pressure, pulse repetition frequency, pulse duration and insonation time 
and with decreasing pulse centre frequency.  32 ±4% cell permeability and 96 ±1% 
viability were achieved at 570 KPa peak negative pressure, 8 µs pulse duration, 3 KHz 
pulse repetition frequency, 500 KHz centre frequency and 12 sec in sonation time with 
microbubbles at 3.3% volume concentration. 
 
Figure 2-16: A schematic diagram of the ultrasound exposure apparatus[45] 
Later Ward et al employed 2 MHz continuous ultrasound with a spatial peak amplitude 
of 0.2 MPa. They studied ultrasound induced cell lysis and sonoporation enhancement Chapter 2 Literature Review 
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with contrast agent (Optison
TM and Albunex
®)[46]. HeLa S3 (2x10
5/mL) was used in 
this study. This research carried out an experimental investigation of the relationship 
between the enhancement of bioeffects and the duty cycle of tone burst ultrasounds. 
Both contrast agents appeared to indicate a significant role causing the bioeffects and 
improved sonoporation efficiency. The enhancement of cell destruction by ultrasound 
showed that Optison
TM was much more effective than Albunex
® for similar bubble and 
ultrasound conditions. The duty cycles of 10% and 15% had no significant effect on the 
enhancement of the process. 15% duty cycle was significantly higher than 10% duty 
cycle in causing the cell lysis during an exposure time of 5 to 10 min. This study 
confirms that microbubbles do have an influence on sonoporation performance.  
2.6  Ultrasonic particle manipulation 
Ultrasonic particle manipulation relies upon acoustic standing waves to concentrate 
particles at nodal and anti-nodal plans within a fluid as described by Kundt and 
Lehmann in 1874 [47]. This can be used to separate particles from a fluid stream i.e. act 
as a filter. The first patent on ultrasonic separation was in Germany in 1936 which 
concerns separating a clarified liquid from a particle suspension using kilohertz 
frequency ultrasonic standing waves. More recently, [48, 49] ultrasonic standing waves 
have been used to manipulate small particles (5x10
6cell per ml
-1) in an acoustic field as 
shown in figure 2-17 and theoretical modeling of ultrasonic separators has been 
described. The resonator layer model was used to determine the thickness of each layer 
of the resonator [50-52]. For example, Hill et al. have described a design of a 
multilayer resonator suitable for use as a microfluidic filter. They have presented the 
model of an ultrasonic separation device to predict the acoustic pressure field in the 
separation chamber within the device [53-55].  
 Chapter 2 Literature Review 
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Figure 2-17: The design of a layered resonator [48, 49]  
The analytical models used in the design of the ultrasonic separator model can also be 
used to determine the dimensions of a sonoporation chamber. The analytical model 
provides the energy density and frequency response of the chamber. Furthermore, the 
dimensions of the chamber will be chosen to allow us to both use ultrasonic 
manipulation and control the position of the cells in the chamber and simultaneously 
achieved sonoporation. This will enable the chamber to combine ultrasonic 
manipulation and sonoporation. It is possible this combination will increase 
transfection rates and enable greater control over the sonoporation process. Ultrasonic 
cell manipulation simultaneously achieves the control of cell position and the target 
material plasmid DNA location within the chamber and can place them in close 
proximately. This could possibly raise the chance of transfection. 
Kuznetsova, L.A., et al. have reported that cavitation microbubbles collect at the node 
plane in a liquid half wave resonant of chamber [56]. They explored the potential of a 
custom designed, single half wavelength (λ/2) ultrasound standing wave system to 
encourage cell-bubble interaction. The paper defined the conditions for microbubble 
excitation in a single half wavelength (λ/2) ultrasound standing wave and this was used 
to study the behaviour of human erythrocytes and 1µm diameter fluorescent latex beads 
in the presence of Optison
® contrast agent. The resonance frequency was 1.56 MHz and 
acoustic pressure 0.98 MPa in the chamber. A numerical simulation was used to predict 
behaviour of a bubble of sub resonance as its size moves toward and translates about 
the pressure nodal plane. The paper reports the detection by microscopy and evolution Chapter 2 Literature Review 
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of microbubbles in the pressure node plane. Moreover, this paper contributes to the 
meaning of the physical environment in which sonoporation of the cell membrane 
happened in standing wave fields. Microphone and spectrum analyzers were used to 
monitor acoustic emissions. This study demonstrated the numerical model can predict 
the movement of microbubbles at a pressure node plan. Moreover, the experimental 
observation showed that the particle and cell circulation was induced by the movement 
or translation motion of microbubbles (Optison
®) at the pressure node plane. Finally, 
this study also showed the microbubbles in the node plane combined with the streaming 
pattern to improve mechanisms of cell membrane poration. 
Khanna et al. [57] have employed a 1.5 MHz ultrasound standing wave with contrast 
agent and human erythrocytes. The minichamber was designed to produce a high Q 
resonant system using the fundamental thickness resonance frequency of a 5 mm 
diameter PZ26 piezoceramic mounted on the cylindrical chamber. The acoustic 
minichamber was exposed to a continuous ultrasonic wave at 1.56 MHz and the 
pressure was varied between 0.98 MPa and 1.96 MPa and for different times from 1 to 
10 min. In addition, all experimental blood cells postsonication were examined and 
recorded by video microscopy at speed up to 500frames/sec. This paper investigated a 
single half-wavelength standing wave system to control cell and bubble position 
together with bubble activity in the chamber. The contrast agent and cells were 
controlled and moved quickly to form an aggregate in the standing wave. It confirmed 
that cells and contrast agent at the pressure node of 0.98 MPa were exposed together. 
The increasing complexity of cavitation emissions detected from the system on 
increasing pressure amplitude correlate with cell shape changes and protein release. 
The experimental results in the absence of contrast agent, cells moved rapidly to form 
in the standing wave pressure node plane. 
Currently, Kuznetsova, L.A., et al. [30] continued the discussed from Khanna and   
studied a sub micron particle captured at an immuno sensor surface in an ultrasonic 
standing wave. An ultrasonic standing wave resonator was studied with dimension of 
one half wavelength (λ/2), to capture 200 nm biotinylated latex beads in suspensions of 
concentrations from 10
7 to 2.5 x 10
8 particles/ml on an immuno-coated surface of the 
acoustic reflector. A 12 mm diameter and 1.33 mm thickness transducer disk was used 
in this research. The transducer’s nominal thickness resonance frequency is 1.5 MHz. Chapter 2 Literature Review 
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The transducer’s back electrode was etched to produce an active radiation area of 8 mm 
in diameter. The screw–top and elastic O-ring gasket of the chamber is able to adjust 
depth from 0.5 mm (λ/2) to 0.25 mm (λ/4). A 25 mm diameter quartz glass is used as a 
reflector. The channel depth measured in air by focusing the microscope on the inner 
surface of the reflector and then on the base of the chamber is 250±10µm. The 
experiment showed that particle cells of 1 μm were primarily affected by the direct 
radiation force and 0.5 µm particles were affected both by the radiation force and 
acoustic streaming.  
In recent times, Pan, H., et al. [58] have been investigating and studying sonoporation 
dynamics and the affects of ultrasound duty cycle, in order to select optimal parameters 
and conditions and to minimize unwanted side effects such as apoptosis and cell lysis. 
This study observed decreased membrane resistance due to pore formation induced by 
ultrasonic applications. Results showed a controlled duty cycle is able to improve the 
process of membrane poration and cell survival rates declined at duty cycles (5%, 10% 
and 15%). This method might predict the sonoporation dynamics and optimal 
parameters for biological cells. 
As explained above, many different previous works have been used in frequencies of 
ultrasonic particle manipulation and sonoporation and have been investigated 
experimentally with contrast agents. In order to design a basic sonoporation chamber, it 
is necessary also to know suitable the frequency range and duty cycle suitable for use 
with biological cells. The acoustic pressure in the sonoporation chamber should be high 
enough to manipulate small particles within the acoustic field. 
Kinoshita et al. [59] have investigated key factors that affect sonoporation efficiency in  
the in vitro setting. This study showed how different experimental setting affected 
transfection efficiency and cell viability. They have compared result of sonoporation 
with standing waves and without standing waves in term of transfection and cell 
viability. The transfection efficiency achieved about 30% at 4w/cm
2  and 21% at 
1.6w/cm
2 when this study investigated experiment setting with standing wave as shown 
in figure 2-18 whereas about 10% at 1.6w/cm
2 and about 7% at 4w/cm
2 of transfection 
efficiency was attained without standing wave condition. Chapter 2 Literature Review 
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Figure 2-18: Experimental setup for cell sonication using planer ultrasound [59] 
 
Moreover, the cell viability was obtained about 100% with conditions non standing 
wave after sonoporation of 5w/cm
2. In contrast, standing wave condition was given 
approximately 80% and about 60% at 1.6w/cm
2  and 4w/cm
2 respectively. More 
recently, Kinoshita et al. have also investigated key factors that affect sonoporation 
efficiency in vitro[60]. In this study, they investigated how different experimental 
settings would affect transfection efficiencies and cell viabilities. This research way 
evaluated based on two factors which included cell cultures and the conditions of the 
absence and the presence of standing wave.  The result again confirmed that the 
presence of a standing wave has a potential impact on sonoporation efficiency. This 
research was successful in achieving a transfection efficiency of about 35% with the Chapter 2 Literature Review 
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standing wave (4w/cm
3). The cell viability was approximately 60% of Rat C166 cells. 
However, in the absence of standing wave only achieved ~ 22% of transfection and  
about 10% cell viability.  
Finally, Pepe, J. et al [3] have studied sonoporation and electroporation to compare 
efficiency and cell viability. Primary and nonprimary cells were used in this research. 
The results showed that electroporation was superior to sonoporation in terms of 
viability (65.8±3.5% vs. 50.8±4.5%) and transfection efficiency (15.83±3.5% VS 
7.53±0.4%) for Jurkat lymphocytes (nonprimary cells). However, sonoporation was 
superior in terms of viability (64.8 ±1.51% VS 53.7±1.53%) and transfection efficiency 
(2.73±0.21% VS 0.43%±0.06%) for human peripheral blood mononuclear cells. 
Electroporation was achieved using a Gene Pulser® II with voltage of 250 V, and the 
sonoporation was performed using 2 MHz pulses of ultrasound exposure 
(ISPPA=80W/cm
2).  
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2.7  Applications of sonoporation in vitro and in vivo 
The following table summarise sonoporation conditions used in a range of studies and 
result of obtained.  
Table 2-2: Summary of application sonoporation in vitro  
In Vitro transfection  Condition used  Efficiency  Reference: 
3T3-MDEI cells 
 
 
 
1 MHz, 0.5- 
3w/cm
2,20% duty cycle 
probe under Meath well 
in water bath, 5-80 sec. 
15% transfection 
efficiency increase in 
a dose-dependent 
manner. 
Chen, Y.-C., et 
al [61] 
DU145  500 KHz,6% 
duty cycle, 1-60 J/cm 
Increase transfection 
by almost 100 fold in 
the absence of 
significant DNA 
damage. 
Zarnitsyn, V.G. 
& M.R. 
Prausnitz [62]  
Endothelial  , Human umbilical 
vein endothelial (HUVE) ECV 
304 cells 
0.8 MHz, 
1w/cm
2, 10 duty cycle 
25% increase 
transfection rate 
versus with different 
treatments plasma 
DNA, Microbubbles  
Dongping 
GUO, et al.[63] 
HepG2 cells  0.8 MHz ,1w/cm
2,10% 
duty cycle 
45% transfection 
efficiency 
Guo, D.-P., 
et al [64] 
Kidney, baby hamster kidney 
cells 
1 MHz,20-30% duty 
cycle, 1-2 w/cm
2 
44% increase 
compare with  
Therapeutic 
ultrasound 
Duvshani-Eshet  
et al.[65] 
MC38  1MHz,10-20 w/cm
2  3 fold combine with 
naked DNA   
Manome Y, et 
al. [66] 
Myoblast,H2K  1MHz,20% duty 
cycle, 2-3 w/cm
2, 5 sec 
Cell viability 83%  Liang, H.-D., et 
al. [67] 
Neuronal cells  20 KHz,0.5-3 w/cm
2  20%  transfection 
efficiency 
Fischer, A.J., et 
al.[68] Chapter 2 Literature Review 
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Table 2-3: Summary of application sonoporation in vivo 
In vivo transfection  Conditions used  Efficiency  Reference 
Artery  1MHz,0.75w/cm
2 
continuous wave, 3 min 
 
 
1MHz,1w/cm
2, 20% duty 
cycle, 30 sec 
10 fold increase 
compare with 
Plasmid alone 
 
200 fold increase 
compare with the 
number of FITC 
positive cells 
Pislaru SV, et al 
[69]  
 
 
Inagaki Hiroshi, 
et al.  [70] 
Brain  0.2 MHz, 5 w/cm
2,5 sec  5 fold increase in 
gene expression  
Manome, Y., et al 
[71] 
 
Leg muscle  1MHz,2 w/cm
2,1 min  7 fold increase in 
gene expression 
Zhang, Q., et al 
[72] 
Subcutaneous tumours  1MHz, 50% duty cycle, 2 
w/cm
2 
80% reduction in 
tumour growth 
Sakakima Y, et 
al. [73] 
Skeletal muscle  1MHz,3ww/cm
2,20% duty 
cycle 
10 fold increase in 
gene expression 
Lu QL, et al [74]  
Spinal chord  1MHz, 0.5 w/cm
2,20% 
duty cycle 
15-60 fold 
increase in gene 
expression 
Munehisa 
Shimamura, et al 
[75] 
Muscle+artery  1MHz,2.5 w/cm
2  7000 fold increase 
in gene expression 
Taniyama, Y., et 
al  [76] 
Most researchers have found a frequency of around 1 MHz to be most effective when 
used in conjunction with different cells. In addition, ultrasonic power output can be 
used from 0.5 to 2w/cm
2. These parameters have been used in both in vitro and in vivo 
and sonoporation will be effective both in vitro and vivo.  
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2.8  Electroporation 
Electroporation is the application of an electrical field which alters the electrical 
conductivity and permeability of the cell plasma membrane [77]. It is usually used in 
molecular biology as a way achieving transfection, such as loading cells with a 
molecular probe, a drug that can change cell's function, or a piece of coding DNA. 
Recently, electroporation has been used to deliver a large variety of molecules and ions 
to drug and tracers, antibodies and water to RNA and DNA. These pores are commonly 
called “electro pores”. Figure 2-19 shows the process of electroporation. When the 
correct parameters for the electric field are used cells can recover and the electro pore 
reseal. Normally, the pore is opened in about one microsecond, but the time to reseal is 
measured in minutes. Electroporation has shown useful both in vitro and in vivo.    
  
  
Figure 2-19: The process of electroporation with cell membrane [77] 
In addition, the process of electroporation can also be used for the transformation 
of bacteria or plant protoplasts. The bacteria and plasmids can be mixed together. The 
plasmid can be transferred into the cell after application of electroporation. It causes 
pore formation in the bacterial plasma membrane. More than 100 volts applied across a 
distance of several millimeters are typically used in this process. After that, the cells 
can be handled carefully until they can be divided producing new cells that contain 
reproduced plasmid. This process is also highly efficient for the introduction of Chapter 2 Literature Review 
  34
foreign genes into tissue culture cells, especially mammalian cells, or similar.  In the 
early 1980s, Neumann et al. demonstrated the feasibility of electroporation for 
delivering DNA to a population of mammalian cells and since then, this method of 
electroporation has become a standard technique routinely used to simultaneously 
transfect millions of cell in culture [78].  
2.8.1   Permeability  
Permeability is theoretically described as a process of formation of very small opening 
pores in the plasma membrane [79]. If the strength of electrical field and duration of 
exposure to it are properly chosen, the pores formed by the electrical pulse reseal after 
a short period of time, before which the extra cellular compounds have a chance to get 
inside the cell. However, excessive exposure of live cells to electrical fields can also 
cause apoptosis and/or necrosis (the processes that result in cell death).  
2.8.2  Basic circuit for electroporation 
 
Figure 2-20: A diagram of the basic circuit setup of the electroporation apparatus 
Figure 2-20 presents the basic circuit setup of the electroporation apparatus.  The 
typical process of electroporation circuit is controlled by switch 1 and switch 2. The 
capacitor is charged by the closing the switch 1 and the capacitor stores a high voltage Chapter 2 Literature Review 
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is about 10,000-100,000 V/cm. Once the second switch is closed, this voltage 
discharges through the liquid of the cell suspension. The pulse DC is thought both to 
disrupt temporarily the cell membrane and allow DNA into cells. 
2.9  Method for enhanced Electroporation 
A method for enhancing electroporation involves the application of a short electric 
pulse that transiently disrupts cellular membranes [80]. The electric field is typically 
applied as one or more short (μs to ms) pulse with a rectangular or exponential decay 
waveform. The increase of cell permeability is thought to be due to the formation of 
short lived aqueous pathways (“pores”) in the plasma membrane. It depends upon the 
field strength, length, and number of pulses [81]. The most important parameters for 
effective electroporation are electric field strength and the pulse length applied [82]. 
 
Figure 2-21: The basic relationship between the parameters of major important field 
strength and pulse length 
In order to electroporate the cell membrane a transmembrane potential difference of 
between 0.7 V- 1V needs to achieved. The required field strength E is inversely 
proportional to the cell diameter. 
a Er V cos 5 . 1 =  
Where  r is the cell radius  Chapter 2 Literature Review 
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     a is the angle between the field and the cell surface vector 
High field strength and generator pulse length enhance the permeability of the cell 
membrane, applying too high a field strength can result in the cell being unable to 
repair itself. On the other hand, if the field strength is too low, the breakdown of the 
cell membrane may not be achieved. If the pulse length is too short, the pore of the cell 
membrane will not be opened. 
2.9.1  Electroporation of suspension 
Most researchers have demonstrated that electroporation can be successfully applied to 
different types of mammalian cells [12, 83, 84], yeast [85], bacteria [86] and red blood 
cells [87]. However, the electroporation is not meaningful for cells e.g. epithelial cells, 
because it poorly mimics in vivo cell function and geometry found in tissues [88].  
2.9.2  Electroporation with pulsed generator power technology 
Recent developments in the field of electroporation circuitry have led to renewed 
interest in pulse power technology.  For example, R.J Baker have investigated and 
designed a nanosecond high voltage pulse generator using power MOSFETs (Metal 
oxide semiconductor field effect transistor). This design can create 1500 V pulse 
generation within 3 ns fall time and a 15 ns rise time. This pulse generator should find 
uses in high energy physics [89]. Chaney, A. and R. Sundararajan have carried out an 
experiment with simple MOSFETs based high voltage nanosecond pulse circuit [90]. 
They have designed successfully a single MOSFET pulse generator circuit for 
electroporation. Similarly, Kuthi, A., et al. has also designed a nanosecond pulse 
generator using fast recovery diodes for cell Electromanipulation. The pulse generator 
produces 3.5 ns wide, 1200 Volt amplitude unipolar pulses. The bipolar pulses are used 
to study biological cell response to high electric field [91]. Additionally, Paul et al have 
also continued to develop a high voltage amplifier for use in medical applications of 
electroporation [92]. They have employed pulsed AC with an output voltage of 4 KV, a 
bandwidth of 500 Hz-5MHz and output impedance of <100 Ω. These literature reviews 
have shown that power MOSFETs can be used to achieve high voltage pulse circuits. Chapter 2 Literature Review 
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Therefore, this research will concentrate on design of an electroporation circuit using 
power MOSFETs. 
2.10  Applications of Electroporation  
Jamieson, R.D., et al. [78] have studied cell gene transfer using electrical impulses and 
a new process in blood cancer research. This paper describes a three stage impulse 
generator designed to transfect viral genes into human blood cells. The three stages are 
constructed for the simulation of transient pores. The impulses could not trigger pore 
formation below about 2.4 kV for live cells. However, this paper has indicated an 
electrical impulse of about 1 kV is adequate for the human blood cells used. In 
addition, transfection by electroporation has been achieved, implanting viral DNA into 
human leukaemia blood cells. S I Sukharev, et al. have reported that the first pulse of 
electroporation 6KV/cm, 10 μs efficiently creates pores, but the transfection is low 
[93]. The second pulse (0.2KV/cm, 10ms) did not cause poration and transfection by 
itself, despite being substantially longer. This study demonstrated that the mechanism 
of cell transfection depends upon the pulse of electroporation, electric field and 
electrophoretic movement of DNA through membrane pores. 
Recently, Kine et al. have developed a polydimethylsiloxane (PDMS) chip with 
individual lateral cell trapping that can select and locally electroporate single cells in 
parallel [13]. This research has discovered that the average transmembrane potential 
required for electroporation of HeLa cells to be 0.51 V±  0.13. Additionally, HeLa 
cells can be used in low voltage (<1V) electroporation systems. Therefore, the cell 
membrane breakdown was achieved by low voltage (~0.76 ±0.095V). This device can 
introduce materials, such as drugs, DNA, and protein into individual cells using low 
voltage. 
In recent years, Hung et al. [94] have designed a new microfabricated electroporation 
chip for single cell membrane permeabilization. This research can incorporate a live 
biological cell in the electrical circuit of a microelectroporation chip. This research 
investigated the fundamental biophysics of membrane permeabilization on a single cell 
level. It can control introduction of macromolecules into individual cells. The Chapter 2 Literature Review 
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experiment showed that the chip has a good ability to manipulate and induce 
electroporation in specific cells. 
In addition, low power micro fabricated devices have been developed by Tresset et al. 
[95] who have developed a micro fabricated device with high aspect ratio electrodes for 
liposomes and cells. The device is designed suitable for liposome diameters larger than 
10µm. The device consists of 250 µm thick silicon electrodes bonded to glass substrate 
and covered by a PDMS-coated glass slide. This research has found that chain 
formation of liposomes occurred at a frequency of 300 KHz at an electric field density 
of 0.1-0.2 Kv/cm
-1. Membrane breakdown was achieved by short pulses of 10μs with 
electric field intensity over 0.5 Kv/cm
-1.This research has achieved 75% transfection 
rate in liposomes but their experiment found that the membrane was not soft enough to 
allow high fusion rate.  
Furthermore, Rivera F, et al. have designed a fluidic microchip to inject therapeutic 
molecules in the whole targeted tissue [96]. The great advantage of this device is that it 
is a stand alone device. The device uses gold electrodes and leads are passivated with 
silicon oxide. A stand alone device is 500 µm square sections, so that it is small enough 
to be inserted deep into a target tissue. It can apply high voltage electric impulse into 
therapeutic molecules, genes or drugs which are injected into targeted tissue. Moreover, 
the device is designed to allow electrotransfection in vivo because of its invasiveness.  
The electroporation microsystem has been developed and combined with a logic circuit 
for gene transfection. Min, L,et al. [97] have designed an electroporation microchip 
device for gene transfection and system optimisation. The device combines micro 
fabrication techniques, logic circuit and electrophoresis design to create a multi 
function gene transfection device that can be used in wide areas of medical science 
research applications.  In experiments, 10
4 NIH 3T3 cells were subject to an 
electroporation process with a 50μm electrode gap, 6 volt applied and 2 pulses. They 
used a fluorescence microscope to observe the experimental results. They have reported 
the efficiency of gene transfection with an electric field becomes higher than without 
electric field. In this study, delivery rate was increased to 35.89% when putting GFP 
gene into NIH 3T3 cells. This device has been applied in cancer research, protein 
transfection, and drug delivery.  Chapter 2 Literature Review 
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2.10.1 The advantages and disadvantages of sonoporation and electroporation 
This table compares the pros and cons of sonoporation and electroporation. The 
advantages of sonoporation are several: transfection both in vitro and in vivo, it can 
focus on any location in the body and has fewer immunogenic side effects. However, 
cells might be damaged depending upon the power of ultrasound and duty cycle of 
sound. Additionally, the positive view of electroporation is the efficiency which cells 
take in the target DNA or molecule.  
 
Table 2-4: the advantages and disadvantages of two transfection methods 
Physical method  Advantages  Disadvantages 
Sonoporation  •  Better Safety 
•  Less immunogenic and 
inflammatory side 
effect 
•  Can carry relatively 
large DNA sequences 
•  Increase DNA 
transfection 
•  Transfection in vitro 
and in vivo 
•  Focus on  almost any 
location in the body 
•  Cell damage: 
ultrasound duty cycle, 
power output 
Electroporation  •  Versatility: 
Electroporation is 
effective with single 
cells and species types  
•  Efficiency: A large 
majority of cells take in 
the target DNA or 
molecule. In a study on 
electro transformation 
of E. coli, for example, 
80% of the cells 
received the foreign 
DNA 
 
•  Cell Damage: If the 
pulses are of the wrong 
length or intensity, 
some pores may 
become too large or 
fail to close after 
membrane discharge 
causing cell damage or 
rupture 
•  Non-specific 
Transport: The 
transport of material 
into and out of the cell 
during the time of 
electro permeability is 
relatively non-specific. 
This may result in an 
ion imbalance that 
could later lead to 
improper cell function 
and cell death Chapter 2 Literature Review 
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2.11  Conclusion 
The concept of sonoporation, ultrasonic particle manipulation and electroporation and 
their associated important parameters have been reviewed and need to be explored. 
This research is to explore the basic theory of sonoporation, analyse the characteristics 
of ultrasonic particle manipulation and explore the basic theory of electroporation. The 
literature review describes design, development, evaluation and advantages of each 
method with several types of biological cell. Most research has only studied and 
investigated each concept of transfection independently, whereas this research will try 
to combine the advantages of each concept. For example, previous studies have found 
that sonoporation transfection efficiency was increased successfully by the addition of 
microbubbles [38] [39]. Also other researchers have found that ultrasonic standing 
wave was a key factor to enhance sonoporation for cell permeability [59]. The first aim 
of this research is to develop sonoporation with ultrasonic particle manipulation for cell 
poration. According to the previous research results indicated the potential of cell 
manipulation using ultrasonic standing wave approaches to assist control of the position 
of the latex beads [30]. This research focuses on studying, developing and examining 
sonoporation in combination with ultrasonic cell manipulation. Furthermore the 
analytical model from the previous research was used to design a system that can be 
used to generate a standing wave [51, 52] and achieve sonoporation in the same 
chamber. Thus, the chamber is able to achieve sonoporation and control the position of 
cells. Moreover, the second purpose of this research is to investigate an electroporation 
system for cell poration. The electroporation system design is presented in chapter 4. 
Finally, this research will explore the advantages of sonoporation with ultrasonic 
particle manipulation to increase transfection efficiency and determine the usefulness 
of cell manipulation.  
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Chapter 3   
Design of Sonoporation System 
3.1  Introduction 
This section presents a general overview of the basic model for an ultrasonic resonant 
chamber. The model is applied to the design of a chamber that combines ultrasonic 
resonance with sonoporation. To produce the sonoporation chamber, it is necessary to 
determine the acoustic pressure and acoustic energy in the chamber. This is achieved 
by simulation, and the basis for the simulation is presented. This chapter also describes 
the fabrication of the chamber and the results from impedance measurements that 
identify resonant modes. 
3.2  Basic model 
This basic model of a resonant ultrasonic chamber has been designed and developed by 
Hill et al [51, 52]. The schematic of an acoustic sonoporation chamber is shown 
in figure 3-1 and a cross section of the chamber is shown in figure 3-2. This basic 
model is used to help understand the behaviour of a layer resonator in acoustic chamber 
design. This model consists of a piezoelectric transducer transmitting power into a 
matching layer, a fluid layer and a reflector layer. The function of the transducer is to 
generate an ultrasonic pressure wave which is transmitted through each layer. The 
ultrasound wave reaches the reflector layer where it rebounds across the chamber. 
When acoustic energy is transmitted to the fluid layer, the matching layer reduces the Chapter 3 Design of sonoporation system 
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high acoustic impedance of the transducer bringing it closer to the lower acoustic 
impedance of the fluid. This improves the efficiency of transferring acoustic energy to 
the fluid. The other purpose of the matching layer is to isolate the transducer from the 
fluid layer. The fluid layer contains the biological cells and reagent and enables the 
formation of an ultrasonic standing wave. The final part is the reflector plate which 
reflects most of the acoustic energy back into the fluid layer. 
 
 
 
 
 
 
 
Figure 3-1: Schematic of acoustic sonoporation chamber 
 
 
 
 
 
 
 
 
 
Figure 3-2: Cross section of the structure of the ultrasonic separation chamber 
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3.3  Modelling of acoustic parameters within the acoustic chamber 
 
Figure 3-3: Equivalent circuit of transducer 
Figure 3-2 can be represented by the equivalent circuit shown in figure 3-3. The 
transducer that drives into impedance Zo is a PZT transducer element working close to 
its first thickness resonance. In this circuit, Co denotes the static capacitance of the 
transducer,Cm, Lm, and Rm represent the equivalent mechanical capacitance, inductance 
and resistance respectively. Zo represents the input impedance of the layer resonator 
structure as a whole and is given by equation 1.  
m m f m
m m m f
m t k jZ S r
t k S jr Z
S r Zo
tan
tan
+
+
=      (1) 
Co, Cm and Lm can be determined from the mechanical parameters of transducer using 
the method explained by Stansfield [98]. The mechanical resistance Rm, along with 
other damping values within the system, is estimated experimentally. In equation 1, Zo 
is the input mechanical impedance to the matching layer. The acoustic impedance of 
the fluid layer is represented by Z f, S is the cross section active area and tm is the 
thickness of matching layer respectively. The acoustic impedance of the matching layer 
is represented by rm and km represents the wave number in the layer and is given by 
equation 2. 
 km=
λ
π 2 .         ( 2 )  
The wave number is typically complex to allow for losses within the layer. Zf can be 
determined using the same impedance transfer relationship given in equation 1 for the Chapter 3 Design of sonoporation system 
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liquid layer, and so on until an acoustic free field boundary is encountered, at which 
point the terminating impedance can be calculated from the specific acoustic 
impedance of the final medium (usually air). 
3.4  Acoustic pressure and velocity 
Figure 3-4 shows the equivalent network of the piezoelectric transducer used as 
described above. The transducer consists of a 4 terminal network which comprises two 
electrical input terminals (1, 2) and two mechanical terminals (3, 4). V is defined as an 
alternating voltage. When the input voltage is applied at the input terminals, the 
piezoelectric action of the transducer makes it radiate into impedance Zo and an 
alternating force F and a velocity u are generated at the output. This can be expressed 
with a transformation ratio φ, which relates the piezoelectric generated force to the 
applied voltage when the motion of the face is blocked (u=0). It also relates to the 
piezoelectric generated current between the electric terminals when they are short-
circuited (V=0) to applied the velocity at mechanical side [99]. 
 
 
 
Figure 3-4: The equivalent network of the transducer in resonator 
Equation 1 can be used to determine an estimate of the electrical impedance 
characteristic of the acoustic chamber. In order to understand the acoustic chamber in 
more detail, we need to model the acoustic behaviour within the acoustic chamber and 
the liquid layer. Therefore, equation 3 can be used to calculate the acoustic pressure in 
the acoustic chamber [53].  
o m
o
o Z Z
VZ
F
+
=
ϕ
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where i is the input current, Ye is the blocked electrical input admittance as shown in 
equation 4 and Zm is the mechanical impedance of the transducer at the output terminals 
when the electrical are short circuited  and Zm can be presented by a mechanical system 
with lumped element as shown in equation 5. 
u V Y i e ϕ − =       ( 4 )  
                                     u Z V F m + =ϕ     ( 5 )  
Typically, the transducer will radiate into the load impedance Zo which can be obtained 
by relating the mechanical force acting on the transducer face at a velocity u as shown 
in equation 6 [99]. 
                                   u
F
Zo
−
=       ( 6 )  
When substituting equation 6 into equation 5 and substituting for u, the alternating 
mechanical force F is given in equation 3                                           
The input voltage is defined by V. φ represents a transformation ratio between electrical 
and mechanical quantities and Zm  is the acoustic impedance of the piezoelectric 
transducer at resonance at the output while short circuited at the electrical terminals. As 
a result, Ff   can be expressed as the force between the matching layer and the fluid 
which is given by equation 7 [53]. 
                
m m m m m f
f o
f t k S Jr t k Z
Z F
F
sin cos +
=                   (7) 
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Figure 3-5: acoustic pressure in the matching layer 
Equation 8 can be used to determine the pressure distribution in the matching layer of 
the acoustic chamber. This equation assumes that pressure is applied in the thickness 
(x) direction [53]. 
)] ( [ )] ( [ x t k t j x t k t j m m m m Be Ae p − − − + + = ω ω
     ( 8 )  
where tm is the thickness of the matching layer, x is the distance from the output surface 
of the transducer along the thickness direction of the matching layer as shown in figure 
3-5, ω is the angular frequency, km is the wave number in the matching layer (see 
equation 2), A and B can be determined by the boundary conditions at x=0 and x = tm 
The equation (8) can be given as: 
     
) ( ) ( ) ( x t jk x t jk m m m m Be Ae x p − − + =      ( 9 )  
          1 ) /(
1 ) /(
+
−
=
S c Z
S c Z
A
B
m m
m m
ρ
ρ
                            (10) 
Where ρ is the density of the matching layer, cm is the speed of sound in the matching 
layer given by cm = ω/ka. Equation 10 can be rearranged to give the mechanical 
impedance
B A
B A
S c Z m m −
+
= . ρ , where S is the cross section active area. 
Substituting equation (9) into equation (10) gives: 
m m m m t jk
m m
m m t jk Ae
S c Z
S c Z
Ae
S
F
p
ρ
ρ
+
−
+ = = ) 0 (     (11) 
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Therefore, A can be obtained as follows 
m m m m m m
m m
t k S c j t k Z
S c Z
S
F
A
sin cos
.
ρ
ρ
+
+
=       ( 1 2 )  
So, we can obtain the acoustic pressure p(x) through the matching layer from equation 
13.  
) ( ) ( . ) ( x t jk
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Next, the fluid layer can be analysed. The fluid layer has a thickness tf, and x equals 
zero at the matching layer and fluid boundary. The spatial variation of acoustic pressure 
p(x) through the fluid layer is given by equation 14. 
 
f f f f f r
f f f f f r f
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F
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) (
+
− + −
=      (14) 
This gives an acoustic velocity variation through in the acoustic chamber as shown in  
equation 15 [53]. 
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Where rf   is the specific acoustic impedance in the fluid layer and kf  represents the 
wave number in the fluid layer. Zr is the mechanical impedance looking into the 
reflector layer. The acoustic impedance of a fluid acting on a surface of area S is the 
quotient of the complex acoustic pressure at the surface divided by the complex 
acoustic velocity at the surface. 
3.5  Acoustic energy measures 
When the chamber is used at resonance, a standing wave is formed in the fluid layer. 
The instantaneous energy density, εi at a point within the standing wave field of a fluid 
of density ρ can be defined as [53] 
⎟
⎟
⎠
⎞
⎜
⎜
⎝
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+ =
2
2
2 ) (
) (
2
1
) (
f
i
r
x p
x u x ρ ε              (16) 
The total energy stored in the fluid layer is calculated by equation 17. 
∫ =
f t
t i f dx x S E
0
) ( ε      (17) 
The acoustic radiation force on a small particle can be calculated from the product of 
the energy density in the standing wave and the driving frequency. These equations can 
be used to model the performance of the sonoporation chamber when at resonance. 
Acoustic force in a standing wave shows in figure 3-6. 
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Figure 3-6: Acoustic force in a standing wave 
To determine radiation force Fac in the x direction and function of x position, it can be 
expressed by equation 18 [100]. 
) 2 sin( ) ( kx F x F O
ac ac =      (18) 
Where  φ ε π 3
3
4
kR F
o
ac =  
From the equation 18  ε  represents the time average energy density and is a function 
of the acoustic pressure amplitude. k is the number of wave (k =
λ
π 2 ) and R«λ is much 
smaller than wave length. The acoustic contrast factor is presented byφ  and is given by 
equation 19.  
p p
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−
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=      (19) 
Where  p ρ and f ρ represent the respective particle and fluid density, and  f c and  p c  are 
the fluid mediums and particle speed of sound, respectively.  
The acoustic contrast factor represents the relationship between densities and the sound 
of velocity of two media. It is often used in the context of biomedical ultrasonics and 
the field of ultrasonic manipulation of particles much smaller than the wave length 
using an ultrasonic standing wave. The acoustic contrast factor is the number which 
Acoustic pressure 
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depending on its sign tells whether a given type of particle in a given medium will be 
attracted to the pressure node or antinodes. For a positive value of the acoustic contrast 
factor, the particles will be attracted to the pressure node. 
3.6  Simulation of sonoporation chamber 
This section presents a simulation of the sonoporation chamber. The analytical models 
of the ultrasonic separator presented previously can be used to simulate and determine 
the optimum dimensions of a sonoporation chamber. This model allows identifying the 
material thickness, the frequency response and predicts the energy density level in the 
sonoporation chamber. The software package MATLAB has been used to implement 
the model of an acoustic chamber and the equivalent circuit of the transducer and to 
predict the input impedance of the acoustic chamber [55, 101]. 
For the initial simulation, the model of the acoustic chamber has been designed with a 
variable thickness of matching layer ranging between 1.0 mm and 3.0 mm. A variable 
reflector has also been included ranging from1.0 mm to 4.0 mm. The thickness of fluid 
is fixed at 750µm. In this research, the key parameters used in the acoustic chamber are 
given in the table 3-1which shows the default values for the resonator layer. 
Table 3-1: Default values for resonator layer parameters 
Layer Material  Density 
ρ(kgm
-3) 
Speed of 
sound c(ms
-1) 
Thickness         
t (mm) 
Fluid Water  1000 1500 0.75 
Matching Macor  glass  2520  5580  Variable 
Reflector Glass  2240  5640  Variable 
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Table 3-2: The parameters of the PZT transducer 
The parameters of the PZT transducer used in this simulation is shown in table 3-2   
   Piezoelectric  characteristic   
  Symbol Unit  PZT26 
Electric properties      
Dielectric loss tan  tanδ 10
-3% 3 
Dielectric constant  K33
T   1340 
Electromechanical properties      
Coupling factor  Kc   0.48 
Mechanical properties      
Resonant frequency   MHz  1 
Mechnical quality factor  Qm,t   >1000 
Density  ρ           Kgm
-3 7700 
Sound velocity  c m/s  4042 
Thickness   mm  2 
Disc diameter   mm  10 
      
The aim of simulation is to establish the best thickness of matching layer and reflector 
layer. Optimising the thickness of these layers will maximise the energy density and 
also achieve a design with a high tolerance for fabrication errors. This will simplify the 
fabrication of the chamber and will mean energy densities will not reduce too much if 
optimum thicknesses are not achieved in practice. The energy density in acoustic 
chamber is not the only consideration; the simulation will also identify the resonant 
frequency.  
3.6.1  Simulation results 
This section presents the simulation results from the analytical model. This simulation 
identified an optimum matching layer thickness ranging from 2.2 mm to 2.5 mm and Chapter 3 Design of sonoporation system 
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the reflector layer thickness ranging between 1.2 mm and 1.5 mm. The result is shown 
in figure 3-7 where there is a broad range of thicknesses that give the maximum energy 
density. We can observe that the maximum energy density is approximately 43 Jm
-3. 
 
Figure 3-7: Modelled stored energy density versus matching layer and reflector layer 
thickness 
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Figure 3-8: Energy density versus matching layer 
Figure 3-8 shows a graph of energy density against matching layer for a reflector layer 
of 1.2 mm. Again the peak energy density (43 Jm
-3) is clearly visible at a thickness of 
2.3 mm. 
 
Figure 3-9: Energy density versus reflector layer 
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Figure 3-9 shows a graph of energy density versus reflector layer for a matching layer 
thickness of 2.3 mm. We can notice that the peak of energy density is clearly at about 
43 Jm
-3 and an optimal reflector layer is between 1.2 mm and 1.5 mm. 
 
Figure 3-10: Modelled effect of frequency versus variations in matching and reflector 
layer thickness  
Figure 3-10 shows a graph of the simulated of resonant frequency versus matching 
layer and reflector thickness. The resonant frequency is sensitive to reflector thickness 
but fairly insensitive to matching layer thickness. For example, for a fixed reflector 
layer thickness of 1.2 mm, the resonant frequency varies from 1 to about 1.05MHz. At 
the optimum thicknesses for maximum energy density the resonant frequency is ~1 
MHz and is showing it is relatively insensitive to thickness variations at this point. 
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Figure 3-11: Comparison of Energy Density and Frequency (MHz) 
To consider in more detail the energy density and resonance frequency, we can 
compare the energy density with driving frequency in the sonoporation 
chamber. Figure 3-11 shows energy density versus frequency. The thickness of the 
matching layer and the reflector layer is 2.3 mm and 1.2 mm respectively. This shows a 
resonance frequency of 1.018 MHz. It also gives a maximum energy density in the 
sonoporation chamber. 
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Figure 3-12: Acoustic pressure standing wave at 1 MHz 
The ultrasonic standing wave will be used to generate radiation force on particles 
within the fluid. The acoustic pressure within the fluid layer in the acoustic chamber 
has also been simulated using equation 13. The acoustic pressures in the standing wave 
have been plotted through the 750 µm thickness of the fluid layer in the acoustic 
chamber and are shown in figure 3-12. 
3.6.2  Summary and discussion 
The simulations have been applied to the design of a combined resonant sonoporation 
chamber and have identified an optimal matching layer thickness ranging from 2.2 mm 
to 2.5 mm and reflector layer thickness ranging from 1.2 to 1.5 mm. These give a 
maximum energy density of approximately 43Jm
-3at a resonant frequency of 
1.018MHz. The acoustic pressure has also been calculated across the chamber 
thickness and is predicted to vary from 0 to 0.45 MPa. Given this dimension, operating 
the sonoporation chamber at a resonant frequency of 1.018 MHz produces a standing 
wave which will move cells to the position of minimum pressure at the node plane. 
Therefore, this device should be able to control the cell and target material DNA 
location within the chamber and can place them in close proximity. Therefore, this 
device will potentially increase the rate of cell transfection. These results can be 
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compared with Kuznetsova, L.A., et al [56]who demonstrated that cavitation can be 
achieved using microbubbles and an ultrasound standing wave at 1.56 MHz and a 
pressures at 0.98 MPa. They also suggested cell movement may occur in the standing 
wave as described in section 2.6. Therefore, the predictable result of acoustic pressure 
at 0.45MPa is able to control the position of cell and DNA location within the resonant 
chamber. The next section will give more detail of the design of a resonant 
sonoporation chamber from the simulation results. 
3.7  Chamber design 
The prototype chamber was designed using the Inventor CAD package base upon the 
results of the simulations. The prototype components were produced by the School of 
Electronics and Computer Science workshop. The sonoporation chamber is composed 
of a PZT transducer, a macor ceramic matching layer, a plastic base containing 
input/output fluid channels, a rubber gasket, a glass reflector plate, a plastic cover 
clamp and a stainless steel cover clamp. The dimensions of each component are given 
below.  
 
Figure 3-13: The PZT26 transducer 
Figure 3-13 shows the PZT26 (Ferroperm Kirsgad, Denmark) details which are given 
in table 3-2. It has a 10 mm diameter and 2 mm thickness. This PZT is attached to the 
underside of the macor matching layer. 
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The dimension of the macor ceramic matching layer is 22x40x2.3 mm thickness as 
shown in figure 3-14 (a). The macor matching layer consists of an inlet and an outlet 
flow channel shows in figure 3-14(b). 
  
(a) 
Figure 3-14: (a) A macor ceramic matching layer 
 
(b) 
Figure 3-14: (b) A macor ceramic matching layer 
Figure 3-14(b) illustrates the flow channel inlet and flow channel outlet of the macor 
ceramic matching layer. The flow channel inlet will allow medium, cells and plasmid 
DNA which go into the sonoporation chamber. The medium, cells and plasmid DNA 
flow out at the flow channel outlet.  
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Figure 3-15: The base of sonoporation chamber 
Figure 3-15 illustrates the base of sonoporation chamber. The main purpose of the base 
is to enable fluid connection to be made to the assembly. The size of the base is 38 x 56 
x 10 mm thickness.  
 
Figure 3-16: The plastic clamp of a sonoporation chamber.  
Figure 3-16 shows the plastic clamp of a sonoporation chamber. It has a dimension 22 
x40x4 mm thickness. It is the bottom clamp used with the top cover to hold the 
assembly together. 
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Figure 3-17: A gasket 
Figure 3-17 shows the gasket which is shaped to from the fluid chambers and the 
sonoporation chamber which is positioned at the centre and the diameter is 6 mm in 
diameter. The depth of the gasket chamber is 0.75 mm which is the thickness of fluid 
layer.  
 
Figure 3-18: The glass cover slide 
Figure 3-18 shows a reflector which is a glass cover slide. The dimension of the glass is 
15x40x1.2 mm thickness. 
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Figure 3-19: A cover clamp 
Figure 3-19 shows the cover clamp of the sonoporation device. This is made from 
stainless steel. The cover is 38 by 56 mm and has a window 15 by 35 mm in the middle 
and it is 3 mm thick. The cover will clamp the glass reflective layer in place over the 
chamber allowing visual inspection of the sonoporation process   Chapter 3 Design of sonoporation system 
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Figure 3-20: The prototype sonoporation chamber design 
The prototype sonoporation chamber consisting of the seven components is shown 
in figure 3-20. The assembly process is as follows. First, the PZT26 was glued using a 
conductive epoxy resin to the macor matching layer. Next, the macor and PZT26 were 
placed onto the base of sonoporation chamber. Then, the rubber gasket was located 
onto the matching layer and is aligned to the flow holes. The reflector layer was then 
placed over the rubber gasket forming the chamber. A plastic spacer was used to 
sandwich the matching layer, the chamber and the reflector layer. Finally, the Chapter 3 Design of sonoporation system 
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aluminium cover clamp and plastic spacer was placed in position and clamped together 
with nuts and bolts holding the assembly in place. The assembled sonoporation 
chamber is shown in figure 3-21.  
 
      
 
Figure 3-21: The prototype sonoporation chamber 
3.8  Method and experiment results  
This section presents the experimental evaluation of the sonoporation chamber. The 
purpose of this experiment is to investigate the performance of the sonoporation 
chamber, it is necessary to measure the impedance of the PZT transducer in order to 
find the resonant frequency. This experiment is also searching for the resonance of the 
transducer and the fluid layer resonance when the device presents without the fluid and 
with the fluid. Also, this experiment is to verify the validity of the model against the 
experimental results from the impedance of the sonoporation chamber. This impedance 
of the PZT transducer was investigated under three different conditions. An impedance 
analyzer (HP 4192A Impedance analyzer 5HZ-13 MHz) was used to measure the 
impedance of the PZT transducer in the three conditions. 
•  PZT without the sonoporation chamber  
•  PZT attached to the sonoporation chamber but no fluid present in the chamber 
•  The final condition is the PZT with the sonoporation chamber full with water.  
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The first and second conditions are to determine the resonance frequency of the 
transducer. The other purpose of the second condition is to identify the resonance 
frequency of the transducer and matching layer when the device is filled with air. The 
final condtion is to identify the resonance frequency in fluid layer, when the fluid is 
filled into the device. Additional resonances will be obtained and related to the fluid 
layer. These resonances will be carried out in a study on the sonoporation in chapter 5. 
The correlation of the modelled and measured results for the sonoporation chamber will 
be described to give confidence that the model approach is valid [4]. 
3.8.1  Condition 1:PZT without the sonoporation chamber result 
 
Figure 3-22: Measured impedance (solid line) and modelled impedance (dotted line) of 
PZT transducer from 0.5 MHz to 2.5 MHz 
Figure 3-22 shows the theoretical and measured frequency response of the transducer 
from 0.5 to 2.5 MHz in the first condition. At about 1.174 MHz, there is a large 
resonance. When comparing the measured and modeled data, there is good agreement 
between the measured and modeled results. However, the measurement data was not 
reliable in the frequency range 0.7 MHz to around 1MHz where the impedance is 
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observed to fluctuate. This is possibly due to external resonance e.g. in connecting 
wires.  
This result can be compared to a simple analysis of fundamental resonant frequency in 
the PZT transducer. The fundamental resonant frequency is given by fo = c/2d ; where c 
is a speed of sound in PZT26 and d presents a thickness of PZT. The speed of sound is 
4530 m/sec and the thickness of the PZT is 2 mm. 
f   
4530 m/sec
2x2 mm.
  1.13 MHz 
The basic analytical resonant frequency is 1.13MHz and this corresponds to the 
fundamental half wavelength resonance. This shows good agreement with the 
simulation and measured results. 
3.8.2  Condition 2: PZT attached to the air filled sonoporation chamber   
 
Figure 3-23: Measured impedance (solid line) and modelled impedance (dotted line) of 
PZT transducer attached air filled chamber for frequency range from 0.5 MHz to 2.5 
MHz. 
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Figure 3-23 presents the experimental data of the impedance of the PZT attached to the 
resonant sonoporation chamber with no liquid from 0.5 MHz to 2.5 MHz. Both 
measured and modelled impedance shows a high peak at approximately 1.09 MHz. 
(1150 Ω and 1094 Ω respectively). Modelled and measured data show good agreement 
under this condition. However, a maximum peak is also visible in the simulation result 
at approximately 0.53MHz due to the resonant frequency that occurs with a quarter 
wave in the PZT plus and a quarter wave in the matching layer. This was been not 
observed in the measured impedance. It may have occurred before at a resonant 
frequency of 0.5 MHz. This result can be checked by calculating of fundamental 
resonant frequency in the matching layer. The speed of sound in macor matching layer 
is 5580 m/sec from table 3-1 and fundamental resonance frequency in PZT and macor 
matching layer was observed to be 1.094 MHz. Therefore, the wavelength in the 
matching layer can be calculated as follows. The wavelength is given by λ=c/f; where c 
is the speed of sound and f presents the fundamental resonant frequency. 
  
5580  /   
1.094    
 
    5.10   . 
 
2
 2 . 5    .  
Therefore, this basic analysis shows the half wave length is 2.5 mm and which 
corresponds to the fundamental half wave resonance in the matching layer simulation 
result as shown in section 3.3. In addition, the fundamental resonant frequency of a half 
wave layer including the PZT transducer is 0.54 MHz. This shows good agreement 
with the resonant frequency identified in the simulation result. Both result nodes in the 
transducer and matching layer are shown in figure 3-24. 
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Figure 3-24: The resonant frequency in the transducer and matching layer at 
1.094MHz and at 0.54MHz 
3.8.3 Condition 3: PZT attached to the sonoporation chamber full with water filled 
result 
 
Figure 3-25: Measured impedance (solid line) and modelled impedance (dotted line) of 
PZT transducer attached to water filled chamber for frequency range from 0.5 MHz and 
2.5 MHz 
The impedance of PZT transducer with water in the fluid layer of the resonant 
sonoporation chamber from 0.5 MHz to 2.5 MHz is illustrated in figure 3-25. We can 
see that the overall plot of the modelled impedance versus frequency has a maximum 
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peak in the region of interest of 1499 Ω at 1.095MHz and a smaller peak at 
approximately 0.97MHz. The measured data shows a large peak of 1604 Ω at 
1.065MHz and a smaller peak at approximately 0.968MHz. As with condition 2, there 
is a peak at about 0.53 MHz due to the resonant frequency and the half wave resonance 
across the PZT and matching layer. This has not been observed in the measured 
impedance.  
This result can be checked by calculating the fundamental resonant frequency in the 
fluid layer. The speed of sound in the fluid layer is 1500 m/sec, the thickness of fluid is 
fixed 750 µm from the table 3-1.Therefore, the resonant frequency of the full wave 
mode in the fluid layer is obtained as follows. 
    750μ  2  
    1500μ  
  
1500  / 
 
 
   
1500  /   
1500 μ 
 
   1       
The fundamental resonant frequency of fluid layer is 1MHz and a half wave resonant 
frequency in the fluid layer is 0.5 MHz. This shows a good agreement of resonant 
frequency with in the simulation result. Figure 3-26 shows a half wave resonant 
frequency in the fluid layer. 
 
Figure 3-26: A half wave resonant frequency in the fluid layer Chapter 3 Design of sonoporation system 
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3.9  Conclusion 
This chapter has described the simulation optimisation of a resonant sonoporation 
chamber. The acoustic pressure across the resonant sonoporation chamber was 
predicted to vary from 0 to 0.45 MPa and the maximum acoustic energy was 43Jm
-3 in 
the fluid layer. The resonant sonoporation chamber design is presented in detail and 
this will be used in the following sonoporation experiments. The prototype 
sonoporation system has been assembled with dimension 38x56 mm and a fluid 
chamber depth of 0.75 mm. In addition, the thickness of matching layer and reflector 
layer is 2.3 mm and 1.2 mm respectively. The measured impedance shows good 
agreement with the modelled data. It provides an indication of a resonance at about 
1.174 MHz in the PZT transducer without the sonoporation chamber. The simulation 
and modelling have identified a resonant frequency at ~1 MHz in the resonant 
sonoporation chamber which produces a standing wave that should be able to move 
materials such as cells and plasmid DNA to the location of minimum pressure at the 
node plane. This resonant sonoporation chamber will be investigated using yeast, cells 
and plasmid DNA in order to understand the performance of resonant sonoporation 
chamber, cell transfection and cell viability in more details and this is described in 
chapter 6, 7 and 8. Cell manipulation was subsequently validated by experimentation 
and this is described in chapter 7. The chamber has also been used to sonoporate cells 
away from resonance and at resonance and this is also described in chapters 5, 6 and 7. 
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Chapter 4   
Electroporation System Design 
4.1  Introduction 
The purpose of this chapter is to describe the design and construction of an 
electroporation system that can be used in biological applications such as mediated 
gene therapy and enhancement of drug delivery. The electroporation work presented in 
this chapter uses a commercially available cuvette driven by a custom designed pulse 
generator circuit. In order to design a circuit, typical electroporation parameters are 
reviewed enabling a range of electric fields and pulse lengths to be specified for the 
circuit. The results from the testing circuit are presented. The electroporation system is 
used later in the thesis to evaluate electroporation and compare the result gained against 
these obtained for sonoporation.  
4.2  Electroporation parameters 
Most of the unipolar pulse generators that have been used in bioelectric experiments 
produce microsecond to millisecond pulses. The most common pulse shape is a 
rectangular pulse which is the most efficient at producing pores [102]. Typically, 
electric field strengths of 1000V/cm and 100 µsec pulses are used for drug delivery and 
low field and longer pulses, such as 200 V/cm, 20-50 msec are used for gene therapy. 
In addition, the electric field and pulse duration (between 10
-5 and 10
-7) are used for 
Bacterial decontamination. The electric field employed under these parameters can Chapter 4 Electroporation system design 
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facilitate transfer plasmid DNA into the bacterial cell. However, application of higher 
fields can results in bacteria death as it is possible to open permanent pores. Figure 4-1 
shows the typical parameter range for different biological applications [103]. The 
electroporation system designed here is targeted at drug delivery and gene therapy. It is 
therefore desirable to be able to control a range of electric fields between 10
3 and about 
10
4 V/cm and pulse durations varying from 10
-5to 10
-3sec. 
 
Figure 4-1: Parameter range of electric field and pulse width for biological 
applications [103] 
To illustrate electroporation the lipid bilayer of a cell membrane is shown in figure 4-2, 
with a directly applied electric field pulse. The lipid bilayer consists of two layers of 
elongated molecules that are hydrophilic at one end and hydrophobic at the other. 
When in an aqueous environment, these molecules form a bilayer with the hydrophilic 
heads pointing outwards. Such a structure is very good at isolating the contents of the 
cell from the outside, thus providing a barrier to entry. Electroporation is a mechanism 
of temporarily disrupting the bilayer membrane, in such a way that a hydrophilic pore 
is established, allowing a pathway into the cell for molecules such as DNA, which then 
heals up, once again protecting the cell from the outside. There are many theories as to 
how this can occur, but the simplest view is that a short pulse creates an increase in the Chapter 4 Electroporation system design 
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trans-membrane potential which if it exceeds a certain threshold (dependent on size and 
and shape of cells) can lead to a thinning of the bilayer, either due to a local dislocation 
in the membrane, or local field intensity maximum usually near the electrode. This can 
allow a hydrophobic pore to be created (figure 4.2 (d)) which looks like a tear or 
discontinuity in the bilayer. The layer will then try to reorganise itself locally as the 
hydrophilic tails will be repelled by the proximity of the aqueous medium that is now 
able to get into the membrane, and the hydrophilic heads will rearrange themselves to 
face this medium. This results in a hydrophilic pore as shown in figure 4.2 (e) Electric 
fields pulses can induce pore formation, if the electric field pulse is appropriately 
selected (typically 300-400 mV for < 1ms across the membrane). Too much field can 
result in cell rupture and the formation of a permanent pore. The electric field pulse 
applied results in a rapid polarization change that can deform mechanically 
unconstrained cell membranes leading to local thinning as described above. At a critical 
field strength we cause a rapid localized rearrangement of the lipid morphology as 
described above. A temporary hydrophobic pore is rearranged at the pore edge. 
Eventually, the lipid heads fold over to create a hydrophilic interface during the 
transition to a conductive state. The pores are formed in the membrane and reseal after 
a short period time depending on applied electric field and bilayer edge energy. Several 
researchers have demonstrated that electroporation can be successfully applied to 
different types of cells such as mammalian cells, yeast, bacteria, plant cells [104], 
cancer cells [105] and blood cells [79]. 
 
Figure 4-2: Process of pore formation (a) normal cell membrane, (b) a cell excited by a 
short electrical pulse resulting in irregular molecular structure (c) the membrane being Chapter 4 Electroporation system design 
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notched (d) the cell with a temporary hydrophobic pore and (e) the cell with a 
membrane restructuring [104]. 
4.3  Electroporation system 
  
 
 
 
 
 
Figure 4-3: Block diagram of an Electroporation system 
The block diagram of the electroporation system is shown in figure 4-3. It is composed 
of five stages comprising a programmable pulse generator, an inverter/driver, a high 
voltage switch, a high voltage power supply and a load (electroporation cuvette). To 
control the parameters of the pulses and the number of pulse it was decided to use a 
microcontroller. The microcontroller produces square wave pulses and it can control 
pulse width between 100 μsec and 10 msec. In addition, the user can program a duty 
cycle. The criteria for choosing the microcontroller are a fast clock frequency which 
would allow a high rate of instructions per second and a sufficient number of 
input/output pins. The PIC16F84 microcontroller by Microchip Technology Inc. was 
selected (see data sheet in appendix A). The inverter and driver circuits are designed 
using transistors. The basic purpose of the inverter circuit is to invert the 5 volt signal 
from the pulse generator. The function of transistor driver circuit is to increase the 
signal from the inverter circuit to 15 volt. The ideal transistor for this research would be 
able to survive a high drain-voltage and have a high pulsed current rating. The high 
power transistor must be able to turn on and turn off quickly and have a low on-state 
resistance. The function of this high power transistor is used to switch high voltage. 
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4.3.1  Microcontroller pulse generator 
A microcontroller circuit used to control and generate pulse parameters for the 
applications of pulsed electric fields is shown in figure 4-4. It allows the user to control 
the pulse width and number of pulses in a period of time. The PIC 16F84 (Microchip 
Technology Inc.) has a clock frequency of 4MHz, giving it a 200 ns instruction cycle 
and an instruction set consisting of 35 single word instructions. The MPLAB IDE v 
7.50software and MPLAB ICD2 in circuit debugger was used to program the 
microcontroller. In use, the electroporation parameters are input by the user through 
two push button switches. The switch1 and switch 2 are used to select the duration of 
the pulses are applied for, either 5 or 10 sec respectively. When the push button switch 
1 or switch 2 is pressed, the microcontroller will read the status of push button and 
execute a code for selected square wave pulse. The duty cycle and pulses width is 
programmed into the microcontroller. Next, the microcontroller generates the square 
wave pulse at port RB0. The square wave pulses have an amplitude of 5 Volt.  
 
 
Figure 4-4: The schematic of the microcontroller circuit 
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4.3.2  Transistor inverter and driver circuit 
Figure 4-5 shows a schematic transistor inverter and driver circuit. This transistor used 
in the inverter and driver circuit must be able to turn on and turn off quickly (<100nsec) 
and must be able to provide a pulsed signal. The transistor (ZTX450 see appendix b) 
was chosen. It has a maximum collector-base voltage (VCBO) of 60 Volt, and continuous 
collect current Ic of 1A. The first transistor in the circuit inverts the output signal from 
the microcontroller. After the square wave signal was inverted from the 
microcontroller, it goes through to the base of the second transistor. At this point the 5 
volt square wave signal is amplified to 15 volts. The high break down voltage of the 
transistor allows the amplitude of the output pulse to be 15 volt. This was used because 
it is sufficient to operate the high power switch. 
 
 
 
Figure 4-5: A schematic of inverter and driver circuit 
4.3.3  Power MOSFET high voltage switch 
A power MOSFET switch is required to switch the high voltages necessary for 
electroporation system. The MOSFET has a high drain source voltage and a high 
pulsed current rating. It must be able to turn on and turn off quickly and have a low on 
state resistance. Thus, the MOSFET (STFV4N150) was used, it has a drain source 
breakdown voltage of 1500 V and it has a drain current of 4 A. (see appendix C for full 
datasheet). In addition, the MOSFET has resistance drain source (RDS(on)) of 7 Ω. The 
STFV4N150 has an input capacitance of 1300 pF that must be charged and discharged 
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in order to turn on and off. The MOSFET will rapidly charge and discharge when the 
square wave pulse from the driver circuit is applied to the gate of the MOSFET. In 
addition, the current will pass through the resistor which acts as a current limit and 
protects the MOSFET by damping the voltage during the turn on time. The MOSFET 
can produce square wave pulses with amplitudes up to 1500V and width of a few 
micro-second to dc. In order to turn off MOSFET quickly, the diode (1N4148) was 
chosen because of its fast reverse recovery time of 4ns and it is used to permit the 
current to bypass the resistor at the gate of MOSFET. Two zener (1N5248) diodes are 
required to protect the gate of MOSFET which is common cause of failure in a power 
MOSFET. The gate of the MOSFET should not exceed ±18V. 
 
 
Figure 4-6: A schematic of a power MOSFET 
When the MOSFET is in turn off state, the capacitor (2.2 μF) will be charged up to the 
voltage of the high voltage power supply. The capacitor is charged through the 5 kΩ 
resistor. The MOSFET is switched on then the capacitor will discharge through the 
load i.e. electroporation cuvette. The capacitor produces negative pulse voltage across 
the load.  
The design of the power MOSFET circuit is based on the ideas that are presented in 
[89, 105]. It uses a gate side technique that uses its MOSFETs internal capacitance to 
achieve synchronization of the gate signals. The design uses a single MOSFET driver 
and an additional capacitor placed between the gate of MOSFETS and ground. The 
proper operation of the circuit relies on the voltage division between the effective gate 
source capacitance and Cgate. 
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When switching takes place the effective capacitance between the gate and source of 
MOSFET is  
) (
g
d
gd gs gseff dV
dV
C C C + =    (4.1) 
During these two intervals, Cgs and Cgd are effectively in parallel for the change in 
voltage and are charged by the gate current. 
) )( (
t
vgs
gd gs G d
d
C C I + =     (4.2) 
 
Initially the charge on the gate Capacitor (Cgate) is given by.  
DS gate V C Q . =      (4.3) 
 
Figure 4-7: Circuit schematic of the electroporation system 
A circuit schematic of the electroporation system is shown in figure 4-7. 
4.3.4  Modelling of the electroporation load 
The Electroporation load in this research is a 1 mm gap electroporation cuvette from 
BTX Harvard which is typically used for in vitro experiments. Figure 4-8 is a picture of 
electroporation cuvette. The decision to use the 1mm gap was made because it provides 
the high electric field strength from a high voltage power supply up to 100 volt. 
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Figure 4-8: A picture of electroporation cuvette [106] 
 
 
Figure 4-9: Circuit of a 1 mm electroporation cuvette 
The electroporation cuvette, which consists of two parallel plate electrodes, is a parallel 
model of a resistor and a capacitor as shown in figure 4-9. The parameters of resistor 
can be calculated in equation (4.4). 
A
Rcuvette
. σ
l
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Where l  is the gap distance between the electrodes, σ is the conductivity of the buffer 
solution between the electrodes and A is the area of the electrodes. The value of the 
load capacitor is calculated using equation (4.5). 
d
A
C
r
cuvette
ε ε 0 =     ( 4 . 5 )  
Where ε0 is the permittivity of free space (8.85 x 10
-12 F/m), εr is relative dielectric 
constant of water which is 80 at room temperature, A is the area of the electrode and d 
is the gap distance between the electrodes. 
 
 
Figure 4-10: An electroporation system 
4.4  Method and experiment electroporation circuit 
To investigate the performance of the electroporation system, it is necessary to compare 
the simulations and measured amplitudes of the output connect to the load. The 
amplitude of the electroporation was investigated under a range of voltage 100 to 
1000Vdc which is presented in section 4.4.1. The other condition of amplitude of 
electroporation was investigated under a range of 10 to 100Vdc which is presented in 
section 4.4.2. Both the measured and modelled performance of electroporation circuit 
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have been discussed and compared in this section. The electroporation system is shown 
in figure 4-10. 
4.4.1  Simulation electroporation circuit 
This section presents a simulation of the electroporation circuit. The aim of this section 
is to validity of simulation perdition against measured results. This circuit was 
investigated and simulated in PSpice Design manager program version 9.2.1 as show 
in  figure 4-11. In order to evaluate this circuit for different input high voltage 
amplitudes, the simulation used a range of input voltage between 100Vdc and 
1000Vdc. The table 4-1 shows the simulation results for input voltage versus output 
voltage.  
 
 
Figure 4-11:  A picture of simulation electroporation circuit 
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Table 4-1: The result of simulation amplitude input versus output voltage of 
electroporation circuit 
Voltage Input (Vdc)  Voltage Output (Vdc) 
100  99.72 
200  199.49 
300  299.16 
400  398.88 
500  498.60 
600  598.32 
700  698.04 
800  797.76 
900  897.48 
1000  997 
 
The simulated result of electroporation circuit is also given in table 4-1. It can be seen 
that this circuit can be generated the output voltage for electroporation circuit.  
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4.4.2  Comparison of modelled and measured electroporation circuit 
To compare modelled and measured electroporation circuit, an oscilloscope Tektronix 
TDS2002 (60 MHz, 1Gs/S) was used to measure output waveform in various voltage. 
In addition, water (20µl) was placed into a 1 mm gap electroporation which was 
connected to the electroporation circuit. 
 
Table 4-2: The comparison of measured and simulation electroporation circuit with the 
load (electroporation cuvette) 
Voltage Input 
(Vdc) 
Simulation 
(Vdc) 
Measured  
(Vdc) 
10  9.97 9.4 
20  19.94 18.6 
30  29.92 27.6 
40  39.89 38 
50  49.86 46.8 
60  59.83 56 
70  69.80 64 
80  79.78 70.4 
90  87.75 76.8 
100  99.72 84.0 
 
Table 4-2 shows the comparison of input voltage and output voltage between modelled 
and measured. There is good agreement between the modelled and measured results. It 
can be seen that the modelled results remain consistent when the circuit was under 
increased the voltage. Also the measured data gives similar results with the modelled.  Chapter 4 Electroporation system design 
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4.4.3  The output waveform of electroporation circuit 
This section presents an example of the output waveform of electroporation circuit with 
electroporation curette. The electroporation circuit of output waveform at 10, 50 and 
100 volt are shown in figures 4-12, 4-13 and 4-14 respectively.  
 
 
(a) 
 
(b) 
Figure 4-12: Output waveform of modelled and measured: (a) output simulation (9.9 
Volt) (b) output voltage 9.4 volt. Input voltage 10 volt. Vertical scale: 5V/division. 
Horizontal: 1 ms/division 
Figure 4-12 shows the output waveform of modelled and measured at 10 volt. The 
modelled output waveform is 9.4 volt and the measured result of output waveform is 
9.4 volt and pulse width is 4.5msec.  
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(a) 
 
(b) 
Figure 4-13: Output waveform of modelled and measured: (a) Output waveform of 
simulation (49 volt) (b) output voltage 46.8 volt. Input voltage 50 volt. Vertical scale: 
10V/division. Horizontal: 1 ms/division. 
The output waveform of modelled and measured at 50 volt is shown in figure 4-13. The 
modelled result of output waveform is 49.4 volt and the measured result of output 
waveform is 46.8 volt and pulse width is 4.5msec. 
 
            Time
0s 10ms 20ms 30ms 40ms 50ms
V(Vout_c:1)
0V
12.5V
25.0V
37.5V
50.0V
200µs 
4.5ms 
200µs 
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(a) 
 
(b) 
Figure 4-14: Output waveform of modelled and measured: (a) Output simulation 
waveform (99 volt) (b) Output voltage 84.0 volt. Input voltage 100 volt. Vertical scale: 
20V/division. Horizontal: 1 ms/division. 
Figure 4-14 illustrates the measured output waveform at 100 volt. The modelled result 
of output waveform is 99 Volt and the measured result of output waveform is 84.0 volt 
and pulse width is 4.5ms.  
The simulation and measured data are presented in figures 4-12, 4-13 and 4-14. They 
represented the example at 10, 50 and 100 volt. There is a good agreement between the 
measured and modelled results of output waveform. However, the measured data at 100 
volt was 84 volt, lower than the modelled result. This electroporation circuit will be 
investigated for poration rate in chapter 5.  
            Time
0s 10ms 20ms 30ms 40ms 50ms
V(Vout_c:1)
0V
25V
50V
75V
100V
200µs 
4.5ms 
200µs  5ms Chapter 4 Electroporation system design 
  86
4.5  Conclusion 
The electroporation system has been designed, assembled and electrically tested. The 
electroporation system can be used to supply a range of voltages between 0 and 100 
volt and is shown to generate a square wave pulse signal every 4.5msec (although this 
time is programmable). The electroporation system parameters have been set up to 
match the parameters described in the literature review (see section 4.2). This system 
will be used to evaluate the poration rate of cancer cells using propidium iodide dye in 
the next chapter.  
87 
Chapter 5   
Initial Evaluation of Sonoporation 
and Electroporation of HeLa Cells  
5.1  Introduction 
The aim of this chapter is to present the initial evaluation of sonoporation and 
electroporation systems that can be used in biological applications. The sonoporation 
and electroporation systems have been designed, assembled and tested as presented in 
chapters 3 and 4. In order to evaluate their performance, they were used to porate cells 
and poration efficiency and cell viability were determined under a range of conditions. 
In this study, human cervical cancer (HeLa cells), propidium iodide dye and trypan 
blue were used. The chapter describes the experimental methodology used in the 
preparation of the cells and the procedure followed for attempting poration and 
observing the results. Sonoporation was investigated with a range of voltages from 0 to 
100 V and with a fixed sinusoidal frequency of 1.1 MHz. The electroporation system 
was evaluated with a range of voltages from 0 to 100 V/cm and a fixed pulse length of 
5 msec. The sonoporation chamber is also investigated for cell manipulation. The 
sonoporation system is also used later in chapters 6, 7 and 8 to investigate cell 
transfection using plasmid DNA, a range of exposure times and a range of frequencies.  Chapter 5 Sonoporation and Electroporation experiment 
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5.2  Material and sonoporation methods 
This section presents the procedures followed to prepare the materials used in this 
study. 
The evaluation of sonoporation involves four steps: 
1.  Preparation and culture of cells (HeLa cells). 
2.  Sonoporation of HeLa cells. 
3.  Calculate the poration percentage achieved by Propidium Iodide dye intake 
by the cells. 
4.  Calculate cell viability percentage using Trypan blue 
5.2.1  General procedure  
•  All media preparation and HeLa cell work was performed under a laminar 
flow hood which was turned on for several minutes before starting work. 
•  Wipe down all surfaces with 70% ethanol.  
•  Wash hands with 70% ethanol before handling the cultures. 
•  Prepare the sterile pipettes, disposable test tubes and sterile pipette tips 
used with cell cultures. 
All cultures vessels, test tubes, pipettes tips boxes were opened only under laminar flow 
hood in order to keep sterility. If something was opened in a non-sterile environment by 
accident, it was assumed it is contaminated. Therefore, any contaminated material was 
immediately discarded into the biohazard container, or used only for non-sterile 
purposes. 
5.2.2  Procedure A: Preparation of culture cells (HeLa cells) 
The cell culture was prepared by taking a 10 ml solution with a HeLa cell concentration 
of 100,000 cells/ml. The HeLa cells were cultured as monolayer in a humidified 
atmosphere of 95% air and 5% CO2 at 37 ºC in DMEM (Dulbecco’s modified eagle 
medium) tissue culture medium (Gibco, UK) supplemented with 4mM L-glutamine, Chapter 5 Sonoporation and Electroporation experiment 
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HEPES buffer, Pyruvate (Invitrogen) with 0.5% Ultroserum G (Pall Biosepra) and 
100μg/ml Pencillin/Streptomycin (Invitrogen). The cells were grown in 75cm
3 flasks 
with 20 mL of culture medium [107]. To maintain good cell growth, the cells were split 
between flasks every 3rd or 4th day, and following procedure B. 
5.2.3  Procedure B: Trypsinization  
Trypsinization is the process where cell cultures or tissue cultures are dissociated from 
the container and each other i.e. the cells were detached from the culture flask. 
1.  Wash cells in PBS without calcium (200μl), add trypsin and incubate for about 
5 minutes at 37ºC 
2.  Observe cell detachment under the microscope.  
3.  10 ml of culture medium (supplemented with 10% Fetal Bovine Serum) is 
added to the flask to neutralize the trypsin.  
4.  They were centrifuged for 5 minutes at 1000 rpm and the supernatant aspirated 
and disposed of. The pellet was then resuspended in fresh complete medium 
(200μl). 
5.2.4  Procedure C: Determine total cell counts by using a Hemocytometer 
A hemocytometer is used to determine a number of cells in a sample as shown in figure 
5-1. Ten microliters of the diluted cell suspension from procedure B was pipetted and 
transferred to the hemocytometer with the cover slip in place by carefully touching the 
edge of the cover slip with the pipette tip and allowing each chamber to fill by capillary 
action. The chamber could not be overfilled or under filled. The hemocytometer was 
observed using a microscope and the number of cells in 4 blue squares and the middle 
one were counted (typically 35-45 cells but not more than 100 cells per square), and the 
average calculated. To calculate the total number of cells per ml, multiply the average 
number of cells per square by the dilution factor. Multiply this number by 10,000 to 
calculate the number of cells in one ml of suspension [108]. This is shown in equation 
5-1.  Chapter 5 Sonoporation and Electroporation experiment 
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Figure 5-1: Haemocytometer 
Number of cells/ml = the average number of cells per square x 10
4x dilution factor   
                                (5-1)                          
Dilution factor = diluting an aliquot of the cell suspension 1:10  
The dilution factor is equal to the final volume divided by the aliquot volume (a 
measured sub-volume of original sample):10 ml/1ml = 1:10 dilutions (10
1) 
5.2.5  Procedure D:  Prepare sonoporation system  
1.  The sonoporation system consists of a TTi 40MHz, arbitrary wave form 
generator (TGA 1241), high power amplifier 0.15-230 MHz, 25W (HD 
communications Corp) and the sonoporation chamber (shown in figure 5-2). 
The sonoporation chamber has been described in chapter 3. 
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Figure 5-2: Sonoporation system 
 
2.  Sonoporation experiments were performed at room temperature (25 ºC) at a 
fixed sinusoidal frequency of 1.1 MHz and with a range of amplitudes (0-
100Vp-p) across the transducer. The frequency of 1.1 MHz is used because this 
is the resonant frequency of the chamber. 
3.  The HeLa cells suspensions are mixed with the Propidium Iodide dye and then a 
syringe pump (1ml) is used to transfer the HeLa cells into the sonoporation 
chamber. 20μl of the HeLa cell suspension was introduced into the sonoporation 
chamber in this manner.   
4.  Then, the test voltage and frequency were applied for 5 sec continuously. 
5.  After 5 sec, the 20μl of sonoporated HeLa cells are transferred into an 
eppendorf tube and kept at room temperature. 
6.  Next, the process is repeated from step 2. 
7.  The sonoporation chamber, input fluid tube and output fluid tube are washed 
with 70% ethanol before performing another experiment 
Sonoporation chamber  Syringe pump 
Function generator 
Oscilloscope 
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5.2.6  Procedure E: Determine the number of sonoporated cells using a 
Hemocytometer 
Take 10μl from the 20μl of sonoporated HeLa cells and leave aside for cell viability 
experiment (see the procedure F below) 
 
1.  The 10μl solution from procedure D was pipetted and transferred to the 
hemocytometer with the cover slip. 
2.  The hemocytometer was observed using a fluorescent microscope and the 
number of unstained cells and stained cells in each square was counted. Again 4 
squares were used and the average was calculated as described in section 5.2.4. 
The number of stained cells will include some dead cells. 
3.  Take pictures from the fluorescent microscope. 
4.  Wash the hemocytometer with 70% ethanol. 
5.  Finally, calculate the sonoporation percentage 
          
The sonoporation percentage = The total number of stained cell x100%      (5-2) 
                     The total number of cells   
5.2.7  Procedure F:  cell survival  
1.  Each 10μl reserved for assessing cell viability was added to 300µl of fresh 
complete medium and then seeded into one well of a 24 well plates. (22 wells in 
total) 
2.  The cells were then incubated for 24 hours in a 37 ºC humidified incubator. 
3.  After 24 hours, cells in suspension were collected into a test tube, and the 
remaining attached ones were washed with PBS (200μl), which was also 
collected in the same tube. 
4.  To ensure all cells are recovered, add 75 µl of trypsin into the 22 well plates. 
The cells suspension was incubated at 37 ºC in an incubator for 5 min.  Chapter 5 Sonoporation and Electroporation experiment 
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5.  The detached cells from step 4 were then collected in the same tubes from step 
3. 
6.  Mix thoroughly and then centrifuge for 5 min at 3000 rpm (equivalent 900 g) 
where g = 9.81m/s
2. 
7.  Resuspend the cell pellet (300µl) in fresh medium (10 µl).  
8.  Finally, 110μl of the cells suspension was transferred into a test tube for 
checking the number of viable cells; as described in the next procedure. 
5.2.8  Procedure G: Prepare the trypan blue staining of cells 
1.  Combine 0.5 ml of Trypan blue solution and 0.3 ml of Hank’s balanced salt 
solution or PBS [108]. 
2.  Add the 110μl of the suspension to the Trypan blue mix, mix thoroughly and 
incubate for 5 min at room temperature. 
3.  Spin down cells, remove approximately 80μl of solution and resuspend 
remaining solution in medium (20μl). 
4.  Fill a hemocytometer as for cell counting. 
5.  Since dead cells will take up the trypan blue stain, under the microscope, the 
number of stained non-viable cells that have absorbed dye and appear blue was 
observed, as well as the number of unstained viable cells that have not (and are 
not blue) absorbed dye.  
6.  Determine the percentage of viable cells as following equation 5-3 
 
The viable cell percentage (%) =  Number of unstained cell x 100 %       (5-3) 
                                              Total number of cells (unstained and stained cell) 
Following, the procedures A to G were followed in all the sonoporation experiments. 
The results from the experiments are given in the next section. Chapter 5 Sonoporation and Electroporation experiment 
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5.3  Sonoporation efficiency  
5.3.1  Sonoporation efficiency: Evaluation of amplitude 
In this study, the sonoporation system was investigated with HeLa cells and Propidium 
Iodide dye at a fixed sinusoidal frequency of 1.1 MHz and with a range of amplitudes 
from 0 to 100Vp-p. For each condition, the sonoporation efficiency was investigated 
three times with the same batch of cells, following procedure A to procedure E. Each 
experiment was then repeated twice using different batches of cells. By means of 
illustration, three sample cases of the poration results are shown in figure 5-3. Figure 
5-3(a) shows the cells after sonoporation with 0Vp-p (control condition). This shows 
approximately 10% of stained cells. Figure 5-3(b) shows the cells after sonoporation 
with 10Vp-p, which yield 20% stained cells. Finally, figure 5-3(c) shows cell 
sonoporated at 50Vp-p which gives 87% of stained cells.  
 
       
(a) 
Figure 5-3: Sonoporation results observed by fluorescent microscopy (a) sonoporation 
control (yellow square indicated the area of interest) 
HeLa cells 
Area of interest Chapter 5 Sonoporation and Electroporation experiment 
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(b) 
      
(c) 
Figure 5-3: Sonoporation observed by fluorescent microscopy (continue) (b) 10Vp-p, 
sonoporation percentage (~ 20 %) (c) 50Vp-p, sonoporation (~ 87%)  
This cell suspension contains cells of different sizes and also clumps of cells which 
have agglomerated. 
 
HeLa cells and PI 
Optical Reflection  Chapter 5 Sonoporation and Electroporation experiment 
  96
5.3.1.1  Sonoporation experiment 1 
The sample control cell suspension of 1 ml contained 4,300,000 cells. Figure 5-4 shows 
the result of sonoporation percentage from experiment 1. The vertical axis shows the 
percentage of sonoporation and the horizontal axis shows the applied voltage. When the 
amplitude increased from 10Vp-p to 40Vp-p, the sonoporation percentage increased 
from 20.91% (SD±3.06) to 41.51% (SD±5.07). At 50 Vp-p, the maximum sonoporation 
percentage (up to 87% SD±1.89) was achieved. Thus, the sonoporation percentage does 
appear to depend upon the amplitude applied across the transducer. After voltage was 
applied from 60Vp-p to 90 Vp-p the sonoporation percentage decreased slowly to 
54.48% (SD±10.5). However, the percentage of sonoporation rises up again to 70.72% 
(SD±7.92) at 100Vp-p. 
 
 
Figure 5-4: Sonoporation percentage: Experiment 1 
5.3.1.2  Sonoporation experiment 2 
In the second experiment, the sample cell suspension was approximately 2,700,000 
cells per 1 ml. The experiment was investigated in the same conditions as experiment 1, 
albeit with a reduced concentration of cells.  
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Figure 5-5 shows the result of sonoporation percentage from experiment 2. From the 
figure, it can be seen that the control condition gives 21.84% (SD±1.5). When the 
applied voltage increases from 10Vp-p to 30 Vp-p, the sonoporation percentage rose up 
consistently from 39.58% (SD±2.9) to 62.19% (SD±1.52). The peak sonoporation 
percentage was 74.17% (SD±1.17) at 50Vp-p. With applied voltage from 60 Vp-p to 
70Vp-p, the sonoporation percentage decreases to 47.3% (SD±0.94) and 35.71% 
(SD±6.9) respectively. Then the sonoporation percentage increases again to 69% 
(SD±10.97) at 90Vp-p.  
 
 
Figure 5-5: Sonoporation percentage: Experiment 2 
5.3.1.3  Sonoporation experiment 3 
In experiment 3, the number of cultures cell was about 2,000,000 cells per 1 ml. 
However, in this culture, cells appeared unhealthy under the microscope. This may be 
due to contamination by trypsin, the cells were resuspended in fresh new medium 
before continuing. Later results show that viability was similar to the first experiment. 
In addition, the Propidium Iodide dye was not mixed well with cells before starting 
experiment, and this is likely to have reduced the indicated sonoporation percentage as 
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not all cells will have been able to take up the PI. This is indicated by the percentage 
value of the control experiment, which is about half the value of experiments 1 and 2. 
Figure 5-6 illustrates the result of sonoporation percentage. As can be seen from the 
graph, the percentage of sonoporation steadily rises to 34.78% (SD±1.0) after applied 
voltage at 20Vp-p. Then, it dips before rising again at 40-50Vp-p. Then, the percentage 
varies at 60-90Vp-p before rose up to a peak at 100Vp-p of 46.07% (SD±0.2). In this 
experiment, the sonoporation percentage is lower than the previously experiments due 
to the unproductive mixing of the propidium iodide dye.  
 
 
Figure 5-6: Sonoporation percentage: Experiment 3 
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Figure 5-7: Sonoporation percentage from experiment 1, 2 and 3 
Figure 5-7 shows the combined results of sonoporation percentage from experiment 1, 
2 and 3 on the same graph. 
5.3.2  Assessment of accuracy of counting live and dead cells after 24hrs 
An experiment was undertaken to check the validity of counting the number of dead 
cells after 24 hours, in order to give confidence that cells had not lysed completely. In 
this experiment, the number of cultured HeLa cells was about 850,000 cells per 1 ml.  
This study was performed to investigate the suitability of assessing cell death using the 
trypan blue dye exclusion method after 24 hours. A haemocytometer and bright field 
microscopy were used to observe and count the number of cells. In this experiment 
cells were deliberately killed by electroporation and cell count was determined 
immediately after. The cells were then left alone for 24 hours, after which the count 
was repeated again. The number of cells at 0 hour was 850,000 cells and at 24 hours 
was 830,000 cells. The cell survival results show little difference in both conditions. 
Therefore, the number of cells does not degrade or disappear appreciably in that time 
frame.  
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Figure 5-8 shows a typical result of electroporation of HeLa cell after 80 V/cm were 
applied. The picture shows a comparison of dead cells versus live cells after 24 hours. 
It can be seen that dead cells (stained) are not as well formed as the live cells. However, 
they are still easily distinguishable, so we can conclude that it is possible to 
successfully differentiate between live and dead cell after 24 hours. 
This is also evidenced by Y. Chen et al. [61] who also used the Trypan dye exclusion 
method 24 hours after sonication for their experiments on viability and transfection. 
Also V.G. Zarnitsyn et al. [62] reported that viability is measured after 24 hours in their 
experiments because measurements made immediately do not account for longer term 
effects of ultrasound on viability, such as apoptosis. For this reason, all subsequent 
experiments measured cell viability 24 hours after sonoporation.  
Although under ideal conditions, HeLa cells will divide after 24 hours, [107] it is the 
experience of the laboratory that after processes such as sonoporation and 
electroporation, surviving cells will not divide in this time frame as they need time to 
recover from the process. Other studies have shown this to be the case. For example J. 
Landr and M. Marceau [109] reported that changing the ideal conditions of HeLa cells 
(in this case by elevating the temperature) resulted in up to several days recovery time 
before the normal cell cycle resumed. It is therefore concluded that waiting 24 hours 
after poration to allow the GFP to express does not affect the count of living and dead 
cells. 
 
Figure 5-8: dead cells versus live cells 
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5.3.3  Cell survival of sonoporation experiment  
In order to investigate viable cells, the procedure F and G were used to determine the 
cell viability using the trypan blue dye exclusion method. A haemocytometer and bright 
field microscopy were used to observe and count the total number of cells. Then the 
percentage of viable cells can be calculated using equation 3 from procedure G. Three 
sample cases of the cell viability results are shown in Figure 5-9. Figure 5-9 (a) shows 
the control condition after sonoporation with 0Vp-p. Figure 5-9 (b) shows the cells 
survival (~92%) after sonoporation with 10Vp-p and stained with trypan blue. 
Finally, Figure 5-9 (c) shows cell sonoporated at 50 Vp-p which give a cell viability of 
56%.  
Although different numbers of cells are shown in the pictures this is a result of the 
random nature of their distribution. The total number of cell concentration is the same 
in all cases.  
 
(a) Control condition 
Figure 5-9: Cell viability was observed by the microscope. (a) Control condition 
Unstained cell Chapter 5 Sonoporation and Electroporation experiment 
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(b) 10 Vp-p  
 
(c) 50Vp-p  
Figure 5-9: (b) 10 Vp-p, cell viability (~92%) from experiment 1 (c) 50Vp-p, cell 
viability (~52%) from experiment 2 
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5.3.3.1  Cell viability: Experiment 1 
 
Figure 5-10: Cell viability from experiment 1 
Cell viability was calculated for the full range of sonoporation experiment. Figure 5-10 
shows the percentage of cell viability by voltage. The peak percentage of cell viability 
is 92.09% (SD±6.9) occurred at 10 Vp-p. However, the cell viability dropped to 64.8% 
(SD±9.26), while applied voltage of 40Vp-p. The result shows a fairly consistent 
percentage of cell viability that does not vary greatly with applied voltage. This result 
shows a high percentage remain viable.  
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5.3.3.2  Cell viability: Experiment 2 
 
Figure 5-11: Cell viability from experiment 2 
Figure 5-11 illustrates the result of cell viability from experiment 2. As can be seen 
from the graph, the cell viability percentage is less than in experiment 1. The peak of 
cell viability is 72.87% (SD±18) at amplitude 20Vp-p, while the minimum is 45% 
(SD±7.07) at 40 Vp-p. The reason of low percentage cell viability was found to be due 
to procedural error. After mixing with Trypan blue, the cells had to wait for one and 
half hour before the microscope became available. This compares with a delay of 5 
minutes for experiments 1 and 3. Therefore, the result of experiment 2 does not achieve 
such high cell viability percentages. 
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5.3.3.3  Cell viability: Experiment 3 
 
Figure 5-12: Cell viability from experiment 3 
 
Figure 5-13: Cell viability results from experiment 1, 2 and 3 
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Figure 5-12 shows the result of cell viability from experiment 3. As can be seen from 
the picture, the percentage of viability cell is maximum (93.4% SD±0.4) at 90Vp-p and 
a minimum of cell viability percentage is 75% (SD±7.07) at 50Vp-p. The percentage 
rate in experiment 3 is almost the same as for experiment 1 with little variation across 
the voltages. 
5.3.4  The combined sonoporation and cell viability percentages 
This section presents the combined data from the sonoporation and cell viability 
experiments. The effect of sonoporation on the cell viability is studied. The 
sonoporation and cell viability percentages are investigated from experiment 1, 2 and 3. 
5.3.4.1  The combined sonoporation and cell viability percentage: experiment 1 
Figure 5-14 shows a sonoporation and cell viability percentages on the same graph. The 
vertical axis shows the sonoporation percentage and the cell viability percentage. The 
horizontal axis shows the applied voltage. From the plot, cell viability percentage 
shows a small amount of variability, but sonoporation percentage does vary depending 
upon the applied voltage. For example, at a voltage of 50V, the sonoporation rate is 
86.52%±1.8, with a viability rate of 87.56% ±1.2 yet at 10V, the sonoporation 
percentage is 20.91%±3.0, and the the cell viability percentage was (92.09%±6.9). 
Thus, the high sonoporation efficiency does not appear to be affecting the cell viability. Chapter 5 Sonoporation and Electroporation experiment 
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Figure 5-14: Sonoporation and cell viability percentages from experiment 1 
5.3.4.2  The combined sonoporation and cell viability percentage: experiment 2 
Figure 5-15 shows the combination of sonoporation percentages and cell viability from 
experiment 2.  The result of sonoporation percentage is similar to previous experiment, 
but the cell viability percentage was not as high as for experiment 1. The reason has 
been described in the section 2.3.2. From the graph, the variation cell viability 
percentage was between 45% (SD±7.0) and 76% (SD±1.9).   
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Figure 5-15: Sonoporation and cell viability percentages from experiment 2 
5.3.4.3  The combined sonoporation and cell viability percentages: experiment 3 
 
 Figure 5-16: Sonoporation and cell viability percentages from experiment 3 
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Figure 5-16 illustrates the combination of sonoporation and cell viability percentages 
from experiment 3. As can be seen from the graph, the percentage cell viability shows 
good correlation with experiment 1. The sonoporation percentage was not as high as 
experiments 1 and 2 (see section 5.3.4). Although the results show a relatively low 
sonoporation percentage, the cell viability percentage achieved was high. However, 
propidium dye is not appropriate for use in evaluating transfection efficiency because 
this dye is also used to evaluate cell death and therefore dead cells may well take in the 
propidium dye. Therefore, the sonoporation results presented are not accurate because 
they may also include the number of dead cells. However, as the viability is very high 
for these experiments, this still implies a high rate of poration. To investigate 
transfection efficiency correctly, plasmid DNA will be used as described in chapter 6, 7 
and 8. This is widely used to determine the influence of sonoporation when transfecting 
cells [62]. 
5.3.5  Comparison with the literature 
Table 5-1: Sonoporation transfection efficiencies and cell viability percentage from the 
literature 
Name of researchers  Sonoporation  Method 
Transfection efficiency  Cell viability 
Loreto B. Feril et.al [110]  16%  80% 
Chen et.al [111]  26%  - 
Chun-Yen et.al [11]  35%  45% 
 
Table 5-1 illustrates transfection efficiencies and cell viability percentages based on 
sonoporation reported by other researchers. These examples are the closest found in 
terms of experiment procedure to the work presented here. These studies have also used 
HeLa cells. For example, 16% transfection efficiency and 80% of cell survival were 
successful in HeLa cells by Loreto B. Feril Jr. et. al [110]. In addition, 26% of 
transfection rate was achieved by Chen et. al [111]. This report investigated ultrasound Chapter 5 Sonoporation and Electroporation experiment 
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mediated gene transfection in vitro using contrast microbubbles. Finally, 35% 
transfection rate and 45% of cell viability were achieved by Chun-Yen et. al [11]. This 
research studied the ultrasound induced acoustic cavitation assisted gene delivery and 
transfection of cells. The results of experiment 1, 2 and 3 showed a higher sonoporation 
efficiencies and cell survival rates when compared to these other experiments [11, 111]. 
Although, they are performing transfection rather than just perform sonoporation. The 
work presented in this thesis uses an ultrasonic chamber operated deliberately at its 
resonant frequency. It is believed that this is the main differentiator between this work 
and previous published work. These initial results were extremely encouraging and 
more investigation was required to establish the exact mechanism at work.  
5.4  Electroporation experiment with HeLa cells and Propidium 
Iodide dye 
This section presents the experimental methodology for the preparation of the cells and 
the procedures followed for investigating poration and cell viability using the 
electroporation system. HeLa cells, propidium iodide and trypan blue dyes were again 
used. The electroporation system was investigated with a range of voltages from 0 to 
100 V/cm and a fixed pulse length of 5 msec. The results from this experiment are 
presented in sections 5.4.2 and 5.4.3. 
The evaluation of electroporation involved four steps:  
1.  Preparation and culture of cells (HeLa cells) as described in section 5.2.2. 
2.  Electroporation of HeLa cells. 
3.  Calculate the electroporation percentage achieved by Propidium Iodide dye 
intake by the cells. 
4.  Calculate cell viability percentage using Trypan blue. 
5.4.1  Electroporation procedure 
The procedure is very similar to that used in the sonoporation experiment. The 
following variations are noted. Chapter 5 Sonoporation and Electroporation experiment 
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1. The electroporation system is shown in figure 4-3 from chapter 4.  
2. The HeLa cell suspensions are mixed with the propidium iodide dye (10μg/mL) and 
then a pipette (20µl) is used to transfer the HeLa cells into the electroporation cuvette 
with 1mm gap (BTX, Holliston, MA, USA) 
3. Then, the high voltage from the high voltage power supply was applied to the 
electroporation system which generated a pulse length of 5 msec. The high voltage and 
pulse length of 5 msec were applied for 5 sec continuously with the duty cycle shown 
in figure 4-13. 
4. After 5 sec, the 20µl of HeLa cells are transferred into a sterile eppendorf tube and 
kept at room temperature. 
5. This process is repeated. The electroporation cuvette was replaced before performing 
the next experiment. 
Procedure E in section 5.2.6 is used to determine the number of electroporated HeLa 
cells. After the HeLa cells were electroporated, a 10 µl sample was taken from the 20µl 
of electroporated HeLa cells and put aside for cell survival experiment. The 10 µl were 
plated into 24 well plates and incubated for 24 hrs at 37 ºC. In order to investigate cell 
survival after electroporation, procedure F and G as shown in section 5.2.7 and 5.2.8 
were followed.  
5.4.2  Electroporation experiment results  
The results from this experiment are presented in terms of electroporation efficiency 
and cell viability.  
5.4.2.1  The electroporation efficiency: Evaluation of amplitude  
The electroporation efficiency was evaluated with a range of voltages from 0 to 
100V/cm. For each condition, the electroporation efficiency was investigated from 
three experiments using different batches of cells, following procedures described in 
section 5.4.1. Each experiment has been repeated twice and analyzed. Three sample 
cases of the poration results are shown in the figure 5-17. Figure 5-17 (a) shows the 
control condition of HeLa cells (3.86% ±SD1.56). Figure 5-17 (b) shows Chapter 5 Sonoporation and Electroporation experiment 
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approximately 7.5% ±SD3.24 of stained cell at 10V/cm. Finally, figure 5-17 (c) 
presents cells electroporated at 90V/cm which gives 21 % of stained cells. 
  
(a) Control 
  
(b) Control (Fluorescence) 
Figure 5-17: Electroporation results observed by fluorescent microscopy: (a) control 
(no electroporation) (b) control electroporation percentage (~7.49%) (A yellow square 
indicated the area of interest) 
HeLa cells 
Area of interest 
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(c) 90 V/cm (Fluorescence) 
Figure 5-17: Electroporation results observed by fluorescent microscopy: (c) 90V/cm, 
electroporation percentage (~21%) 
5.4.2.2  Electroporation experiment 1 
In experiment 1, 1 ml of control sample cell suspension which contained 3,200,000 
cells was used. Figure 5-18 shows the result of electroporation efficiency dependent on 
field strength. From the graph, it clearly shows that, there is a step change in 
electroporation efficiency at 60V/cm. The region from 10 to 50 V/cm gives less than 
10% electroporation efficiency. At a field strength of 60 V/cm and above, it shows a 
significant improvement of electroporation efficiency. The maximum electroporation 
rate was 21.19% (±SD4.71) at 90 V/cm. Thus it can be concluded that at field strength 
lower than 60V/cm, the field strength is not sufficient to open the pores of HeLa cell; 
with a resulting low dye uptake into the cells.  
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Figure 5-18: Electroporation percentage from experiment 1 
5.4.2.3  Electroporation experiment 2 
In the second experiment, the sample cell suspension contained approximately 
3,500,000 cells per 1 ml.  
Figure 5-19 shows the result of electroporation percentage from the experiment 2 
which similar to those obtained from experiment 1. Again electroporation efficiency 
appears to improve above 50V/cm. The maximum electroporation rate was 19.08% 
(SD±0.67) at 90V/cm, compared to the control condition of 8.81% (SD±1.5). 
Electroporation efficiency then decreases to about 11% again at 100 V/cm/, the reason 
for this is not known at present.  
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Figure 5-19: Electroporation percentage from experiment 2 
5.4.2.4  Electroporation experiment 3 
Experiment 3, the number of cultured cells was about 3,200,000 cells per ml. The 
results from this experiment are less conclusive from 10V/cm to 60V/cm; the 
electroporation efficiency is lower than 15%; Maximum electroporation efficiency of 
17.21% SD± 3.44 occurred at 80V/cm which is shown in figure 5-20. 
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Figure 5-20: Electroporation percentage from experiment 3 
 
Figure 5-21: The combined result of electroporation from experiment 1, 2 and 3 
Figure 5-21 illustrates the combined result of electroporation experiment 1, 2 and 3 in 
the same graph. 
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5.4.3  Cell viability measurement for the electroporation experiment  
The cell viability was investigated under three independent cases. One sample was kept 
for control and compared with other electroporation conditions. Two sample cases of 
the cell viability results are shown in figure 5-21. Figure 5-21(a) shows control 
condition. Figure 5-21(b) shows cell viability at 100V/cm.  
 
 
(a)  Control condition 
Figure 5-22: Viable cells observed by the microscope. (a) control condition  
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(b) 100 V/cm 
Figure 5-22: (b) The cell viability observed by microscope of 100V/cm condition 
(experiment 3) 
5.4.3.1  Result of the electroporation cell viability: experiment 1 
For this analysis all experiments were performed at least 3 times (n > 3) [61]. Each 
experiment was analysed and the viability was counted in a hemocytometer with the 
trypan blue dye after electroporation after 24 hours. The experiment results were 
presented with the viability percentage and standard deviation (SD). From experiment 
1, a high cell viability percentage is obtained for all voltages. Maximum cell viability is 
94.7% (SD±3.53) and occurred at 70V/cm. The lowest percentage of cell viability was 
found at 90 V/cm but it increased again at 100V/cm and therefore there seems to be no 
simple relationship between cell viability and field strength.  
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Figure 5-23: Cell viability from experiment 1 
5.4.3.2  Result of the electroporation cell viability: experiment 2 
From figure 5-24, it can be seen that the control condition gives 94.2% (SD±3.13).  
The average percentage cell viability is 89.7% (SD±2.9) and there is a little variation 
with applied voltage. The electroporation voltage has a small affect on the cell viability 
when high voltage is applied. The maximum peak cell viability percentage was 92.01% 
(SD±2.17) at 40V/cm. 
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Figure 5-24: Cell viability from experiment 2 
5.4.3.3  Electroporation cell viability: experiment 3 
Experiment 3 shows lower cell viability than experiment 1 and 2. It appears that the 
cells are less healthy than those used in experiment 1 and 2. This may have had an 
effect on the results presented in section 5.4.2.4 which do appear less conclusive than 
for experiment 1 and 2. 
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Figure 5-25: Cell viability from experiment 3 
 
 
Figure 5-26: the combined cell viability from experiment 1, 2 and 3 
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Figure 5-26 shows good agreement between experiment 1 and 2. Cell viability for 
experiments 1 and 2 is quite high averaging 89% and 87% respectively. 
5.4.4  Summary  
This section has shown that the electroporation system can achieve poration and 
maintain a high cell viability percentage. It can be concluded that the percentage of 
electroporation is a function of electric field and accesses at 60V/cm. This work 
illustrates a low electroporation percentage and high cell viability compared to other 
research work. Türk M et.al [112] investigated transfection efficiencies of HeLa cells 
with DNA (pEGFP-N2) using various types of polythyleneimine as temperature 
sensitive cationic copolymers (non viral vector). They reported a transfection efficiency 
of 70%. Also Jacob et.al [113] evaluated transfection efficiencies of HeLa cells with 
pEGFP plasmid using impedance power assisted electroporation and using field 
strength 75V/mm and pulsed length 0.1ms. This demonstrated 10% transfection 
efficiency and a cell viability of 25%. Finally He, H et.al [114] examined the uptake of 
different dextran weight bio molecules in HeLa cells using a micro electroporation. 
This work presented an increase in fluorescent cells with an increase in the electric 
field from 0.5KV/cm to 8KV/cm. The maximum fluorescent cells of 50% occurred at 
8KV/cm for large molecules of 40KDa and 70KDa weight, and cell viability gives 
lower than 20%with increasing in a range of electric field of short duration (400µs).  
5.5  Experimental cell manipulation 
This section investigates cell manipulation using the resonant sonoporation chamber. 
The sonoporation system was operated at resonant frequency. Simulation and 
modelling has identified a resonant frequency between 970 KHz and 1.06 MHz in the 
resonant sonoporation chamber which produces a standing wave. This would be able to 
move materials such as yeast, cells and plasmid DNA to the location of minimum 
pressure at the node plane. This section also describes the details of the preparation 
procedure. The experimental results of the cell manipulation are given in section 5-7. Chapter 5 Sonoporation and Electroporation experiment 
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5.6  Materials and method 
The procedure to investigate the cell manipulation of the sonoporation chamber on 
yeast is described in the following. In this study, green fluorescent yeast cells (10 
micron) were used to investigate cell manipulation. The yeast cells were mixed well 
with 1 ml of water. The experiment set up consists of the resonant sonoporation 
chamber, a function generator, RF amplifier, an oscilloscope and fluorescent 
microscope. The schematic sonoporation system is shown in figure 5-27. The cell 
manipulation was investigated under three different conditions.  
•  The first condition is the sonoporation chamber without applied power,  
•  The second condition is sonoporation chamber with voltage applied across the 
transducer.  
•  The final condition is the condition some time after the applied voltage across 
the transducer has been removed. 
Prior to investigating cell manipulation, the yeast cell (10 micron) were mixed with 
water (1ml). Then 20 µl of yeast cells were transferred into the sonoporation chamber. 
Then, the sonoporation chamber was driven by a fixed gain (50dB) amplifier and a 
signal generator at the resonant frequency of the resonant sonoporation chamber. An 
optical microscope is used to observe to monitor the position of yeast particles inside 
the sonoporation chamber under three different conditions. The microscope was 
focused on the boundary between the reflector and fluid layer of the sonoporation 
chamber. The results are given in the next section. Chapter 5 Sonoporation and Electroporation experiment 
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Figure 5-27: The schematic of the sonoporation chamber and equipment 
5.7  Results of cell manipulation 
The optical microscope was used to observe the position of green fluorescent yeast 
within the fluid layer of the sonoporation chamber. In this experiment, the cells were 
observed under three different conditions such as before, during and after applying the 
voltage across the transducer. In order to monitor the cell manipulation in the 
sonoporation chamber, it is necessary to identify voltage minima. This voltage minima 
can indentify the region of resonant frequency more conveniently than impedance as 
shown in section 3.8. In this study, the resonant frequency of the sonoporation chamber 
mode was found at 980 KHz. Figure 5-28 (a) shows the experimental result from the 
first condition which is the random distributed green fluorescent cells before applying 
the voltage across the transducer. Figure 5-28 (b) shows the cells shortly after the 
power has been applied, and moving towards the boundary of the fluid layer and 
reflector layer at 980 KHz. Figure 5-28 (c) shows the final situation after applying the 
voltage across the transducer 
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(a)                                                        (b) 
    
(c)                                                         (d) 
a) Power off, Particles randomly distributed 
b) Power on 50Vp-p at 980 KHz focus on reflector boundary 
c) Power on 50 Vp-p at 980 KHz, the yeast cells are transported to nodal 
position of the sonoporation chamber 
d) After the acoustic is turned off (1-2 minutes) 
Figure 5-28: The result of a cell manipulation sequence to move cells to the 
reflector boundary under three conditions at 980 KHz  
It can be seen that figure 5-28 (a) shows the distributed random cells before acoustic 
power is applied across the transducer with the microscope focussed at fluid layer and 
reflector layer boundary. Figure 5-28 (b) shows the yeast being moved into the focus 
after acoustic power is applied for about 5 seconds. Figure 5-28 (c) shows there are 
now many more yeast cells in the focus. Figure 5-28 (d) shows after the acoustic power 
is turned off. The clump of yeast cells is slightly away from the nodal position in the 
Concentrated yeast cells Chapter 5 Sonoporation and Electroporation experiment 
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fluid layer and so they are out of focus. In this study, the sonoporation system has 
demonstrated that it can used to move the yeast to the location of minimum pressure at 
the node plane. The yeast cells are driven against gravity whilst acoustic power is 
applied at resonant frequency 980 KHz. After the acoustic power has been turned off, 
the yeast clump starts to move away from the reflector layer to the matching layer and 
under the influence of gravity, and so go out of focus. This method is advantages, for 
example, it is appropriate for manipulating cells in a short space of time. Also it enables 
the control of cells and plasmid DNA and places them in close proximity. This is a 
good way of providing a more consistent sonoporation technique because the 
concentrate of cells is not random while these cells are applied the energy. The cell 
manipulation technique does not damage cells because it uses the minimum pressure at 
the node plane. The cell manipulation can be applied to different type of cells (e.g. 
HeLa cells, human mesenchymal stem cells) [115]. Therefore, the cell manipulation 
offers great promise in supporting the sonoporation system. However, the investigation 
of cell manipulation and sonoporation is still valid and ways to implement these are 
detailed in the section on future work. Survival of cells when sonoporated with plasmid 
DNA will be investigated further in chapters 6, 7 and 8.  
5.8  Conclusion 
This chapter has described the procedure for the sonoporation and electroporation 
methods. This research explored the advantages of sonoporation and electroporation to 
investigate poration efficiency and determine cell viability. This study has shown the 
sonoporation system can achieve successful poration of HeLa cells and enable uptake 
of the dye. The poration efficiency of sonoporation was greater than electroporation 
method which is shown in section 5.3. Additionally, the cell viability remained high 
over the three experiments. This work has shown that the results gained vary depending 
upon the health of the cells and great care must be taken in following the procedure 
carefully. It can be concluded from these experiments that sonoporation is potentially 
better than the electroporation method, certainly for HeLa cells, with extremely good 
results. Therefore, it was decided to investigate sonoporation further. Chapter 6 
investigates transfection efficiency with plasmid DNA versus frequency. Chapter 7 
investigates transfection efficiency with plasmid DNA based on a resonant frequency Chapter 5 Sonoporation and Electroporation experiment 
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(980 KHz) of the sonoporation chamber. Finally, chapter 8 presents the results from 
using the sonoporation chamber with THP-1 cells and plasmid DNA for a limited range 
of conditions.   
128 
Chapter 6   
Investigation Sonoporation using a 
Range of Frequencies and Sweep 
Frequency  
6.1  Introduction  
This chapter presents the investigation of the sonoporation system using HeLa cells and 
plasmid DNA under a range of frequencies (from 950 KHz to 1.29 MHz) and a swept 
frequency. This investigation aims to identify the optimal frequency for cell 
transfection based on resonant frequency of the sonoporation chamber. The chapter 
also presents details of the preparation of the plasmid DNA and the procedures 
followed for attempting and observing the results. This part also presents the results of 
impedance measurement and resonance frequency data with different concentrations of 
HeLa cells.  
6.2  Material and Methods  
This section presents the procedure and preparation of materials used in this study. Chapter 6 Investigation Sonoporation using a range of frequencies  
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6.2.1  Procedure A: Prepare of plasmid (pEGFP-N1)  
Green fluorescent protein (GFP), which has been used in other work [62, 97], was used 
in this experiment (pEGFP-N1 (size: 4.7Kb)) [116]. The GFP plasmid 
deoxyribonucleic acid (DNA) was provided by the University of Southampton, School 
of Medicine. This pEGFP-N1 has been optimized for fluorescence with a peak 
wavelength of 507 nm. This plasmid was prepared and extracted from bacterial cells by 
alkaline lysis and purified by the Qiagen Giga kit (Qiagen Inc., CA, and USA) [117]. 
The final DNA concentration was determined by measuring absorption at 260 nm and 
280 nm by a Nanodrop 1000 spectrophotometer (Thermo Scientific). The result of this 
measurement showed a ratio of 1.3 of plasmid (the ratio between 260nm and 280 nm 
wavelengths) which indicated that the purified DNA was a free of proteins and RNA. A 
concentration of 50 µg/ ml of GFP plasmid were added to the HeLa cell culture 
medium before sonoporation. This pEGFP-N1 vector information is shown in figure 
6-1.  
 
Figure 6-1: pEGFP-N1 Vector information [116] 
6.2.2  Procedure B: Preparation of culture cells (HeLa cells)  
The cells used in this study are HeLa cells which were grown in a humidified 
atmosphere of 95% air and 5% CO2 at 37 ºC in DMEM (Dulbecco’s Modified Eagle Chapter 6 Investigation Sonoporation using a range of frequencies  
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Medium) tissue culture medium (Gibco, UK) This media consists of 4mM L-glutamine, 
HEPES buffer, Pyruvate (Invitrogen) with 0.5% Ultroserum G (Pall Biosepra) and 
Pencillin/Streptomycin (Gibco, UK). The HeLa cells were grown in 75 cm
3 flasks with 
20 mL of culture medium. In order to maintain good quality HeLa cell growth, these 
cells were split every 3
rd or 4
th day. Culture cells were resuspended with trypsin/EDTA 
(0.05%, Invitrogen) before using and plating in polystyrol flasks. Each experiment used 
1 ml of solution (4,000,000 cells). The remaining cells were used by other researchers 
or other experiments. 
6.2.3  Procedure C: Trypsinization 
The trypsinization process is used to dissociate the cell culture from the container and 
is the same process as described in section 5.2.3. 
6.2.4  Procedure D: Determine the number of cell counts by using a Hemocytometer 
This is the same as used in pervious experiments, see section 5.2.4. 
6.2.5  Procedure E: Determine transfection efficiency using Flow cytometry (FACS 
scan) 
This section describes the procedures followed to determine the transfection efficiency 
using fluorescence assisted flow cytometry (FACS scan) (Becton Dickinson 
FACScalibur Flow Cytometer) and Cell Quest software. Flow cytometry is a technique 
that is used to measure and analyse characteristics of cells. Normally, these cells flow 
in the fluid stream and are carried passed a beam of laser light. Provided cells can 
fluoresce, the incident light excites this fluorescence and the number of cells excited in 
the manner can be counted. This enables the FACS scan to accurately determine the 
transfection efficiency and it can also be used to measure and analyse the physical 
characteristic of cells such as relative particle size, relative granularity or internal 
complexity, and relative fluorescence intensity. The following procedures were 
followed.  
1.  Each 180μl sample from procedure E was transferred to the FACS tube.  Chapter 6 Investigation Sonoporation using a range of frequencies  
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2.  Prior to measurement, the samples were placed in the incubator on ice at 4 ºC. 
3.  Before cells are transferred to the FACS scan machine, the FACS machine was 
setup as follows.  
3.1 Fill sheath fluid container approximate by ¾ full with FACS flow 
solution.  
3.2 Waste container was emptied and ½ precept tablet added to the 
container to prevent potential infection from samples of biological material. 
3.4 Pressurise the sheath container using the vent value. 
3.5 With UHQ tube approximate ¾ full run on High for 2 minutes. Do not 
allow tube to run dry. Press “stand by” when complete. 
4. The BD cell Quest Pro software was used to create a FSC (Forward Scatter) vs. SSC 
Height (Side scatter) plot. The FSC measurement indicates the relative difference in the 
size of the cells and this SSC measurement is related to differences in the inner 
complexity of the cells or particles. Next, a dot plot of FL-1(fluorescent detectors) is 
created. The FSC amp gain and SSC voltage need to be adjusted in order to correctly 
display the scatter properties of the experiment. After the analysis, the machine is 
cleaned using a fresh tube filled with 3 ml of FACS Clean (or 10% Sodium 
Hypochlorite), followed by a fresh tube of water. The waste is emptied down into the 
sink and tablet of virkon placed into the empty tank 
6.2.5.1  Data analysis by flowcytometer 
This section presents the analysis of the transfection efficiency using a flowcytometer 
(FACS scan). Typically, the flowcytometer produces a histogram that displays data 
from a population and the level of fluorescence. Cell populations that have been 
sonoporated will demonstrate high fluorescence when transfection has successfully 
occurred. The number of fluorescing cell from the sonoporation population is compared 
to a control condition population by observing the histograms. The flowcytometer is 
able to indentify the population of non-transfected and transfected cells based on the 
fluorescence intensity. In this study, data analysis consists of displaying the control 
condition histogram and the histogram of the sonoporated cell population. In order to 
identify non transfected and transfected cells, a gate is applied to the data plot as a Chapter 6 Investigation Sonoporation using a range of frequencies  
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boundary drawn around a subpopulation, to isolate events for analysis. This is a 
numerical analysis which can be used to selectively visualize the cells of interest while 
eliminating results from unwanted cells e.g. dead cells. Each dot point represents an 
individual cell. For example, in the dot plot shown in Figure 6-2, a gate has been drawn 
around the area of interest selecting the desired population of cells for the analysis. In 
this example, the population of Hela cells were selected in the area of interest with a 
forward scatter from around 400 to 1000 because the dead cells have lower forward 
scatter and higher side scatter than living cells (follow the template of HeLa Cells, 
school of Medicine). The histogram marker (M1) is used to assess the negative and 
positive cells. In this study, the histogram of the control condition is used to determine 
where the marker (M1) will be placed. The position of the marker has a significant 
affect on the measurement of the result, so it is important to position the marker 
reasonably. To get an indication of a reasonable position a control sample was looked 
at using a fluorescent microscope. Figure 6-3: (a) control condition (phase contrast) (a) 
shows control condition (phase contrast).  From figure 6-3 we can see the control level 
of fluorescence and pixels in a fluorescent image. The result in control condition 
(fluorescence) is similar to a fluorescent image detect by image segment. In figure 6-3 
(c) a threshold analysis has been done to show the number of fluorescence cells shown 
in figure 6-3 (b). The threshold is set arbitrarily but has been set to emphasise the green 
cells in figure 6-3 (b). In this case we estimate about 4% fluorescence. Figure 6-3(a) 
show 248 cells and figure 6-3 (c) show 12 cells as positive. This gives 4.8 percent.  As 
expected background fluorescence is low with only a few cells being visible. So, in this 
example the marker has been placed at 4.29% to give a fair case result (see Figure 6-2). 
From figures 6-4 and 6-5 we can see an example of phase contrast compare to an image 
of GFP transfected cells and pixels in a fluorescent image under condition of amplitude 
90 Vp-p and 100 Vp-p. These figures show a definite increase in transfection but the 
fluorescence is very low. Therefore, the number of fluorescent is difficult to count. 
However, there are definitely some transfected cells. For this reason, all subsequent 
experiments the flowcytometer is used to analysis the population of transfected cells. 
This flowcytometer helps automated reading. 
The flowcytometer result presents the total number of cells and the number of 
fluorescent cells (see Figure 6-6). Figure 6-6 shows the transfected cells after Chapter 6 Investigation Sonoporation using a range of frequencies  
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sonoporation with 100 Vp-p. The result shows approximate 53.3% (±SD4.5). 
Furthermore, the fluorescent cells may exhibit different levels of fluorescence 
depending upon the amount of plasmid DNA uptake into the cells. A whole population 
shifts which means that potentially all cells are taking up the plasmid DNA. Therefore, 
the population with high percentage of transfected cells may be only shifted slightly 
from the control condition because of the low intensity of the fluorescence. This has 
been demonstrated in other research discussed in the following section. 
 
 
 
Figure 6-2: Creation of the dot plot with the region of interest and statistical analysis of 
the histogram view  
Gate  
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(a)  Control with DNA condition (Phase contrast) 
  
(b) Control with DNA condition (fluorescent cells) 
Figure 6-3: (a) control condition (phase contrast) (b) Control with DNA 
condition (fluorescent cells) (~4% fluorescence cells) 
 
 
GFP transfected 
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(c)  Control with DNA condition detect by image segmentation  
Figure 6-3: (a) control condition (phase contrast) (c) control with DNA condition 
detect by image segmentation using MatLab  
               
(a)  90 Vp-p (phase contrast) 
Figure 6-4: (a) 90Vp-p (phase contrast) (263 cells) 
GFP transfected 
cells
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(b) 90 Vp-p ( fluorescence) (43 cells) 
(c) 90Vp-p (fluorescence) detect by image segmentation (55 cells) 
Figure 6-4: (b) 90 Vp-p (fluorescence) was observed by a fluorescent microscope (c) 
90 Vp-p (fluorescence) detect by image segmentation 
GFP transfected 
cells
GFP transfected 
cells
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(a)  100 Vp-p (phase contrast ) (279 cells) 
 
(b) 100 Vp-p (fluorescence) (102 cells) 
Figure 6-5: (a) After sonoporation of 100 Vp-p (phase contrast) (b) After sonoporation 
of 100 Vp-p (fluorescence) 
GFP transfected cells 
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(c) 100 Vp-p (fluorescence) detect by image segment (135 cells) 
Figure 6-5 (c) 100 Vp-p (fluorescence) detect by image segmentation 
 
Figure 6-6: Histogram of GFP expression after sonoporation 100 Vp-p compare to 
control condition 
 
 
Transfected cells 
Control  Control 
Transfected cells 
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6.2.5.2  Previous research data analysis 
This section presents some previous data analysis from other researchers. The previous 
work illustrates that flowcytometer is widely used to detect transfected cells, but that 
there is no standard way of analysing overlapping populations. Manabu et al. [59] have 
reported the result of the sonoporation efficiency performed in vitro using 
flowcytometer. They reported a transfection efficiency after sonoporation (4W/cm
2) of 
approximately 33%. Positive C166 cells were labelled with siRNA and detected on FL-
1.  Figure 6-7 shows two populations between control and sonication on the same 
histogram. It can be seen that the sonicated population was shifted but it was not shifted 
far from the control condition because the weak fluorescence is similar to the control 
condition. No indication of how these plots are translated to percentage transfection is 
given, illustrating the difficultly in making assessments of overlapping populations. 
Also Vladimir G et al. [62] examined the physical parameters influencing optimization 
of sonoporation with plasmid DNA. This work also demonstrated transfection 
efficiency using flowcytometer detect uptake of fluorescence labelled DNA. Figure 6-8 
shows a histogram intracellular uptake of fluorescence labelled DNA. Figure 6-8 (a) 
shows the control population cells and Figure 6-8 (b) shows the distribution after 
intracellular delivery of fluorescent labelled DNA. It claims that 9.8% of cells show a 
positive result, although again the method for determining this percent is not clear. 
Based on the difficulty of analysing overlapping populations, the results shown in this 
thesis can only be compared against themselves due to uncertainty in the measurement 
method for work reported in the literature. The results in this thesis are therefore 
measured against a marker, obtained from control populations. Due to the shape of the 
distributions i.e. the whole distribution of the sonicated results is shifted, rather than 
spread out, the results here are likely to be conservative, as it can be argued that a 
whole scale shift of the population with no change in the distribution is a result of 
100%.  Chapter 6 Investigation Sonoporation using a range of frequencies  
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Figure 6-7: Sonoporation cell were detected by flowcytometer [59] 
 
Figure 6-8: Intracellular uptake of fluorescent labeled DNA [62] 
F.L Rocio T. Mainez-Numez et al. [118] reported the result miR-155 praticipates in the 
maturation of human dendritic cells (DC). They demonstrated miR-155 level by 
transfected and the level of DC cells using a flowcytometer. Figure 6-9 shows the 
percentage of positive population cells and the increase in miR-155 is normalized as 
percentage of maximum. They also reported that levels of DC-SIGN were increased 
(88.15%) compared to the control population (80.28%). It claims that a positive 
population result occurred. The overlay of Anti-miR-155 is not shifted far from Anti-
miR-control. However, the whole population is shifted and there is not a two humped 
distribution. Chapter 6 Investigation Sonoporation using a range of frequencies  
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Figure 6-9: Histogram of pathogen binding capacity of DCs is affected by miR-155 
[118] 
6.2.5.3  Result data analysis 
In this study, data analysis consists of displaying the control condition histogram and 
the histogram of the sonoporated cell population. Figure 6-10 shows the corresponding 
histogram with parameter (FL1) displayed on the horizontal axis as an illustration. FL1 
represents the intensity of fluorescence and the vertical axis illustrates the number of 
cell events counted. 
 
 
 
 
Figure 6-10: Histogram of transfection cells after sonoporation of amplitude 100 Vp-p Chapter 6 Investigation Sonoporation using a range of frequencies  
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In order to find out the transfected cells, the histogram of transfection was created. The 
histogram was produced from the population of transfected cells. Next, the marker on 
the transfected cells histogram was placed the same position as control condition ie 
about 4% of the control condition, as previously discussed. Then, it can be seen clearly 
that there are two distinct frequency distributions on the second histogram. The second 
histogram plot presents the same result with the control condition overlaid. The one on 
the left is control condition while the one on the right represents transfected cells and 
exhibit higher fluorescence. This histogram shows the difficulty in identifying the 
transfected cells. The transfected cells population is shifted and does not show a two 
humped distribution but it is overlapping with the control case due to the low amount of 
plasmid DNA uptake into HeLa cells after sonoporation. In order to establish the 
percentages of the fluorescence, it is necessary to compare the all event counted with 
the gated events. This gated event was used and it was the same as control condition. 
There are 4969 events in total. The percentage of fluorescing cells is given by the 
percentage of gated events. The number of fluorescence of 2651 was found in the area 
of the marker (M1). Next, the percentage of fluorescence histogram was analysed. The 
percentage gated of the all events divided by the percentage of marker (2651/4969 = 
53.35%). Therefore, this histogram gives a percentage of 53.35% of transfected cells.  
6.2.6  Procedure G: Cell viability 
This procedure is the same as used in chapter 5, section 5.2.8. 
6.3  Evaluation of impedance of sonoporation chamber with HeLa 
cells 
This section presents the preparation of material and method used for evaluating the 
impedance of the sonoporation chamber when filled with different materials such as air, 
water and different concentrations of HeLa cells. This experiment also intends to 
characterise the sonoporation chamber with HeLa cells. This measured impedance data 
allows the identification of the fluid layer resonant frequency of the sonoporation 
chamber. Chapter 6 Investigation Sonoporation using a range of frequencies  
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6.3.1  Material 
This study uses different concentrations of HeLa cells which were prepared as 
described in section 6.2.2. A number of HeLa cell concentrations were prepared in 
medium RPMI 1640: 1,000,000cells/ml, 2,000,000cells/ml and 4,000,000cells/ml. 
These cells were kept at room temperature until the impedance of the sonoporation 
chamber were analysed. 
6.3.2  Method of measurement impedance of sonoporation chamber 
In this study, an impedance analyzer (HP 4192A Impedance analyzer 5 Hz – 13 MHz) 
was used to measure the impedance of the sonoporation chamber over a range from 500 
KHz to 2.5 MHz. In order to verify the validity of the sonoporation chamber, the 
sonoporation chamber was investigated in the five different conditions: air filled, RPMI 
1640 filled, and with different concentrations (1,000,000cells/ml, 2,000,000cells/ml 
and 4,000,000cells/ml respectively). The approach to test the validity of the 
sonoporation chamber was to find out the resonance frequency of the transducer and 
matching layer when the chamber was filled with air. This experiment also aims to 
investigate the fluid layer resonance. As the sonoporation chamber was filled with air, 
the fluid layer was not able to achieve a detectable resonance. When the sonoporation 
chamber was filled with water, any additional resonance will be related to the fluid 
layer. There are the resonance frequencies of interest in investigations of transfection. 
The different concentrations of HeLa cells might change the resonance frequency of the 
device, as the resonance frequency is dependent upon the speed of sound in the fluid 
layer which may change when the device was filled with different concentrations of 
HeLa cells. The impedance of the sonoporation chamber results are compared and 
discussed in the following section. 
6.4  Experiment Results 
This section presents the experimental investigation of the sonoporation chamber.  
Figure 6-11 shows the impedance of the PZT transducer with air and fluid in the fluid 
layer of the resonant sonoporation chamber from 0.5 MHz to 2.5 MHz. The chamber is Chapter 6 Investigation Sonoporation using a range of frequencies  
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a complicated device and will resonate at several frequencies. However the frequency 
of interest is the frequency that the fluid layer resonates at 1.1 MHz. It can be seen that 
the overall plot of the measured impedance versus frequency has a maximum 
impedance peak when the sonoporation chamber is filled with air of 737.49 Ω at 1.02 
MHz. This is due to a mechanical resonance of the transducer/matching layer 
combination. The measured data shows an impedance high peak of the sonoporation 
chamber when filled with water is 1116.72 Ω at 1.11 MHz. The empty device also 
shows some activity at this frequency. However, the peak of interest is the new peak at 
980 kHz. This is due to the acoustic resonance generated in the fluid layer and is the 
frequency that the sonoporation chamber should be operated at 980 KHz. 
 
Figure 6-11: Impedance of sonoporation chamber with air and water 
Figure 6-12 shows the impedance of the transducer with a HeLa cell concentration of 
1,000,000cells/ml in medium RPMI 1640. It can be seen that the maximum impedance 
of the sonoporation chamber when it is filled with HeLa cells is 1653 Ω at 980 MHz. 
The other two small peaks occur at 1.04 KHz and 1.1 MHz due to resonance frequency 
mode in the different layers of the device. The resonant frequency shows good Chapter 6 Investigation Sonoporation using a range of frequencies  
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correlation with the measured impedance of transducer with different HeLa cells 
concentrations which are compared in the following experiment.  
 
Figure 6-12: Measured impedance (solid line) of PZT transducer with (1,000,000
 
cells/ml) HeLa cells. 
Figure 6-13 shows the measured impedance of sonoporation chamber with HeLa cells 
concentration of 2,000,000cells/ml. A maximum presents at 980 KHz; however, the 
result of measured impedance decreases slightly from 1653 Ω when filled with HeLa 
cells (1,000,000 cells/ml) to 1097 Ω at 980 KHz when its resonant frequency was 
compared with the impedance of the sonoporation chamber from the previous 
experiment due to the number of HeLa cells was increased. It appears that a number of 
HeLa cells (2,000,000 cells/ml) did not affect resonant frequency of the device. 
 Chapter 6 Investigation Sonoporation using a range of frequencies  
  146
 
Figure 6-13: Measured impedance (solid line) of PZT transducer with (2,000,000
 
cells/ml) HeLa cells. 
The impedance of the sonoporation chamber was measured with the concentration of 
HeLa cells (4,000,000cells/ml). Figure 6-14 presents the experimental data of 
impedance measurement. The maximum impedance of the sonoporation chamber is 
1067 Ω at 980 KHz. It can be seen clearly other resonant frequencies at 1.04 MHz and 
1.12 MHz respectively. There is very good agreement in the resonant frequency for the 
three different concentrates. Therefore, it can be concluded that the concentration of 
HeLa cells in the fluid layer does not cause the resonant frequency of the sonoporation 
device to alter. Section 6.5 carries out to investigate these resonant frequencies in order 
to evaluate the transfection efficiency. Chapter 6 Investigation Sonoporation using a range of frequencies  
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Figure 6-14: Measured impedance (solid line) of PZT transducer with 4,000,000
 
cells/ml HeLa cells. 
6.5  The experimental sonoporation chamber with a range 
frequencies  
This section describes an investigation of the sonoporation system using a range of 
frequencies in order to evaluate the effect of operating the system at resonance has on 
transfection efficiency and cell viability. In this experiment, the sonoporation system 
was operated at the following range of frequencies: 950 KHz, 960 KHz, 970 KHz, 980 
KHz, 1.04 MHz, 1.12 MHz and 1.29 MHz. These were applied with a fixed sinusoidal 
voltage of 90 Vp-p and exposure time of 10 seconds at room temperature. HeLa cells 
and plasmid DNA (pEGFP-N1) were also used in this experiment. These experiments 
were repeated three times. Chapter 6 Investigation Sonoporation using a range of frequencies  
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6.5.1  Material HeLa cells and Plasmid DNA 
HeLa cells were prepared as described in the procedure B in section 6.2.2. Plasmid 
DNA was prepared the same as procedure A in section 6.2.1. For this experiment, 
samples of Hela cells were mixed well with plasmid DNA (pEGPF-N1) of 50µg/ml.  
6.5.2  Sonoporation system apparatus 
This procedure followed is very similar to that used in the initial evaluation of the 
sonoporation system. The sonoporation system consists of a TTi 40 MHz, Arbitrary 
waveform generator (TGA 1241), high power amplifier (AG Series Amplifier T&C 
Power conversion, Inc. and the sonoporation chamber. Sonoporation experiments were 
performed at room temperature (25 ºC) and sweep sinusoidal frequencies and with 
fixed amplitude 90Vp-p across the transducer for 10 seconds. 
6.5.3  Experimental protocol of transfection under range of frequencies 
In these studies, samples of HeLa cells at 4,000,000cell/ml were mixed in medium 
(RPMI 1640) with plasmid DNA (pEGFP-N1) at 50 µg/ml. The sample was kept on ice 
at 4ºC. 20 μl of cell suspension were introduced into the sonoporation chamber. The 
sonoporation chamber was carefully inspected, so that no visible air bubbles were 
trapped inside. Then 90 Vp-p was applied across the PZT 26 of the sonoporation 
chamber for 10 seconds at one of a range of sinusoidal frequencies. This experiment 
was repeated for each selected frequency from 950 KHz to 1.29 MHz. After each 
experiment of the sonoporation system was performed, the cell suspension was 
transferred into eppendorf tube (1.5ml) and kept at 4 ºC. For each experimental 
condition, a non-sonoporated sample was kept. This sample was used as a control for 
transfection efficiency and cell viability measurement. After sonoporation, 300 µl of 
fresh medium DMEM (Dulbecco's Modified Eagle Medium) was added to each sample 
and each sample was placed into 24 well cell culture plates. These cells were incubated 
for 48 hours in a 37 ºC humidified incubator under cell growth conditions. The next 
section presents the transfection efficiency and cell viability determination. Chapter 6 Investigation Sonoporation using a range of frequencies  
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6.5.4  Transfection efficiency and cell viability determination 
The transfection efficiency and cell viability determination follows the same process 
described in sections 6.2.5 and 6.2.6. The transfection efficiency was analysed using 
flow cytometry (Becton Dickinson FACScalibur Flow Cytometry) and viability was 
analysed using a microscopy, Trypan blue (SIGMA) staining and a haemocytometer. 
The result of data from flow cytometry was analysed by Cell Quest software pro. These 
results are shown in section 6.6. 
6.5.5  Statistic of transfection efficiency and cell viability 
To analyse all experiments, the analysis of variance (ANOVA) statistic is used to 
analyse transfection efficiency and cell viability. For this analysis all experiments were 
performed at least three times (n≥3). Each experiment was analysed using SPSS 
statistics 17.0 (SPSS Inc., Chicago, Illinois). A value of p< 0.05 is a level of 
significance. The results presented are the mean and standard error of mean (±SEM) of 
transfection efficiency and cell viability from the three independent cases in each 
condition.  
6.6  Sonoporation experiment based on a range frequency results 
6.6.1  The transfection efficiency versus a range frequency results 
The transfection efficiency was evaluated with a selected range of frequencies from 
950 KHz to 1.29 MHz with correspond to the impedance measured data which 
observed in section 6.4. For each condition, the transfection efficiency was investigated 
for three experiments. Also, each experiment includes a control condition for 
comparison. Table 6-1 illustrates the transfection efficiency vs. frequency. For 
example, after applied frequency at 980 KHz for exposure time of 10 seconds gives 
12.94% ±SD6.2transfection efficiency. An instance histogram of control condition and 
transfection efficiency is shown in figure 6-15. Figure 6-15 shows 4.01% ±SD9.8 for 
the control condition. Figure 6-16 shows the dot plot and histogram graphs after 
sonoporation was applied for frequency 980 KHz and the shift curve in the histogram Chapter 6 Investigation Sonoporation using a range of frequencies  
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can be seen. Maximum transfection efficiency of 12.94% ±SD6.2 occurred at 980 
KHz.  Figure 6-17 and figure 6-18 show the dot plot and histogram graphs after 
sonoporation for 1.04 MHz and 1.12 MHz respectively. Figure 6-17 shows 4.08% of 
transfection efficiency for 1.04 MHz. Finally, figure 6-18 shows that at 1.12 MHz the 
transfection efficiency is 5.4%.  
 
Table 6-1: The transfection efficiency vs. a range frequencies 
Frequency (Hz)  Transfection efficiency (%) 
980 KHz  12.94% 
1.04 MHz  4.08% 
1.12 MHz  5.40% 
 
Figure 6-15: Histogram of control condition Chapter 6 Investigation Sonoporation using a range of frequencies  
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Figure 6-16: Histogram shows GFP expression after sonoporation with sinusoidal 
frequency at 980 KHz. (green is control condition) 
 
Figure 6-17: Histogram shows GFP expression after sonoporation with sinusoidal 
frequency at 1.04 MHz. (green is control condition) Chapter 6 Investigation Sonoporation using a range of frequencies  
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Figure 6-18: Histogram shows after sonoporation with sinusoidal frequency at 1.12 
MHz. (green is control condition) 
6.6.2  Influence of frequency on transfection efficiency 
The transfection efficiency of the sonoporation system at range of frequencies was 
determined. In this experiment, 1ml of sample of HeLa cells which contained about 
4,200,000 cells was used. This experimental transfection efficiency was investigated 
for each frequency condition with the same batch of cells. The results were obtained 
from three independent experiments. The data results show in the mean and ±SEM 
from these three independent experiments. This study indicates that the resonant 
frequency of the sonoporation chamber is an important factor on enhancement of cell 
transfection efficiency. Figure 6-19 shows the maximum of transfection efficiency is 
12.99 % ±SEM 0.67 (ANOVA p>0.05) at 980 KHz to relative control condition which 
is 4.07 ±SEM0.1 (ANOVA p>0.05). The transfection efficiency depends upon the 
resonant frequency. This study can be concluded that resonant frequency at 980 KHz of 
the sonoporation chamber has an improvement of transfection efficiency. If the 
sonoporation chamber was driven at frequencies far from the resonant frequency of 
chamber, the transfection efficiency was not high. In this section, a flowcytometer was 
used to analyse the transfection efficiency of sonoporation. This study employed a Chapter 6 Investigation Sonoporation using a range of frequencies  
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flowcytometer because this instrument allowed more consistent measurements of GFP 
fluorescence compared to results obtained from GFP fluorescence microscopy.  
 
Figure 6-19: The result of transfection efficiency based on a range frequency from 950 
KHz to 1.29 MHz 
6.6.3  Discussion  
This work presents the initial analysis of cell transfection using flowcytometer. It was 
found that it was not easy to distinguish the positive population from those that were 
negative (see Figure 6-18). The results also show in some cases a definite distribution 
shift from the control case which could be argued to be 100% transfection, but because 
of the low fluorescence, the shift was not enough to separate completely the two 
populations. But this is quite good a homogenous population when its comparison to 
electroporation [119]. In order to separate between control population and positive cells 
clearly, there are possibly two methods to approaches. First, the amount of plasmid 
DNA should be increased in order to make positive cells more fluorescent so the 
flowcytometer could detect their fluorescence more significantly. It would be able to 
detect two distinct populations. However, this may not be easy to achieve, as we can 
see that altering the sonoporation conditions has a significant effect on both 
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transfection and viability, and is really the basis of this PhD. As a more straightforward 
solution, laser power in the flowcytometer should be increased in order to increase the 
fluorescence emission of the GFP. The background fluorescence of the cells would also 
be increased but it would be less that the emission of the GFP. 
6.6.4  Cell viability of sonoporation experiment based on a range frequency 
Cell viability was evaluated for each frequency using the procedure as described in 
section 5.2.6. The cell viability was investigated under three independent cases as 
shown in Figure 6-20. Figure 6-20 shows the control condition which gives a cell 
viability of approximately 85% (±SEM 0.8). The cell viability is about 46.7% (±SEM 
6.4) at 980 KHz while this condition gives a high percentage of transfection efficiency 
as shown in figure 6-19. The final example condition gives a cell viability of 64.1% at 
1.12 MHz. However, the peak of cell viability is illustrated at 1.29 MHz 80.98% 
±SD6.27 as shown in figure 6-20. It can be seen that the percentage of cell viability 
depends upon the resonant frequency of the sonoporation chamber. When apply the 
frequencies far from resonant frequency of the device, there are not seriously affect cell 
viability. 
 
Figure 6-20: The result of cell viability with a range frequency (950 KHz -1.29 MHz), 
exposure time: 10 second 
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6.7  Sonoporation experiment results based on swept frequency 
The aim of this study is to determine the transfection efficiency and cell viability using 
a swept frequency. In order to identify optimal resonant frequency, it is probably 
difficult to indentify resonant frequency for different chambers due to manufacturing 
variability, temperature etc. Therefore, the sweep frequency is possibly guaranteed that 
the device is able to work at resonance. If the sweep frequency offers good results, then 
it helps to reduce a problem to maintain frequency at resonance because the device 
does not need to maintain resonance frequency, which might need a closed loop control 
system. Transfection performance was evaluated by the sonoporation system which 
consists of two conditions of the swept frequency. During the first test, the swept 
frequency varies from 975 KHz to 985 KHz. A second test of the swept frequency 
varied between 970 KHz and 990 KHz. A range of exposure times (5, 10, 15 and 20 
second) and fixed amplitude (90 Vp-p) were used to evaluate transfection efficiency 
and cell viability. Frequencies have the same centre resonant frequency of 980 KHz. In 
the first test, the frequency varies by increments of 100 Hz every 50 millisecond (total 
= 100 steps). The second test incremented over 200 Hz of frequency (total = 100 steps). 
All experiments were performed at least three times. Each experiment was analysed 
using an analysis of variance (ANOVA, p < 0.05) to compare the results. These 
experimental results are presented as the mean and standard error of the mean (±SEM) 
for transfection efficiency and cell viability from at least three experiments (n≥3) in 
each condition.  
6.7.1  The transfection efficiency vs. exposure time 
This section presents the data of the transfection efficiency versus exposure time. The 
effect of swept frequency and exposure time are studied. These experiments use 100 
Vp-p at sweep frequency from 975 KHz to 985 KHz for 5, 10, 15 and 20 seconds. Each 
experiment includes a control condition for assessment. Table 6-2 illustrates the 
transfection efficiency vs. exposure time. For instance, transfection efficiency is 
obtained 22.02% after applied the swept frequency and exposure time of 5 
seconds. Figure 6-21 (a) shows the dot plot and FL1 histogram graphs for the control 
condition. Figure 6-21 (b) shows the histogram for an exposure time of 5 seconds. The Chapter 6 Investigation Sonoporation using a range of frequencies  
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maximum peak transfection efficiency of 67.19% ±SD4.9% occurs after 20 seconds 
exposure time. The shift in this histogram can be obviously seen. These experiments 
show an increase in transfection efficiency as exposure time increases. 
Table 6-2: The transfection efficiency vs. exposure time  
Exposure time (second)  Transfection efficiency (%) 
5 22.0% 
10 26.1% 
15 31.4% 
20 67.1% 
 
 
(a) Control condition  
Figure 6-21: Histogram shows GFP expression of (a) control condition without 
sonoporation Chapter 6 Investigation Sonoporation using a range of frequencies  
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(b) Transfection efficiency after sonoporation exposure time for 5sec (green is control 
condition) 
 
(c) Transfection efficiency after sonoporation exposure time for 20 seconds (green is 
control condition 
Figure 6-21: Histogram shows GFP expression of (a) control condition without 
sonoporation (b) transfection efficiency after exposure time for 5 seconds (c) 
transfection efficiency after sonoporation exposure time for 20 seconds 
6.7.1.1  Experiment 1: influence of the swept frequency vs. exposure time  
For experiment 1, the swept frequency starts at 975 kHz and ends at 985 kHz after 5, 10 
15, and 20 seconds. In this study, the sample of HeLa cells was about 4,150,000 cells Chapter 6 Investigation Sonoporation using a range of frequencies  
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per 1 ml. Figure 6-22 shows that a step change in transfection efficiency for exposure 
times from 5 to 20 seconds. At exposure time of 20 seconds, it shows a significant 
improvement of cell transfection efficiency. The highest transfection efficiency of 
67.7% (±SEM 3.2) (ANOVA, p <0.05) occurred at exposure time of 20 seconds. This 
swept frequency condition can be used to achieve cell transfection.  
 
 
Figure 6-22: Transfection efficiency based on sweep frequency (975KHz-985KHz) 
6.7.2  Cell viability of sonoporation with swept frequency experiment1 
Cell viability was investigated for each exposure time using the same procedure as 
described in section 5.2.6. Two different examples of the cell viability are shown 
in figure 6-23. Figure 6-23 (a) shows the control conditions whilst gives a cell viability 
of approximately 91% (±SEM 1.8). Figure 6-23 (b) shows that at exposure 20 seconds 
the cell viability gives approximately 12%. While exposure time of 20 seconds gives 
the highest percentage of transfection efficiency. It appears that 20 seconds exposure 
improves transfection but affects cell viability by killing the majority of cells. 
0
10
20
30
40
50
60
70
80
90
100
Control Control+DNA 5 10 15 20
M
e
a
n
 
t
r
a
n
s
f
e
c
t
i
o
n
 
e
f
f
i
c
i
e
n
c
y
 
(
%
)
Time (second)
The result of transfection efficiency based on sweep frequency 
(975KHz‐985KHz)
Transfection efficiencyChapter 6 Investigation Sonoporation using a range of frequencies  
  159
 
(a) 
 
(b) 
Figure 6-23: Cell viability observed by the microscope (a) control condition, (b) cell 
viability for 20 seconds exposure time 
Unstained cells 
Stained  cells 
20 µm
Unstained cells Chapter 6 Investigation Sonoporation using a range of frequencies  
  160
Figure 6-24 clearly shows a step change in cell viability at 20 seconds. The region from 
5 to 15 seconds gives less than 30% cell viability. The graph also shows a minimum 
cell viability percentage is obtained at exposure time of 20 seconds when compared to 
the control condition of 91% ±SEM1.8 (ANOVA ,p>0.05). This work appears that 
exposure time of 20 seconds kills the majority of HeLa cells. 
 
Figure 6-24: Cell viability based on sweep frequency vs. exposure time 
6.7.3  The transfection efficiency results based on swept frequency (970 KHz – 990 
KHz) 
These experiments investigated transfection efficiency based on swept frequency. 
Sonoporation system was performed at sweep frequency from 970 KHz to 990 KHz 
and used amplitude of 100Vp-p for 5, 10, 15, and 20 seconds. Each experiment 
includes a control condition for evaluation. Table 6-3 shows the transfection efficiency 
versus exposure time. There are three independent cases of transfection efficiency 
shown in figures 6-24 and 6-25. An example of histogram of control condition gives 
4.0% (±SD7.8) shows in figure 6-25 (a). Figure 6-25 (b) shows a histogram of exposure 
time of 5 seconds and the shift in the histogram can be obviously seen. The highest 
transfection efficiency of 69.5% (±SD4.4) occurred at exposure time 20 
seconds. Figure 6-26 shows the histogram for an exposure time of 20 seconds. It was 
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found that the longer exposure time, the greater improvement in transfection efficiency. 
However, it also kills the majority of cells. 
 
Table 6-3: The transfection efficiency vs. exposure time  
Exposure time (second)  Transfection efficiency (%) 
5 21.3% 
10 31.1% 
15 46.3% 
20 69.5% 
 
 
(a) Control condition without sonoporation  
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(b) HeLa cells and pEGFP-N1 after sonoporation exposure time for 5 seconds 
(green is control condition) 
Figure 6-25: Histogram shows GFP expression (fluorescence) of (a) control 
condition without sonoporation (b) HeLa cells and pEGFP-N1 after sonoporation 
for exposure of 5 seconds. 
 
Figure 6-26: Histogram transfection efficiency after exposure time for 20 seconds 
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6.7.4  Influence of swept frequency for different exposure times 
The transfection efficiency was evaluated and used the same procedure in section 6.2.5 
It was investigated for exposure time under four different conditions (5, 10, 15 and 20 
seconds).  
6.7.4.1  Experiment2: influence of sweep frequency vs. exposure time 
In this experiment, the sample of HeLa cell suspension of 1 ml contained 3,963,000 
cells. Figure 6-27 shows the step change in transfection efficiency at exposure time of 
20 seconds. The graph also shows the region for exposure time from 5 to 15 second 
gives less than 40 % (ANOVA p>0.05) of transfection efficiency. At exposure time of 
20 seconds, it presents a significant improvement of cell transfection up to the highest 
transfection efficiency of 69.7% ±SEM 8.9 (ANOVA p>0.05). It was found that the 
exposure time has an influence transfection efficiency based on the swept frequency. 
However, this work shows the transfection efficiency percentage which is obtained less 
than the experiment in section 6.7.1.1 at the exposure time of 15 and 20 seconds due to 
the tolerance of frequency is far from the central resonant frequency. 
 
Figure 6-27: Transfection efficiency based on sweep frequency (970KHz-990KHz) 
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6.7.5  Cell viability of sonoporation with swept frequency experiment 2 
This cell viability was evaluated under three individual samples for each exposure time. 
This experiment used the same procedure as described in section 5.2.6. One sample 
was kept for control condition and compared with other exposure time conditions. 
Three sample cases of the cell viability are shown in Figure 6-28. Figure 6-28 shows 
the cells for control condition whilst it is obtained approximately 91% ±SEM1.1 of the 
percentage cell viability. Figure 6-28 (b) shows that at 5 seconds the cell viability is 
20% ±SEM3.8. At 20 seconds of exposure time gives the highest transfection 
efficiency. This condition also kills all population of HeLa cells. 
 
(a) Control condition 
Figure 6-28: The viable cell observed by the microscope (a) Control condition 
Unstained cells Chapter 6 Investigation Sonoporation using a range of frequencies  
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(b) Cell viability for exposure time 5 seconds 
Figure 6-28: The viable cell observed by the microscope (b) cell viability (20%) for 
exposure time 5 seconds  
Figure 6-29 shows the decrease of cell viability dramatically from 91% to less than 
30% in the region exposure time from 5 second to 15 seconds. At 20 seconds exposure 
time also drops to less than 5.5%±SEM1.4 (ANOVA p>0.05). Therefore, the voltage 
and exposure time have a significant effect on the cell viability. The results show the 
exposure time of 20 seconds influence of transfection efficiency whilst it also kills the 
most population of cells. 
Unstained HeLa cells 
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Figure 6-29: Cell viability of sonoporation based on sweep frequency (970 KHz to 990 
KHz) vs. exposure time. 
6.8  Discussion and conclusion 
This chapter has described the performance of the sonoporation system when operated 
at range of frequencies and sweep frequency. In the range frequency test, the highest 
transfection efficiency occurs at the resonant frequency of 980 KHz. So, it was 
identified the optimal operating frequency sonoporation chamber is 980 KHz. The 
swept frequency test found that the maximum transfection efficiency occurs between 
975 KHz and 985 KHz. This study has demonstrated that the sonoporation chamber is 
able to achieve transfection efficiency. It can be concluded that the resonant frequency 
of the sonoporation chamber is a key factor for successful of transfection efficiency. 
From the impedance measurement, the resonant frequency of the sonoporation chamber 
has been identified. This resonant frequency produces the standing wave which is able 
to move HeLa cells and plasmid DNA in the sonoporation chamber. This work also 
evaluated the transfection efficiency and cell viability under a range of fixed 
frequencies, as well as for the swept frequency. The exposure time improved the 
transfection efficiency results with the optimal time being between 10 and 15 seconds, 
even though, the maximum transfection occurs after 20 seconds but also kills the 
majority of HeLa cells. The sonoporation system has demonstrated a significant 
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improvement compared to other previous work [111]. These results also support the 
theory in section 2.4 that the sonoporation operation with a resonant chamber can be 
used successfully to transfect cells.   
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Chapter 7   
Sonoporation of HeLa Cells and 
DNA (pEGFP-N1) 
7.1  Introduction 
This chapter presents the performance of the sonoporation system when operated 
precisely at its resonant frequency. The efficiency and cell viability were investigated 
using HeLa cells and plasmid DNA (pEGFP-N1). The transfection efficiency and cell 
survival were determined under a range of applied voltages and exposure times. 
Finally, the effect of the sonoporation on the plasmid DNA was evaluated using 
agarose gel electrophoresis. 
7.2  Material and Methods  
7.2.1  Material HeLa cells and Plasmid DNA 
HeLa cells were prepared as described in the procedure B in section 6.2.2. Plasmid 
DNA was prepared the same as procedure A in section 6.2.1. For this experiment, 
samples of Hela cells were mixed well with plasmid DNA (pEGPF-N1) of 50µg/ml Chapter 7 Sonoporation of HeLa cells and DNA 
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7.2.2   Sonoporation system setup  
This procedure followed is very similar to that used in the initial evaluation of the 
sonoporation system. The sonoporation system consists of a TTi 40 MHz, Arbitrary 
waveform generator (TGA 1241), high power amplifier (AG Series Amplifier T&C 
Power conversion, Inc. and the sonoporation chamber. Sonoporation experiments were 
performed at room temperature (25 ºC) and at a fixed sinusoidal frequency of 980 KHz 
and with a range of amplitudes from 0 to 100Vp-p across the transducer. A fixed 
sinusoidal frequency of 980 KHz is used because this was found to be the precise 
resonant frequency of the sonoporation chamber. Exposure times were 5, 10, 15 and 20 
seconds in continuous wave mode. The signal from the waveform generator was 
amplified by a power amplifier. The cultured cells were resuspended in 1 ml of fresh 
medium (RPMI 1640) and mixed with 50 µg of pEGFP-N1 prior to sonoporation. 
Transfection and cell viability results are given in section 7.3.  
7.2.3  Sonoporation with HeLa cells and plasmid pEGFP-N1 
First, the HeLa cells were mixed with the plasmid pEGFP-N1 in an eppendorf tube and 
incubated at 4 ºC for 5 minutes. Then, 20μl of HeLa cells and plasmid pEGFP-N1 was 
transferred into the sonoporation chamber using a syringe pump. Then the fixed 
sinusoidal frequency (980 KHz) signal at the required voltage was applied for the 
specified duration. This procedure was repeated using 20μl of HeLa cells and plasmid 
DNA varying exposure time on each occasion: 5, 10, 15 and 20 seconds. Then they 
were transferred to an eppendorf tube and kept at 4ºC until experiments were finished 
(typically 3-5 minutes). To each 20μl of cell suspension, 300μl of fresh medium 
(DMEM) was added and this was then transferred to one well of a 24 well plate. Next 
the cells were incubated for 48 hours in a 37 ºC humidified incubator. After 48 hours, 
the cells in suspension were collected into a centrifuge tube, the well plates were rinsed 
using PBS and trypsin to remove remaining cells and these cells were also placed into 
the same centrifuge tube. The cells were incubated at 37 ºC for 5 minutes. The cells 
were collected, mixed thoroughly and put in the centrifuge tube. The cells were then 
centrifuged for 5 minutes at 3000 rpm and the cell pellets were resuspended in PBS 
(200μl). Then, 180μl of this solution was transferred into an eppendorf tube for Chapter 7 Sonoporation of HeLa cells and DNA 
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determining the transfection rate as described in the next section. Finally, 20 μl of HeLa 
cells were put aside for the cell viability experiment and kept in the incubator at 4 ºC . 
7.3  Sonoporation experiment results  
For this analysis all experiments were performed at least 3 times (n ≥ 3) plus one 
control condition. Each experiment was analysed using an analysis of variance 
(ANOVA, p < 0.05) to compare the data. This was done using SPSS statistics 17.0 
(SPSS Inc., Chicago, Illinois). The results presented are the mean and standard error of 
the mean (±SEM) for cell transfection and cell viability from the three experiments in 
each condition.  
7.3.1  Transfection efficiency vs. exposure time  
These experiments use 100 Vp-p at 980 KHz for 5, 10, 15 and 20 seconds. Each 
experiment includes a control condition for comparison. Table 7-1 shows the 
transfection efficiency vs. exposure time. For example, after an applied exposure time 
of 5 seconds the transfection efficiency was 53.35% ±SD4.57. An example of the 
histogram of control condition and transfection efficiency is shown in figure 
7-1. Figure 7-1 (a) shows 2.7% ±SD6.63 for the control condition for the 5 seconds 
exposure experiment. Figure 7-1 (b) shows the dot plot and FL1 histogram graphs after 
sonoporation was applied for 5 seconds and the shift in the histogram can be clearly 
seen. Maximum transfection efficiency of 90.6% ±SD7.6 occurs after 20 seconds 
exposure. Figure 7-2 shows the histogram for an exposure time of 20 seconds. These 
results suggest that exposure time has an affect on transfection efficiency. 
Table 7-1: The transfection efficiency vs. exposure time  
Exposure time (second)  Transfection efficiency (%) 
5 53.35% 
10 52.41% 
15 59.62% 
20 90.6% Chapter 7 Sonoporation of HeLa cells and DNA 
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(a) Control for 5 seconds experiment (No sonoporation) 
 
(b) HeLa cells and pEGFP-N1 after sonoporation exposure time of 5 seconds 
Figure 7-1: Histogram shows GFP expression (fluorescence) of (a) control cells 
without sonoporation (b) HeLa cells and pEGFP-N1 after sonoporation for exposure of 
5 seconds.  
Control  Control 
Transfected cells Chapter 7 Sonoporation of HeLa cells and DNA 
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The first histogram graph presents the original graph from transfected cells before 
comparison to the control condition. The 2
nd histogram plots the same result with the 
control condition overlaid. 
 
Figure 7-2: Histogram of transfection efficiency after sonoporation for exposure time 
of 20 seconds. (green is control condition) 
7.3.2  Cell viability of sonoporation experiment  
Cell viability was assessed for each exposure time using the trypan blue dye as 
described in section 5.2.6. Two different cases of the cell viability are shown in figure 
7-3. Figure 7-3(a) shows the cells for the control condition which gives a cell viability 
of approximately 92.5% (±SEM 0.5). figure 7-3(b) the cell viability is just 56% for 20 
seconds exposure. Whilst 20 seconds exposure at 100 Vp-p gives a high percentage 
transfection, it is clear this level of acoustic energy also kills the majority of cells. The 
exposure time of 20 second result is shown in experiment 4. 
 Chapter 7 Sonoporation of HeLa cells and DNA 
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(a)  Control condition 
 
(b) 80 Vp-p for 20 seconds 
Figure 7-3: Cell viability result observed by the microscope (a) control condition, cell 
viability of 92.5% (b) 100 Vp-p, cell viability (56%) for 20 seconds exposure 
(experiment 4) 
Stained cell  
Unstained cell 
20 µm
Unstained cell 
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7.3.3  Influence of voltage for different exposure times  
Transfection efficiency and cell viability was investigated under four different exposure 
time conditions (5, 10, 15 and 20 seconds) with a varying voltage from 0 to 100 Vp-p 
with fixed sinusoidal frequency at 980 KHz. The FACS scan was used to investigate 
transfection efficiency and the haemocytometer was used to determine cell viability in 
the four conditions. For each condition, results were obtained from three independent 
experiments and the data presented is the mean and ±SEM from these three 
independent experiments.  
7.3.3.1  Experiment1: Exposure time 5 seconds 
In this experiment, the sample of HeLa cell suspension of 1 ml contained 4,350,000 
cells. The graph in figure 7-4 clearly shows a step change in transfection efficiency at 
80Vp-p. The region from 10 Vp-p to 70 Vp-p gives less than 10% transfection 
efficiency. At amplitudes of 80Vp-p and above, it shows a significant improvement of 
cell transfection efficiency up to maximum transfection efficiency of 42.8% ±SEM 
6.47 at 100 Vp-p. The graph also shows a high cell viability percentage is obtained with 
all voltages, although, there is a small decrease in cell viability of 20% (75.7% ±SEM 
4.4) at 100Vp-p when compared to the control condition (92.7% ±SEM 0.57). For 5 
second exposure time, the high voltage did not seriously affect cell viability. 
 Chapter 7 Sonoporation of HeLa cells and DNA 
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Figure 7-4: Transfection and cell viability of sonoporation for exposure time of 5 
second using HeLa cells with pEGPF-N1. 
7.3.3.2  Experiment 2: Exposure time 10 seconds. 
In this study, 1 ml of control sample cell suspension which contained approximately 
4,120,000 cells was used. From figure 7-5, the results for 10 seconds exposure are 
similar to those obtained from the previous experiment. Again transfection efficiency 
appears to improve above 80 Vp-p. The maximum transfection efficiency of 58.7% 
±SEM 9.0 occurred at 100 Vp-p. Similarly, cell viability at 100 Vp-p was 
approximately 86% of the control condition. It appears that 10 second exposure 
improves transfection without affecting cell viability too much.  
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Figure 7-5: Transfection and cell viability of sonoporation (980 KHz; time = 10sec) 
using HeLa cells with pEGPF-N1. 
7.3.3.3  Experiment 3: Exposure time 15 seconds. 
In this experiment, the sample of HeLa cells was about 3,900,000 cells per 1ml. Figure 
7-6 shows that of transfection efficiency for an exposure time of 15 seconds also 
increases at 80Vp-p. The highest of transfection efficiency of 42.5% ±SEM 9.5 
(ANOVA, p < 0.05) occurred at 90Vp-p. This exposure time has a larger affect on the 
percentage cell viability than pervious exposure times. Viability has fallen to 65% at 
100 Vp-p. 
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Figure 7-6: Transfection and cell viability of sonoporation 980 KHz (time = 15 sec) 
using HeLa cells and pEGFP-N1. 
7.3.3.4  Experiment 4: Exposure time 20 seconds 
In this study, the sample of HeLa cells was approximately 4,105,000 cells per 1ml. It 
can be seen that there is a change in transfection efficiency at 80Vp-p and a maximum 
transfection efficiency of 68.8% (ANOVA, p < 0.05) occurred at 100 Vp-p. However, 
the percentages of viable cell again fell to approximately 3 %. From this experiment, it 
can be concluded that whilst transfection efficiency increased by ~10% compared to 
other exposure times (5, 10 and 15 seconds),it has a significant affect on the viability of 
cells. 
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Figure 7-7: Transfection and cell viability sonoporation 980 KHz (time = 20 sec) using 
HeLa cells and pEGFP-N1 
 
Table 7-2: Transfection efficiency and cell viability of control condition vs. exposure 
time experiment 
Exposure time (second)  Transfection efficiency  Cell viability 
5 4.1%  92.7% 
10 4.6%  93.4% 
15 4.2%  88.1% 
20 4.7%  91.3% 
Table 7-2 shows the transfection efficiency and cell viability of control condition 
versus exposure time. Note the control cells have not been exposed to sound in these 
results. This is average value of control conditions for the different exposure time 
experiment, showing little variation in the control conditions.  
0
10
20
30
40
50
60
70
80
90
100
Control C_DNA 10 20 30 40 50 60 70 80 90 100
M
e
a
n
 
o
f
 
t
r
a
n
s
f
e
c
t
i
o
n
 
a
n
d
 
c
e
l
l
 
v
i
a
b
i
l
i
t
y
 
(
%
)
Amplitude (Vp-p)
The result of transfection and cell viability (%) HeLa cells 
and pEGFP-N1 (Time =20sec)
Cell viability 20 sec (%) Transfection 20 sec (%)Chapter 7 Sonoporation of HeLa cells and DNA 
  179
7.4  Discussion  
These experiments show that a minimum voltage of 80Vp-p is required to achieve 
transfection with this chamber at resonance. Maximum transfection occurs after 20 
seconds but this kills the cells due to the cells moved to the nodal plane. This is thought 
to be caused by the pressure minimum being at the same place as a velocity maximum, 
potentially giving rise to microstreaming around the cells and generating a viscous 
shearing effect resulting in more cell damage when cells stay longer in the field. 
Optimum operating conditions appear to be in the region of 90 Vp-p for between 10 
and 15 seconds. These results showed 58.7% transfection efficiency and 77.3% cell 
viability for exposure time of 10 seconds. The values demonstrated a significant 
improvement compared to other published work. W.S Chen et al, showed 26% 
transfection efficiency [111] and 35% was obtained by Lai et al[11]. Kinoshita et al., 
showed the presence of standing waves produced approximately 35% transfection 
efficiency which was higher than sonoporation in the absence of the standing wave 
which achieved 22% transfection efficiency [59].  
7.5  The effect of different sonoporation conditions on plasmid DNA 
(pEGFP-N1) 
This section investigates the effect of sonoporation on the plasmid DNA using agarose 
gel electrophoresis. This investigation also aims to separate plasmid DNA into bands 
by electrophoresis and observed results of plasmid DNA after the assessment of 
different sonoporation conditions. The different sonoporation conditions might cause 
degradation of plasmid DNA. If the sonoporation conditions cause degradation of 
plasmid DNA, this plasmid DNA is not able to express GFP in cells. The section also 
describes the details of the preparation procedure. The results from this experiment are 
presented in section 7.5.4. 
7.5.1 Materials and method 
The procedure to study the effect of different sonoporation conditions on the plasmid 
DNA involves four steps.  Chapter 7 Sonoporation of HeLa cells and DNA 
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2.  Preparation of plasmid DNA 
3.  Sonoporation of  Plasmid DNA  
4.  Separate DNA by agarose gel electrophoresis method 
5.  Analysis of the effect on plasmid DNA  
7.5.2 Preparation plasmid DNA 
The plasmid DNA (pEGFP-N1) was used to study the experimental effect of different 
sonoporation conditions. This plasmid was prepared as described in section 6.2.1 and a 
concentration of 50 µg/ml of plasmid was used in each experiment. This plasmid was 
mixed with 1ml of fresh medium (RPMI). Then it was kept in an eppendorf tube on ice 
before it was subjected to different sonoporation conditions.  
7.5.3 Sonoporation of plasmid DNA 
The plasmid DNA was studied with sonoporation conditions comprising a fixed 
frequency of 980 KHz, driving amplitude from 90 to 100 Vp-p and exposure times of 5, 
10 and 15 seconds respectively. The procedure was as follows. 
1.  The plasmid DNA (50 µg/ml) was mixed with the medium (RPMI) and then the 
syringe pump (1ml) was used to transfer the plasmid DNA into the 
sonoporation chamber. 20 µl of plasmid DNA was introduced into the 
sonoporation chamber each time. 
2.  Then, the required voltage signal was applied for 5 seconds continuously. 
3.  After 5 seconds, the 20 µl of plasmid DNA was transferred into eppendorf tube 
and kept on ice. 
4.  Next the process was repeated and exposure time was changed from 5 seconds 
to 10 and 15 seconds respectively in step 4. 
5.  The sonoporation chamber, input fluid, output fluid and syringe pump were 
washed and cleaned with 70% ethanol.   Chapter 7 Sonoporation of HeLa cells and DNA 
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7.5.4  Agarose gel electrophoresis  
Agarose gel electrophoresis was used to investigate the effect of sonoporation on 
plasmid DNA [120]. Agarose gel electrophoresis is a common method for separating 
DNA by size. This method can be used for separating plasmid DNA in a range from 50 
base pairs to several million base pairs. This agarose gel was ran in a buffer (TAE: Tris 
Acetate EDTA) and made from polymer. The experimental procedure of agarose gel 
electrophoresis after sonoporation was as follows.  
1.  Load DNA marker in the first slot or lane as shown in figure 7-8 (a).  
2.  The 10 µl of DNA without sonoporation was loaded into the second slot. 
Plasmid DNA (pEGFP-N1) (10 µl) with the different sonoporation exposure 
time conditions at 90Vp-p were then injected into the third, fourth, and fifth 
slots respectively as shown in figure 7-8 (b). 
3.   The 10 µl of DNA without sonoporation was loaded into slot number six. Then 
DNA (10 µl) with the different sonoporation exposure time conditions at 100 
Vp-p were injected into lane number seven, eight and nine respectively.  
4.  The next process was the separation of DNA using applied current as shown 
in figure 7-8(c). The DNA migrates forwards to toward the positive electrode 
and the DNA bands were separated by size as shown figure 7-8 (d).   
5.  Generally, the DNA was not visible during this process. So, the DNA was 
mixed with marker dye in order to avoid the DNA running entirely off the 
agarose gel. A fluorescent dye marker (ethidium bromide) was added to the 
DNA ladder. Chapter 7 Sonoporation of HeLa cells and DNA 
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                (a)                                                                          (b) 
Figure 7-8: The process of Agarose gel electrophoresis with different sonoporation 
conditions and pEGFP-N1 
 
6.  In order to observe the DNA bands, it is necessary to take the agarose gel into a 
light box and illuminate with ultraviolet light. Finally, the agarose gel 
photograph was taken using a digital camera. Chapter 7 Sonoporation of HeLa cells and DNA 
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          (c)                                                                            (d) 
 
                        (e)                                                                                         (f) 
Figure 7-8: The process of Agarose gel electrophoresis with different sonoporation 
conditions and pEGFP-N1 Chapter 7 Sonoporation of HeLa cells and DNA 
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Figure 7-9:  Standard ladder of liner DNA [121] 
Figure 7-9 shows the standard ladder of liner DNA which can be used for giving an 
idea of the separation of DNA fragments a range from 200 base pair to 10000 base pair 
[121]. The DNA bands describe the separation of DNA size. 
7.5.5  Effect of different conditions on the plasmid DNA (pEGPF-N1) 
 
Figure 7-10: The effect of different sonoporation conditions on the pEGFP-N1. 
Figure 7-10 shows the effect of different sonoporation conditions on the plasmid DNA. 
Lane 1 shows a plasmid DNA marker. Plasmid DNA without sonoporation is shown in 
lane 2 and 6 respectively. Lane 3, 4 and 5 show the plasmid DNA after sonoporation 
conditions and a range of exposure time from 5 to 15 seconds at 90Vp-p were applied. Chapter 7 Sonoporation of HeLa cells and DNA 
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Finally, lane 7, 8 and 9 presents the plasmid DNA after the sonoporation conditions and 
exposure time from 5 to 15 seconds at 100Vp-p were applied. Sonoporation did not 
alter DNA integrity at 90Vp-p. At 100 Vp-p, the DNA appears to be fragmented in 2 
out of 3 samples; however, this result was not indicated of serve degradation which 
would appear as a smear on the gel. Each plasmid DNA from this experiment was not 
obtained a significant affect by sonoporation conditions. If there was any degradation 
that occurred during the process, it would appear clearly on the agarose gel and the 
GFP expression would be visible at the end of process. This study showed that the 
separation of DNA fragments result varied from 400 base pairs to 1000 base pairs as 
shown in the figure 7-10 and related in the standard DNA ladder as shown in figure 
7-9. The DNA size was obtained similarly in the lane 2, 3, 4 and 5. However the DNA 
band (4000 base pair) obtained in lanes 7, 8 and 9 were a little different from that in 
lanes 3, 4 and 5. In addition, the result in lane 8 of the DNA size appears to shown an 
affect on the structure and intensity of the plasmid DNA. These results were dependent 
upon the amplitude of sonoporation conditions and exposure times. To summarise, the 
different sonoporation conditions have shown no significant effect on the plasmid DNA 
size. After the plasmid DNA was sonoporated under various conditions, it appears not 
to be degraded. 
7.6  Conclusion 
This chapter has described the performance of the sonoporation system when operated 
at its resonant frequency. This chapter has also presented the details of the preparation 
of plasmid DNA. The sonoporation system at resonance has demonstrated superior 
transfection to previous work whilst maintaining cell viability. This work identified that 
a minimum operating voltage of 80V is required with the optimal voltage appearing to 
be between 90Vp-p and 100 Vp-p. Exposure time also influences results with the 
optimal time being between 10 and 15 seconds. An exposure time of 20 seconds was 
shown to damage the cells. It was also demonstrated that the different sonoporation 
conditions appear not affect the plasmid DNA. The standing wave in the chamber 
produces optimal conditions for achieving sonoporation. The resonant sonoporation 
process achieves consistent results and enables a high degree of control over the 
process by varying voltages and exposure time. These results support the theory in Chapter 7 Sonoporation of HeLa cells and DNA 
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section 2.4.1 that conducting sonoporation with a resonant chamber that sets up a 
standing wave is of benefit. 
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Chapter 8   
Experiment of Sonoporation   
THP-1 and DNA (pEGFP-N1) 
8.1  Introduction 
The purpose of this chapter is to present the initial investigation of the sonoporation 
system on THP-1 cells (Human monocytic leukemia). The sonoporation system has 
shown promising transfection efficiency for HeLa cells as presented in chapters 6 and 
7. In order to evaluate the performance of sonoporation system, THP-1 cells and 
plasmid DNA (pEGFP-N1) were used. The chapter also describes the experimental 
methodology used in the preparation of the THP-1 cells and the procedure for 
measuring transfection efficiency and cell viability. Transfection efficiency and cell 
viability were determined under a range of frequencies from 950 KHz to 1.29MHz, 
fixed sinusoidal frequency 980 KHz and fixed amplitude (90 Vp-p). All of these are 
given a range of exposure times from 5 to 20 seconds. The results of the efficiency of 
transfection and cell viability are presented. Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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8.2  Material and method 
8.2.1  Procedure A: prepare of culture of cells (THP-1 cells) 
In this experiment, all human monocytic leukemia cell lines were provided by the 
University of Southampton, school of Medicine. The THP-1 cell line was maintained in 
culture media of RMPI-1640 (Gibco, UK) supplemented with L-glutamine, 
Penicillin/Streptomycin, and 10% of fetal calf serum (FBS). The THP-1 cell lines were 
grown in 75 cm
3 flasks with 20 ml of culture medium in a humidified atmosphere of 
95% air and 5% CO2 at 37 ºC [20].  
8.2.2  Procedure B: Prepare of Plasmid DNA (pEGFP-N1) 
In this study, the GFP plasmid deoxyribonucleic acid (DNA) was provided by the 
University of Southampton, school of Medicine. Preparation of plasmid DNA is the 
same as procedure A in section 6.2.1. A concentration 50 µg/ ml of GFP plasmid was 
added to the THP-1 cell culture medium before sonic exposure. 
8.2.3  Procedure C: Determine the number of cell counts by using a Hemocytometer 
Prior to determining the transfection efficiency and cell viability, the total number of 
THP-1 cells line was counted. In order to count the number of cells the Hemocytometer 
(Hausser Scientific, Horsham, PA) was used. Then the number of THP-1 cells was 
counted and recorded. This procedure can also be followed and used the same 
procedure which was presented in section 5.2.4. 
8.2.4  Procedure D:  Sonoporation with THP-1 cells line and plasmid pEGFP-N1 
First, the THP-1 cells (1 ml) were mixed thoroughly with the plasmid pEGFP-N1 
(50µl) in an eppendorf tube and incubator at 4 ºC. 100μl of THP-1 cells and plasmid 
pEGFP-N1 was transferred into the sonoporation chamber using syringe pump (1ml). 
20μl of the THP-1cell lines suspensions was introduced into sonoporation chamber. In 
this chapter, there are two different frequency conditions were used to investigation 
transfection efficiency and cell viability as followed. Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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•  A range of frequencies from 950 KHz to 1.29 MHz and fixed voltage (90Vp-p) 
were applied continuously for exposure times 5, 10, 15 and 20 seconds 
respectively 
•  A fixed sinusoidal frequency (980 KHz) and fixed voltage (90Vp-p) were 
applied continuously for exposure times 5, 10, 15 and 20 seconds respectively. 
The experimental sonoporation results are presented in sections 8.3.3 and 8.3.6. THP-1 
cells and plasmid pEGFP-N1 were sonicated under different frequency conditions and 
exposure times. After sonoporation was performed, the 20μl of cells suspension each 
condition was transferred into the eppendorf tube centrifuge tube and keep at 4ºC on 
ice. Then each 20μl of THP-1 had 300μl of fresh medium RPMI 1640 added and each 
was deposited into one well of a 24 well plate. Next the cells were incubated for 48 
hours in a 37 ºC 5% CO2  humidified incubator. After 48 hours, THP-1 cells in 
suspension were collected into a centrifuge tube, if cells were attached to the plates and 
then they were washed with PBS (200μl), which was also collected into the same 
centrifuge tube. Subsequently, cells were centrifuged for 5 min at 3000 rpm and the cell 
pellets were resuspended (300μl) in PBS (100μl). Finally, 180μl of the cells were 
transferred into the centrifuge tube for determining the transfection rate as described in 
section 8.2.5. 10 μl from the sonoporated THP-1 cells were taken and left aside for cell 
viability experiment in the procedure E. These were incubated at 4 ºC. 
8.2.5  Procedure E: determine transfection efficiency and cell viability  
In order to calculate the transfection efficiency and cell viability, samples of THP-1 
cells after sonoporation were prepared. The determination of the transfection and cell 
viability followed the procedure in section 6.2.7 and 6.2.8. The transfection efficiency 
of THP-1 cells was analysed using flow cytometry (Becton Dickinson FACScalibur 
Flow Cytometry). The cell survival was analysed using Trypan blue (SIGMA) staining. 
In order to observe stained cells, microscopy and haemocytometer were used in this 
experiment. Fluorescent GFP uptake in THP-1 cells was detected by FL1 channel. The 
result of data from flow cytometry was analysed by Cell Quest software pro. Each 
sample of THP-1 cells was identified on the forward-scatter (FS) vs. side scatter (SSC) 
plots. These results are shown in section 8.3. Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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8.2.6  Procedure C: Sonoporation setup  
Sonoporation setup details are shown in figure 8-1. The sonoporation system is a TTi 
40 MHz, Arbitrary waveform generator (TGA 1241), high power amplifier (AG Series 
Amplifier T&C Power conversion, Inc and sonoporation chamber. Sonoporation 
experiments were performed at room temperature (25 ºC). The transducer was applied 
by a signal from a function generator (Tektronix TGA 1241) set to generate range 
frequencies from 950 KHz to 1.29 MHz and the second condition is fixed sinusoidal 
frequency of 980 KHz. This sinusoidal frequency was amplified by the high power 
amplifier (0.15-230 MHz). Amplitude is fixed at 90 Vp-p and drives the ultrasound 
transducer. The amplitude across the transducer was measured by an oscilloscope. The 
sonoporation system was performed with the fixed sinusoidal frequency in continuous 
wave mode. It was used depending on the experiment as we can see in more details in 
sections 8.3.3, 8.3.4, 8.3.5 and 8.3.6. The THP-1 cultured cells were harvested in fresh 
medium (RPMI 1640) and mixed with pEGFP-N1 (50 µg/ml) prior to experiments. 
 
 
Figure 8-1: Schematic diagram of the sonoporation system with THP-1 Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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8.2.7  Statistic of transfection efficiency and cell viability 
The result of transfection efficiency and cell viability on each graph are presented as 
mean and standard error of mean (±SEM). In this study, analysis of variance (ANOVA) 
was used to analysis all experiments. Independent experiments were performed at least 
three times (n≥3). SPSS statistics 17.0 (SPSS Inc., Chicago, Illinois) was used to 
analyse each experiment. ANOVA was a flexible technique which was easy to compare 
more than one set of means at the same time. A value of p< 0.05 is a level of 
significance. We reject Ho at p< 0.05.  
8.3  Measurement of impedance of the sonoporation chamber 
This section describes the experimental investigation of the sonoporation chamber. In 
this study, the impedance of the sonoporation chamber was determined in order to 
determine the resonant frequency as described in section 7.2.2 .This was done because 
a different sonoporation chamber had been manufactured for this set of experiments. 
The impedance of the sonoporation chamber was evaluated under three different 
conditions. 
•  Sonoporation chamber filled with air.  
•  Sonoporation chamber is filled with water (20µl) which is volume of the 
sonoporation chamber. 
•  The sonoporation chamber is filled with THP-1 (80,000 cells per 20 µl).  
8.3.1  Experiment results: Impedance of sonoporation chamber with Air and water  
This section presents the experimental evaluation of the sonoporation chamber. The 
impedance of the sonoporation chamber was investigated under two different 
conditions. First, the sonoporation chamber is evaluated when it was filled with air. The 
second condition, the sonoporation chamber is filled with water. 20 μl of water was 
transferred into the sonoporation chamber in order to measure impedance of 
sonoporation chamber. Figure 8-2 shows the measured frequency response of the 
sonoporation chamber from 0.5 MHz to 2.5 MHz. The maximum impedance of the 
sonoporation chamber when it was filled with air of 692.62Ω presents at 1.02 MHz and Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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the maximum impedance of the chamber when it was filled with fluid of 667.8 Ω 
occurs at 1.03 MHz. However, the fluid layer resonance can be identified at 965 kHz. 
 
Figure 8-2: Measured impedance of air (blue line) and water (red line) of sonoporation 
chamber from 0.5 MHz to 2.5 MHz 
8.3.2  Experiment results: Impedance of sonoporation chamber with THP-1cell 
lines  
In this experiment, the preparation of THP-1 cell followed the procedures B and C in 
section 8.2.2 and 8.2.3 respectively. 20μl of THP-1 cells was transferred into fluid layer 
of the sonoporation chamber using syringe pump (1ml). Then 20μl of the THP-1 was 
presented into sonoporation chamber. The impedance of sonoporation chamber was 
measured when it was filled with THP-1 cell line. Consequently, the impedance data of 
sonoporation chamber with THP-1 cells presents in figure 8-3. Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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Figure 8-3: Impedance of sonoporation chamber with THP-1 (4,000,000 cells/ml) 
 
Figure 8-3 illustrates the impedance of resonant sonoporation chamber with THP-1 
cells from 0.5 MHz to 2.5 MHz. The concentration of THP-1 (4,000,000 cells/ml) was 
used in this experiment. It can be seen that the plot presents the maximum impedance 
of sonoporation chamber when it was filled with THP-1 cells of 987.09 Ω, occuring at 
1.1MHz. Again, the fluid layer resonance is seen at approximately 980 KHz. It is 
similar to when the sonoporation chamber is filled with fluid. 
8.3.3  Transfection efficiency versus a range frequency result 
The sonoporation chamber was used to determine transfection efficiency based on 
range frequencies. This study has observed that sonoporation system can be used to 
uptake plasmid DNA (pEGFP-N1) into THP-1 cells. The sonoporation system was 
investigated based on a range of frequencies from 950 KHz to 1.29 MHz as before and 
exposure time for 10 sec. This experiment investigated transfection efficiency with 
independent experiments three times. Table 8-1 shows the transfection efficiency Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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versus frequency. For instance, an applied frequency of 950 KHz gives 17 % ±SD5.1 
transfection efficiency. The maximum transfection efficiency of 50% occurs at 980 
KHz ±SD3.4. An example of histogram of control condition and transfection efficiency 
is shown in figure 8-4. Figure 8-4 shows 10% of control condition for exposure time 10 
seconds. From figures 8-5 to 8-8 show the dot plot and FL1 histogram graphs after 
sonoporation were applied for 950 KHz, 960 KHz, 970 KHz and 980 KHz respectively. 
It can be seen that the frequency of 980 KHz gives the high transfection efficiency 
when compare to other condition of each frequency and control condition. This result 
indicated that the resonant frequency (980 KHz) of the sonoporation chamber is a key 
factor uptake the plasmid DNA into cell membrane of THP-1 cells. 
Table 8-1: The transfection efficiency vs. frequency 
Frequency (KHz)  Transfection efficiency (%) 
950 17% 
960 12.4% 
970 20% 
980 50% 
 
 
Figure 8-4: Control condition Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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Figure 8-5: Sonoporation with sinusoidal frequency at 950 KHz 
 
Figure 8-6: Sonoporation with sinusoidal frequency at 960 KHz Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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Figure 8-7: Sonoporation with sinusoidal frequency at 970 KHz 
 
Figure 8-8: Sonoporation with sinusoidal frequency at 980 KHz 
In this experiment, the number of THP-1 cells was approximately 4,200,000 cells per 
ml.  Figure 8-9 clearly shows a change in transfection efficiency at 980 KHz. The 
region from 950 KHz to 970 KHz gives less than 20% transfection efficiency. At 980 
KHz, it shows a significant improvement of cell transfection and the highest 
transfection was obtained 45.53% ±SEM 4.5 (ANOVA p>0.05). Transfection 
efficiency has fallen after applying a frequency 1.07MHz and above, the transfection 
efficiency decreased to below 24% ±SEM 2.9 (ANOVA p>0.05). Therefore, this study Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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shows that acoustic frequency of 980 KHz can be used to transfect plasmid DNA 
withTHP-1. It can be concluded that the resonant frequency of sonoporation chamber 
was a key factor for cell transfection. 
 
Figure 8-9: The result of transfection efficiency THP-1 based on a range of frequencies 
from 950 KHz to 1.29 MHz 
8.3.4  Cell viability based on a range of frequencies (950 KHz –1.29 MHz) result 
Cell viability was established for each frequency using the trypan blue dye as described 
in section 8.2.5. A haemocytometer and bright field microscopy were used to observe 
and count the number of stained and unstained cells. Then percentage of viable cells 
can be calculated. Three independent samples of the cell viability results are shown 
in figure 8-10. Figure 8-10(a) shows the cells for the control condition which gives a 
cell viability of 83.7 % (±SEM 0.6). Figure 8-10 (b) shows the cell viability at 980 
KHz.  
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(a) Control condition 
 
(b) 980 KHz for 15 seconds 
Figure 8-10: cell survival observed by the microscope (a) control condition (b) 980 
KHz for 15 seconds 
Unstained THP-1cell 
Stained THP-1cell 
Unstained THP-1cell Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
  199
 
Figure 8-11: the result of cell viability THP-1 based on a range of frequency (950 KHz 
– 1.29 MHz) 
Figure 8-11 illustrates the result of cell viability of THP-1 under different acoustic 
frequency from 950 KHz to 1.29MHz. It can be seen that the acoustic resonant 
frequency had an important role in cell viability. The highest percentage of cell 
viability was 76.57%±SEM1.17 (ANOVA p>0.05) at 960 KHz. Additionally, this 
figure shows clearly acoustic frequencies between 980 KHz and 1.12 MHz gave a 
lower percentage of cell viability at 24.04%, 36.34% and 31.69% respectively 
(ANOVA, p>0.05). It should be noted that the GFP is not toxic and therefore higher 
transfection rates will not lead to increase cell death as a result of a GFP [122, 123]. 
8.3.5  Discussion 
Transfection efficiency is generally inversely proportion to cell viability but not in 
every case (e.g Figure 7-5). The results in Figure 8-10 show highest transfection 
efficiency at an acoustic frequency of 980 KHz. However, the cell viability is lower at 
980 kHz(see Figure 8-11). Therefore, in this case increased transfection efficiency has 
resulted in cell lysis. Also, the percentage of transfection is not as high as from 
previous experiments with HeLa cells. 
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8.3.6  Transfection efficiency with different exposure time and fixed frequency (980 
KHz) result 
This experiment hypothesis investigated exposure time in order to asses effects on 
transfection efficiency. This section presents the sonoporation system performed with 
THP-1 with fixed sinusoidal frequency (980 KHz) and a range of exposure times (5, 
10, 15 and 20 seconds respectively). FACS was used to determine transfection 
efficiency under these conditions. Transfection efficiency results show in figure 8-12. 
There are three independent of samples which were investigated in this study. In this 
experiment, one sample of control condition was kept separately to compare with the 
other conditions of sonoporation. From the figure 8-12 (a), it can be seen that the 
control condition presents 6.5%±0.81SEM (ANOVA p> 0.05) of transfection 
efficiency. The transfection efficiency increased slightly 9.21% ±2.26SEM (ANOVA 
p> 0.05) at exposure time 5 seconds relatively to control condition. In this study, 
exposure time from 5 seconds to 15 seconds did not significantly affect transfection 
efficiencies (9.21%±2.26SEM, 10.29%±1.47SEM and 8.89% ±1.1SEM respectively). 
However, the transfection efficiency achieved a peak at an exposure time of 20 
seconds. It was superior 95.04% ±1.23SEM (ANOVA p> 0.05) in figure 8-12(c). The 
effect of exposure time 20 seconds, the transfection efficiency gives rate enhancement 
up to fifteen times compared relatively with control condition. It can be concluded that 
this sonoporation condition can be used to enhance plasmid DNA in cell membrane 
permeability of THP-1 cells. Additionally, this result clearly presents transfection 
efficiency dependent on the exposure time. Consequently, the transfection rate would 
be increased.  Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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(a) Control condition 
 
(b) Exposure time for 5 seconds Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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(c) Exposure time for 20 seconds 
Figure 8-12: Histogram shows GFP expression (fluorescence) of (a) control condition 
5%± SD 2 (b) THP-1 cells and pEGFP-N1 after sonoporation for exposure time 5 
seconds (12%±SD4.9) (c) histogram of transfection efficiency of 93% ±SD5.4 for 
exposure time 20seconds 
8.3.7  Cell viability based on fixed frequency 980 KHz and different exposure time 
result 
Post sonoporated THP-1 cells were tested after 48 hours to determine the percentage 
cell viability. In this study, one control sample without sonoporation was kept for 
comparison with other sonoporation conditions. In this experiment, a haemocytometer 
and bright field microscopy were employed to observe and evaluate the number of cell 
surviving after sonoporation. Additionally, procedure E was used in this experiment. 
The number of viable cell was calculated by equation 5-3 from chapter 5.  
 Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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(a)  Control condition              
 
(b)  15 seconds exposure time 
Figure 8-13: The result of cell viability under different exposure time: (a) control 
condition (b) cell viability for exposure time 15 seconds (~56%). 
Figure 8-13 shows the result of cell viability after post sonoporated THP-1 with 
plasmid DNA (pEGFP-N1). In order to determine cell viability, it is necessary to keep 
THP-1 cells after sonoporation at room temperature until these cells were assessed. 
Unstained THP-1 cells 
Stained THP-1 cells 
Unstained THP-1 cells Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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Then these THP-1 cells were stained by trypan blue as using the procedure E and 
section 6.2.8. The first condition is the control condition as shown in figure 8-13 (a), 
with about 84.06% ±SEM 1.22 (ANOVA p>0.05) in the surviving population. Figure 
8-13 (b) showed about 84.40% ±SEM2.2 (ANOVA p> 0.05) of THP-1 cell viability at 
exposure time 5 seconds. The result of exposure time at 10 sec was similar to exposure 
time 5 seconds. It was approximately 85% ±SEM 0.85 (ANOVA p> 0.05). After 
increasing exposure time to 15 seconds, the mean of THP-1 cells viability declined to 
56.04% ±SEM 11.35 (ANOVA p> 0.05). Finally, the culture THP-1 cells dramatically 
dropped to 3.41% ±SEM 0.85 (ANOVA p> 0.05) for 20 seconds in cell viability 
population. For this experiment, it can be concluded that the exposure time of 20 
seconds has a significant affect on the viability. It also kills the majority of THP-1 cells. 
8.3.8  The combined result of transfection and cell viability based on fixed 
frequency 980 KHz and different exposure time 
 
 
Figure 8-14: the result of sonoporation with THP-1 
In this experiment, the number of THP-1 cells was about 4,375,000 cells per ml which 
was used to determine experimentally transfection efficiency and cell viability. Figure 
8-14 shows the combined result of transfection efficiency and cell viability in the same Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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graph. It can be seen that the highest peak of transfection efficiency was 
95.04%±1.23SEM (ANOVA p> 0.05), in contrast the cell viability was about 3.41% 
±SEM 1.8. at exposure time 20 seconds. This result indicated that most of THP-1 cells 
in this condition were killed due to exposure time of sonoporation not being suitable 
and power output across the transducer was too high ( ~ 100 Vp-p) for THP-1 cells. It 
can be concluded that successful transfection depends upon the exposure time, resonant 
frequency of the sonoporation chamber and power output at the transducer. The number 
of cells damaged increased due to the exposure time and power output of transducer. 
Consequently, the number of surviving cells decreased. 
8.3.9  Other methods transfection efficiencies and cell viability of THP-1 from the 
literature 
Table 8-2: The transfection efficiency and cell viability of THP-1 cells from other 
researchers 
Method  Type of cells  Efficiency  References 
Transfection Cell viability 
Modified 
Nucleofection-
base 
THP-1 
macrophages 
40%  75%  Schnoor, M., et 
al. [16] 
Modified 
Nuleofecttion-
base 
THP-1 monocytes  50%  80%  Schnoor, M., et 
al. [16] 
Nucleofection THP-1  monocytes, 
pEGFP-N3 
80%  -  Martinet et al 
[124] 
Electroporated THP-1,  pGL3  -  13.25%  Shimokawa,  T. 
et.al [125] 
 
Table 8-1 illustrates transfection efficiencies and cell viability percentages based on 
THP-1 cells from other researchers. These examples are the closest found in terms of Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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type of cells presented here. For example, 40% transfection efficiency and 75% of cell 
survival were successful in THP-1 cell using modified Nucleofection by Schnoor, M., 
et al. [16]. 50% of transfection efficiency was achieved by Schnoor, M., et al. [16].This 
study investigated transfection of THP-1 using the Nucleofector II and used the Human 
Monocyte Nucleofactor Kit. Moreover, 80% transfection rate was achieved by Martinet 
et al [124]. This research studied gene delivery into THP-1 cells via Nucelofector 
technology. The results of our experiment with a range frequency (45.53%±SEM 4.5) 
show similarly transfection efficiencies when compared to these other experiments [16, 
124, 125]. Additionally, the result of experiments with a fixed sinusoidal frequency 
showed a higher transfection efficiency 95.04%±SEM1.23 (ANOVA p> 0.05) but it 
was not achieved cell viability when compared to other researchers [16, 124, 125].The 
work presented here uses an ultrasonic standing wave chamber operated deliberately at 
its resonant frequency. It is believed that this is the main key to the success of this 
work. The method reported here has produced high transfection efficiency results but it 
also kills the majority of THP-1 cells.  
8.4  The comparison of transfection efficiency and cell viability of 
THP-1 and HeLa cells 
This section presents the comparison of transfection efficiency and cell viability of 
THP-1 cells and HeLa cells. The aim of this is to verify the sonoporation system can be 
used in different types of cells. Table 8-3 shows the comparison of transfection 
efficiency and cell viability based on a range of frequencies. It can be seen that HeLa 
cells have a higher transfection efficiency and cell viability than THP-1 cells. The 
maximum transfection efficiency 62% occurred at 980 KHz. However, it also affected 
the cell viability. It can be concluded that the sonoporation system is able to transfect 
both types of single cell lines. 
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Table 8-3: The comparison of transfection efficiency and cell viability based on range 
frequencies 
Frequency 
(Hz) 
THP-1 cells  HeLa cells 
Transfection 
efficiency (%) 
Cell viability (%)  Transfection 
efficiency (%) 
Cell viability (%) 
950 KHz  19%  66%  17%  74% 
960 KHz  14%  76%  16%  79% 
970 KHz  15%  73%  19%  74% 
980 KHz  45%  24%  62%  46% 
1.12 MHz  38%  31%  30%  64% 
1.29 MHz  17%  62%  19%  80% 
 
8.5  Discussion and conclusion 
This chapter has described the experiments of sonoporation with THP-1 and plasmid 
DNA (pEGFP-n1). The experiment was aiming to demonstrate that the sonoporation 
system induced enhancement of plasmid DNA (pEGFP-N1) uptake into the THP-1 
cells. There were two types of experimental results involving the transfection efficiency 
and cell survival. This study demonstrated the procedure of cell culture (THP-1) and 
plasmid DNA. Also sonoporation apparatus and impedance of sonoporation chamber 
with THP-1 cells were explained in this chapter. The resonance conditions of the 
chamber were established. Then, the sonoporation chamber was used to investigate 
sonoporation with THP-1 and plasmid DNA (pEGFP-N1) under a range of frequencies, 
and a range of exposure times with a fixed sinusoidal frequency (980 KHz). The study 
shows that sonoporation can be achieved. The highest transfection rate of 
45.53%±SEM 4.5 (ANOVA p>0.05) was attained at 980 KHz as shown in figure 8-12. 
Studies have shown that cell viability was a peak 76.57%±SEM1.17 (ANOVA p>0.05) 
at 960 KHz. However, 24.04% (ANOVA p>0.05) was achieved at 980 KHz. Four 
different times were used in the experiment of fixed sinusoidal (980 KHz), and these Chapter 8 Experiment of Sonoporation with THP-1 and DNA 
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were 5, 10, 15 and 20 seconds. The data showed that maximum transfection efficiency 
of 95.04%±SEM1.23 (ANOVA p> 0.05) was attained at exposure time 20 sec. 
However, the cell viability was very low at 3.41% ±SD1.8. It can be concluded that 
exposure time and high voltage across transducer leads to damage in THP-1 cells. From 
the previous chapters shown similar results that the majority of HeLa cells were killed 
when exposure time of 20 seconds and applied the high voltage to the sonoporation 
chamber. The sonoporation chamber offers high transfection efficiency with both types 
of cells at its resonant frequency.  
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Chapter 9   
Conclusion and Future work 
9.1   Conclusion  
This thesis describes the development towards a microfluidic system for cell 
transfection using sonoporation and electroporation. The results obtained have defined 
the development of an ultrasonic microfluidic chamber for biological applications that 
combines sonoporation and ultrasonic cell manipulation. In addition a study was also 
conducted into an electroporation system for cell poration. This is all described in more 
detail in the next section.  
9.1.1  Sonoporation method 
This research has built upon the analytical models developed during the design of the 
ultrasonic cell manipulator, which have been used to design and fabricate the chamber. 
To produce the sonoporation chamber, it is also necessary to determine the acoustic 
pressure and acoustic energy in the acoustic chamber as described in chapter 3. The 
value of acoustic pressure, and acoustic energy should be sufficient to achieve 
sonoporation. Therefore, the prototype of the sonoporation system has been assembled 
with dimensions 38 by 56 mm, and a fluid chamber depth of 0.75mm. Additionally, the 
thickness of the matching and reflector layers should be 2.3 mm and 1.2 mm 
respectively. The simulation result indicated an energy density at 43 Jm
-3 in the 
chamber at a resonant frequency of 1.0MHz. Experimental measurements of the 
impedance of the transducer have been performed to validate the simulated result. The Chapter 9 Conclusion and Future work 
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measured impedance of the PZT transducer indicates a resonant frequency of 1.1MHz 
which compares well with the fundamental frequency of 1MHz. This research presents 
a theoretical analysis used to design the sonoporation chamber, whilst also enabling 
ultrasonic cell manipulation using an ultrasonic standing wave as described in chapter 
3. An analytical model developed by previous researchers was used to design a system 
that can be used to perform ultrasonic cell manipulation and achieve sonoporation 
within the same chamber. Both the sonoporation and the cell manipulation are achieved 
using the same piezoelectric transducer (PZT 26) mounted on the micro chamber. 
Ultrasonic cell manipulation is able to control both cell and DNA location within the 
chamber and is able to place cells and plasmid DNA in close proximity. Experimental 
measurements of the impedance of the sonoporation chamber with biological cells have 
been performed using different concentrations of HeLa cells and THP-1 cells. The 
measured impedance of the sonoporation chamber indicated a fluid resonant frequency 
(980 KHz) which can be used to study transfection efficiency and cell viability. 
Further, it has been established that operating at this resonant frequency gives 
significantly improved transfection compared with other frequencies. This thesis has 
also described the material and methods which were used in the sonoporation 
experiment. This study has also demonstrated the preparation and culturing of cells 
which included HeLa cells and THP-1 cells. Moreover, this study has also described 
the preparation of plasmid DNA (pEGFP-N1) used generally to study the transfection 
efficiency and cell viability. 
A range of sonoporation conditions have been investigated in this thesis. In more detail 
for the sonoporation system, experiments were performed based on a fixed frequency, 
sweep frequency, a range of exposure times and excitation voltages, as these were 
identified as the main variables affecting cell transfection and viability. FACS scanning 
was used to analyse transfection efficiency, and trypan blue staining was used for 
checking cell viability. Typically, live cells with intact cell membranes do not absorb 
the stain; however dead cells are shown as a distinctive blue colour under a microscope. 
The key factor in achieving successful transfection efficiency and level of cell viability 
is the applied voltage, exposure time and resonant frequency. This work shows the 
sonoporation combined with cell manipulation is able to achieve significant 
transfection. Additionally, the sonoporation chamber has been demonstrated to achieve Chapter 9 Conclusion and Future work 
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successful transfection of 2 different biological cell lines as described in chapter 6, 7 
and chapter 8, with the results comparing very favorably with published research. 
 
9.1.2  Electroporation method 
This research has also developed an electroporation circuit, suitable for integration into 
the sonoporation system. A range of electroporation conditions has been presented in 
this thesis, and used to investigate the poration rate and cell viability when applied to 
HeLa cells. The results show that the performance of this system is comparable with 
the published literature. However, the resonant sonoporation system showed much 
more potential for improving over other reported results, and so the performance of the 
electroporation system was not investigated with other cell lines, as there was no reason 
to believe that the results would be any different from the literature. 
9.2  Future work 
This thesis has started with the aim of informing the design of a combined system using 
both sonoporation and electroporation to increase the range of cells for which poration 
can be achieved, as described in section 1.1. Although this ambitious aim has not been 
fully realised, significant progress has been made towards this aim, with the 
demonstration of effective sonoporation within a resonant field for 2 cell lines, 
manipulation of the cells within the same device by acoustics, and the potential for 
including electroporation within the same system. In order to realise the vision, some 
extra work will need to be done. 
 
9.2.1  Further development of the microfluidic system for cell transfection using 
sonoporation  
This further work is required to develop and refine the microfluidic system for cell 
transfection using sonoporation. The important parameters for cell transfection and cell 
viability of this system included acoustic field strength and acoustic application time Chapter 9 Conclusion and Future work 
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for sonoporation. These parameters need to be considered in order to more fully 
understand the impact on cell viability. The sonoporation experiments have indicated 
that the resonant frequency has a significant influence on the transfection efficiency 
and cell viability. The system was not intended to accurately quantify the resonant 
frequency due to the control being open loop. Converting the control system to a closed 
loop system would much improve the repeatability of the process, allowing a more 
detailed study of the effects of resonance, transfection and cell viability activity. 
9.2.2  Investigate the sonoporation and cell manipulation 
For future studies, the particle manipulation part should also be more closely integrated 
with the sonoporation process. Again more repeatable results are anticipated if the cells 
are more efficiently manipulated prior to sonoporation. Therefore more work is needed 
to evaluate the effect on viability of manipulation conditions, by studying viability 
across a range of conditions (power levels, frequency, time) for several cell lines. Once 
conditions have been established that maximise viability, close coupling with levels of 
sound to achieve sonoporation can be investigated. Manipulation of the cells prior to 
poration will enable the cells to all experience the same sonoporation field, leading to 
less variable and potentially improved rates of poration and viability. 
9.2.3  Combination the sonoporation and electroporation system 
In order to combine the electroporation and sonoporation systems, some more work is 
required on designing the chamber. This thesis has given the background research 
needed for this, and once this has been done, there needs to be a program of 
experiments to characterise the device. This is likely to be very intensive as there are 
many potential parameters that could be investigated, which may vary between cell 
lines. However, the result would be a realisation of the initial ambition of this research, 
and would provide future researchers with a significant tool for future investigation, 
and it is anticipated that applications of other cell lines such as neuron cells, or stem 
cells would be investigated. 
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;****************************************************************** 
;   This file is a basic code template for assembly code generation       * 
;   on the PICmicro PIC16F84A. This file contains the basic code    * 
;   building blocks to build upon.            *   
;                                                                * 
;   If interrupts are not used all code presented between the ORG     * 
;   0x004 directive and the label main can be removed. In addition    * 
;   the variable assignments for 'w_temp' and 'status_temp' can     * 
;   be removed.                                                   *                         
;                                                                                                                * 
;   Refer to the MPASM User's Guide for additional information on         * 
;   features of the assembler (Document DS33014).                         * 
;                                                                               * 
;   Refer to the respective PICmicro data sheet for additional            * 
;   information on the instruction set.                                     * 
;                                                                               * 
;   Template file built using MPLAB V4.00 with MPASM V2.20 and          * 
;   MPLINK 1.20 as the language tools.                                      * 
;                                                                               * 
;******************************************************************** 
;                                                                               * 
;    Filename:      Delay_5ms.asm                                               * 
;    Date:      8 March 2007                                              * 
;    File Version:                                                            * 
;                                                                               * 
;    Author:     Somphop Rodamporn                                          * 
;        School of Electronics and Computer Science              * 
;                                                                     *  
;******************************************************************* Appendix A 
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  list      p=16F84A            ; list directive to define processor 
  #include <p16F84.inc>   ; processor specific variable definitions 
  __CONFIG   _CP_OFF & _WDT_ON & _PWRTE_ON & _XT_OSC 
; '__CONFIG' directive is used to embed configuration data within .asm file. 
; The lables following the directive are located in the respective .inc file. 
; See respective data sheet for additional information on configuration word. 
;***** VARIABLE DEFINITIONS (examples) 
; example of using Uninitialized Data Section 
;INT_VAR       UDATA     0x0C    
;w_temp        RES     1           ; variable used for context saving  
;status_temp   RES     1          ; variable used for context saving 
; example of using Overlayed Uninitialized Data Section 
; in this example both variables are assigned the same GPR location by linker 
;G_DATA        UDATA_OVR           ; explicit address can be specified 
;flag                   RES     2             ; temporary variable (shared locations - G_DATA) 
;G_DATA       UDATA_OVR    
;count              RES     2             ; temporary variable (shared locations - G_DATA) 
TMR0             equ  1 
COUNT1        equ 0CH    ; count is file 0C , a register to count event 
COUNT2       equ 0DH    ; count is file 0D , a register to count event 
counta            equ 0EH 
countb            equ 0FH 
;********************************************************************** 
RESET_VECTOR  CODE    0x000       ; processor reset vector 
            goto    start             ; go to beginning of program 
INT_VECTOR   CODE    0x004        ; interrupt vector location 
MAIN    CODE 
;************************************************************************ 
; Configuration section Appendix A 
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;************************************************************************ 
start 
  bsf  STATUS,RP0 
  movlw  b'00000011' 
  movwf  TRISA 
                  movlw b'00000000' 
  movwf  TRISB 
  bcf      OPTION_REG,7 
                  bcf  STATUS,RP0 
                 clrf PORTA 
                 clrf PORTB 
;***********************************************************************         
         movlw  0FF                                               ;Deselect 
         movwf PORTA      ; ... all rows on keypad 
        SW0            btfsc  PORTA,0      ;Is A0 clear? 
        goto   SW1              ;No 
       bsf    PORTB,0       ;Yes, Send Pulse 100 us, 5ms  
        bcf    PORTB,1 
        call Delay_100 
        bcf  PORTB,0 
        bsf  PORTB,1 
        call Delay_5                   
         SW1           btfsc  PORTA,1      ;Is A1 clear? 
        goto   SW0                            ; goto SW0  ;No 
        bsf    PORTB,0      ;Yes , Display 4 
        bcf    PORTB,1 
        call   Delay_100 
        bcf    PORTB,0 
        bsf    PORTB,1 Appendix A 
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        call  Delay_10 
        goto  SW0 
        Delay_5      movlw  0x15 
        movwf  counta 
        down2        call  Delay_200 
        decfsz  counta,1 
        goto down2 
        return 
Delay_10    movlw 0x31 
       movwf counta 
down3        call Delay_200 
        decfsz  counta,1 
         goto  down3 
         return  
Delay_100  movlw 0x20 
        movwf countb 
down           decfsz countb,1 
         goto down 
         return 
Delay_200  movlw 0x42 
       movwf countb 
down1        decfsz countb,1 
        goto down1   
       return 
        END                     ; directive 'end of program'  Appendix B 
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%run new model to calculate the Performance number, Electrical impedance and so on  
%for Ultrasonic Cell with arbitrary layered resonator and arbitrary termination 
 
clear,clc 
  
t3=0; %2.5; %thickness of matching layer is 2.5 mm. 
t3=t3*1e-3; 
  
t5=0; %1.2; %thickness of refector = 1.2 mm. 
t5=t5*1e-3; 
  
L0=Transducer;  %data from the transducer 
[nw,L]=Layers;  %data regarding each layer.  nw is the liquid layer 
  
%t4 = [0.75]%fluid layer is fixed (750 micorn milimeter) 
%t4=t4*1e-3; 
%   Structure of L0 is [Rm;Re;alpha;M;K;C0;S] 
%       where Rm and Re are the mechanical and electrical losses, alpha is the  
%       e-m transformer ratio, M and K are the equivalent mass and stiffness respectiveley, 
%       C0 is the static capacitance and S the area. Appendix D 
  221
  
%   Structure of L is t=L(1,:); rho=L(2,:); c=L(3,:); U=L(4,:); 
%       where rows are thickness, density, sonic velocity and 1/Q for each layer, respectively 
 %L(1,3)=470e-6;  
f=[0.5e6:7.5e3:2.5e6]; % Frequency start from 500KHz to 2.5MHz   
%--------------------------------- 
% t3=[1.5:0.1:3]*1e-3;% pervious version t2= [171:2:209]*10e-6 Varying thickness 
n=length(t3); 
m=length(t5); 
EnergyD=zeros(n,length(f)); 
PerfNumber=EnergyD; 
Pall=zeros(62,n,4); 
for T=1:n 
      L(1,3)= t3(T); 
      for T1=1:m 
        L(1,5)=t5(T1); 
        [PZ,Pxout,xout]=us_force(L0,L,nw,f,60);  
        %[PZ,Pxout,xout]=us_sep(L0,L,nw,f); 
        Ze=PZ(1,:); %electrical impedance                            
        Ye=PZ(2,:); %electrical admittance 
        Zim=PZ(3,:); %mechanical impedance 
        V=PZ(4,:);   %Voltage applied to the input terminals of transducer 
        F=PZ(5,:);   %force at the boundary between matching layer and liquid 
        Pin=PZ(6,:); %input power 
        El=PZ(7,:); %the stored energy in the liquid 
        PN=PZ(8,:); %the performance number 
        %------------------------------------------------- 
        EnergyD(T,:)=El/(L(1,4)*L0(7)); 
       I=find(EnergyD(T,:)==max(EnergyD(T,:))); Appendix D 
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       Maxen1(T,T1) = EnergyD(T,I); 
       Frequres(T,T1)=f(I); 
       Pxout = abs(Pxout); % Change from complex to vector 
       r= abs(Ze); 
      end; 
      end;   
%This program calculate the thicknees of each layer 
function [nw,L]=layers 
% parameters for all layers in Cardiff cell     
    nw=4;% The number of the liquid layer 
     t1= 0; %(10 e-16 pervious data)(2~10um),thickness of silver electrode 
    rho1=10.4e3; c1=3650;%properties of silver electrode 
    % pervious version Len=0.02; W=0.01; S=Len*W; %cross section of glue gap 
    U1=0; %U1=1/Q1; Q1=NaN; 
    L1=[t1;rho1;c1;U1]; 
    % parameters for silver electrode 
    t2= 10e-6; % (20 e- 6 pervious data) 15~80um, epoxy resin glue gap 
    rho2=2700; c2=1900; % (1900 + 30j pervious data )properties of gap 
    % pervious version Len=0.02; W=0.01; S=Len*W; %cross section of glue gap 
    Q2=100; U2=1/Q2; %Q2=NaN; 
    L2=[t2;rho2;c2;U2]; 
    % parameters for layer of glue gap between electrode and matching layer  
    % based on section 6.3 in Kinsler & Frey p 128 
      t3=3.1e-3; %thickness of matching layer 
    %rho3=2700; c3=6420;  Aluminum  
    %rho3=8640; c3=4250; %Brass  
    rho3=2520; c3=5631; % new is macro fiber glass % 7800 , 5995 pervious versiton c3 = 5995 + 10j 
properties of stainless steel 
    %rho3=1.293; c3=331.6;%properties of air 
    ft=3e6; Appendix D 
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    wres=2*pi*ft; 
    t3=(1/2)*(c3*2*pi/wres);%Aluminium layer thickness from Cardiff; 
    %pervious version Len=0.02; W=0.01; S=Len*W; %cross section of matching layer 
    %pervious version U3=0; %U3=1/Q3; Q3=NaN; 
    Q3 =300; 
    %Q3= 100;for Macro fiber glass  
    U3=1/Q3; 
    L3=[t3;rho3;c3;U3]; 
    %parameters for matching layer       
    t4=0.75e-3; %0.02; %chamber depth  !NB   Changed for force tests 
    rho4=1000; c4=1500; %properties of water 
    %rho4=1.293; c4=331.6;%properties of air (for no water)  
    Q4=800;%200;%2.5095e2 -5.0000e-001j;%a=1*(1+25e-15*(w/2*pi)^2);  
    %k=w/cw - j*a; %Q=k/2a; 
    U4=1/Q4;                               
    % Len=0.02; W=0.01; S=Len*W; %length and width of the cross section of the liquid cavity 
    L4=[t4;rho4;c4;U4]; 
    %parameters for liquid layer  
     t5=1.2e-3; %thickness of reflector 
    %rho5=8640 ; c5=4250; 
    rho5=2240; c5=5640; % Glass quartz  
    ft=3e6; % transducer resonance frequency 
    wres=2*pi*ft; 
    %t5=(3/4)*(c5*2*pi/wres);%thickness of steel plate 
    %Len=0.02;  W=0.01; S=Len*W; %length and width of the steel plate 
    Q5=300; U5=1/Q5; %Q5=NaN; old q=1000 
    L5=[t5;rho5;c5;U5]; 
    %parameters for layer of reflector in Cardiff cell 
     L=[L1 L2 L3 L4 L5]; Appendix D 
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This programme is to set up parameter of transducer 
function L0=transducer 
%Parameters used in transducer from the second data set by Cardiff 
  ft=3e6; %transducer resonant frequency 
  t=2e-3;%0.67~0.69mm %1880/ft; %thickness; %using t=1880/3.0e6=0.63e-3(m);  
  rho=6200 %7700; %Density of transducer 
  Len=0.01; 
  S=pi*((Len*Len)/4)% area of transducer disc (circula)  
  %r1=0.01; %dimeter of transducer 
  %S=pi*r1^2; 
  %Len=0.01;W=0.01; %30X30 but etched to 20X10;Transducer plate Length and width from Cardiff; 
  %S=Len*W; %area of transducer plate  
  Kc=0.57;%0.48;%85;%electromechanical coupling factor 
  Qm=2000;  %(1000~3000);%mechanical quality factor 
  dc=1340; %1340  %1320~1360;%dielectric constant 
  tanB=0.003; %tangent of loss angle 
  dc1=dc*(1-j*tanB); %complex dielectric constant 
  perm0=8.85e-12; %Permittivity of free space 
  Ks33=830; d33=374e-12; cE33=5.3e10;  
  % Density and characteristic constants from Morgan Matroc handbook 
  % And from Berlincourt Curran and Jaffe% 
  cD33=10.6e10*(1-j/(2*Qm));%10.6e10;%Open circuit stiffness of PZT (consider Q>>1 ref: Groschl 
paper) 
  e33=cE33*d33; %piezoelectric e constant 
  Cablen=0.;% 1.25; %Cable length 
  Cc=Cablen*75e-12;%cable capacitance 
  C0=dc1*(1/(4*pi*9e9))*S/t;    % dc0=1/(4*pi*9e9) %Static capacitance 
  %C0=Ks33*perm0*S/t; %Static capacitance 
  C0=(Cc+C0);%! 
     Appendix D 
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  M=rho*S*t/2; %Motional Mass 
  K=pi^2*cD33*S/(2*t); %Motional stiffness 
   
  Rm=3.2e2%1.3e2; %2.6 %2.9e2g_scale*5e2;% estimated mechanical losses in transducer 
  Re=5e4; %5e4;%Electrical losses - estimated 
   
  alpha=Kc*(K*C0)^(1/2); %Kc^2/alpha^2=1/(K*C0); electro-mechanical transformer 
  %alpha=S*e33/t; %Turns ratio of electro-mechanical transformer     
  L0=[Rm;Re;alpha;M;K;C0;S];  
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